cartagena, colombia october 8-10 - ishcsf 2016 abstract book.pdf · hydrocephalus 2016 cartagena,...

Hydrocephalus 2016Cartagena, ColombiaOctober 8-10The Eighth Meeting of the International Societyfor Hydrocephalus and CerebrospinalFluid Disorders

Hilton Cartagena Hotel

HospitalUniversitarioFundacion Santa Fe de Bogota

AS

OCI

ACION COLOMBIAN

A

DE NEUROCIRUGIA

www.hydrocephalus-meeting.com

ABSTRACT BOOK

The 'International Society for Hydrocephalus and Serebrospinals Fluid Disorders' (or) '“Hydrocephalus 2016” - Eighth Annual Meeting of the International Society for Hydrocephalus and Cerebrospinal Fluid Disorders (ISHCSF)' is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.

The '“Hydrocephalus 2016” - Eighth Annual Meeting of the International Society for Hydrocephalus and Cerebrospinal Fluid Disorders (ISHCSF)' is designated for a maximum of (or 'for up to') 18 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.

EACCME creditsEach medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. The EACCME credit system is based on 1 ECMEC per hour with a maximum of 3 ECMECs for half a day and 6 ECMECs for a full-day event.

Hydrocephalus 2016Cartagena, Colombia

October 8-10

The 8th Meeting of the International Societyfor Hydrocephalus and Cerebrospinal Fluid Disorders



© Copyright 2016, The Organizing Committee of “Hydrocephalus 2016 Cartagena, the 8th Meeting of the International Society for Hydrocephalus and Cerebrospinal Fluid Disorders”Publications Management: ARTION Conferences & Events

http://www.hydrocephalus-meeting.com

3

PRESIDENT’S MESSAGE

Dear Colleagues,

I would like to personally welcome each one of you to the 8th Meeting of the International Society of Hydrocephalus and Cerebrospinal fluid Disorders which takes place in Cartagena, Colombia on 8 – 10 October 2016.

Cartagena is a fantastic and romantic city on the Caribbean, which guards the secrets of history in its balconies and old buildings, surrounded by narrow cobbled stones, with a pleasant weather all year round. This place was the door from the old continent to South America.

In the last years Cartagena has hosted many important political meetings, medical conferences, music movie festivals, making it an attractive safe place to visit. This is going tο be a unique experience taking into account that this city is a world cultural Heritage.

It was here in Colombia where Normal pressure Hydrocephalus was first described, by Dr. Salomón Hakim. All colleagues around the world who have joined us, will be sharing all their knowledge in cerebrospinal fluid disorders, while the experts in this topic will be exposing the latest advances in the diagnosis and treatment of these pathologies. We will be also presenting the results of the most recent investigations in CSF dynamics which are new to everyone.

We wish you a wonderful stay in Cartagena.

Best Regards,

Fernando HakimHydrocephalus 2016 President

4

President: Fernando Hakim

Members: Gunes AygokHernando CifuentesRodolfo HakimMark HamiltonHazel JonesMarianne JuhlerUwe KehlerBryn MartinJuan F. RamónShirane ReizoDaniele RigamontiLaurence WatkinsMichael Williams

Hernando CifuentesRodolfo HakimJuan F. Ramón

INTERNATIONAL ORGANIZING& SCIENTIFIC COMMITTEE

LOCAL ORGANIZING COMMITTEE

MEETING SECRETARIAT

ISHCSF Core Professional Congress Organiser

E-mail: [email protected].: +30 2310 257808, +30 2310 272275

Meeting Director: Valentini AmarantidouDelegates & Accommodation Management: Kelly Angelaki Scientific Program Coordinator: Chara IgnatiadouMarketing Manager: Marianna GeorgitseliCommunications Manager: Maria KantziariIT Coordinator: Orestis Daniilidis

mailto:contact%40ishcsf.com?subject=

WWW.fluidsbarrierscns.biomedcentral.com

MembersoftheISHCSFsendyournextpapertotheofficialjournalofyourSociety:FLUIDSANDBARRIERSOFTHECNSoffersmembers:

• InternationalEditorialBoard• Expertreviewingandhighqualityproduct• Openaccesspublication(freetoviewworldwideviatheinternet)

• 25%discountonpublicationfee

FBCNShaspublishedfortheSociety:

• ThematicSeriesofreviewsandresearchpapers:Hydrocephalus:PromotingResearchforImprovedOutcomes

• AbstractsfromHydrocephalus2015inBanff,Canadahttp://www.fluidsbarrierscns.com/supplements/12/S1

• AbstractsforHydrocephalus2016tobepublishedshortly

EditorsinChief:[email protected](UniversityofMinnesota)HazelJones(King’sCollege,London)RichardKeep(UniversityofMichigan)

Program




Prog

ram

Program Overview

Hydrocephalus 2016The 8th Meeting of the International Society for Hydrocephalus and Cerebrospinal Fluid Disorders

9

PROGRAM OVERVIEW

Saturday, 8 October 201608:00 - 08:30 Registration

08:30 - 08:40 Welcome Address

08:40 - 18:00 Adult Hydrocephalus / Neuroradiology / Technical Advances in Treatment and Diagnosis

08:40 - 09:10 Keynote Speech


09:40 - 10:00 Oral Presentations

10:00 - 10:30 Coffee break & Exhibition



12:30 - 14:00 Industry-sponsored Lunch Seminar



15:30 - 16:00 Coffee break



19:30 - 23:00 Colombian dinner

Sunday, 9 October 201608:00 - 16:00 Congenital and Pediatric Hydrocephalus







12:00 - 12:30 E-Poster Presentations

12:30 - 14:00 Industry-sponsored Lunch Seminar




Program Overview


10


16:00 - 18:00 Presentations eligible for the Young Investigator Awards


18:00 - 19:00 ISHCSF AGM

20:00 - 23:00 Gala dinner

Monday, 10 October 201608:00 - 09:00 Experimental Hydrocephalus and Intracranial Pressure



09:00 - 15:00 Congenital and Pediatric Hydrocephalus



10:30 - 11:30 Round Table


12:30 - 14:00 Lunch break




15:30 - 18:00 IHIWG Meeting


Tuesday, 11 October 2016IHIWG Meeting

09:00 - 11:00 Pulsatility



11:30 - 13:30 CSF Flow and Solute Transport



14:30 - 16:30 Mixed Session


16:30 - 16:35 "Invitation to the Next IHIWG Symposium in Long Beach"

Detailed Program


11

Saturday, 8 October 2016

08:00 - 08:30 Registration

08:30 - 08:40 Welcome address

08:40 - 18:00 Adult Hydrocephalus / Neuroradiology / Technical Advances in Treatment and Diagnosis

Moderators: Marianne Juhler, Juan Fernando Ramón

08:40 - 09:10 KEYNOTE SPEECHBURDEN OF PROOFMichael Williams

09:10 - 09:40 KEYNOTE SPEECHINPH EPIDEMIOLOGYCarsten Wikkelsø

09:40 - 09:50 A COMPARISON OF FOUR ETIOLOGIC SUBTYPES OF ADULT HYDROCEPHALUS FROM THE AHCRN PATIENT REGISTRYNorman Relkin

09:50 - 10:00 APPLICATION OF A 980-NANOMETER DIODE LASER IN NEUROENDOSCOPY: A CASE SERIESFernando Campos Gomes Pinto


Moderators: Mauricio Toscano, Rodolfo Hakim

10:30 - 11:00 KEYNOTE SPEECHHEALTH ECONOMICS OF INPH: IS IT WORTH THE TIME, EFFORT AND COSTS?Michael Williams

11:00 - 11:10 ASSESSMENT OF COMMONLY USED SCALES TO EVALUATE NORMAL PRESSURE HYDROCEPHALUS (NPH) POST SHUNT SURGERYAtif Adam

11:10 - 11:20 ASSESSMENT OF THE DYNAMIC OF THE CEREBROSPINAL FLUID IN THE SPINAL CANAL OF HYDROCEPHALUS PATIENTSOlivier Balédent

11:20 - 11:30 ATROPHY OR NORMAL PRESSURE HYDROCEPHALUS?María Fernanda Cárdenas

DETAILED PROGRAM

Conference Room: Gran Salon Bolivar

Detailed Program


12

11:30 - 11:40 BARRIERS TO STANDARDIZING CARE FOR HYDROCEPHALUS IN THE MIDDLE EASTAtif Adam

11:40 - 11:50 COMPARISON OF LUMBOPERITONEAL SHUNT SYSTEMS USING SMALL LUMEN ABDOMINAL CATHETER VERSUS GRAVITAIONAL ADD-ON VALVE IN IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUSMadoka Nakajima

11:50 - 12:00 COMPLICATIONS POST VENTRICULAR-ATRIAL AND VENTRICULAR-PERITONEAL SHUNT IN NORMAL PRESSURE HYDROCEPHALUS PATIENTS: RESULTS OVER A TWO-YEAR FOLLOW-UP FROM A RANDOMIZED CONTROL TRIALAtif Adam

12:00 - 12:10 CREATING AN NPH PATHWAY FOR NEW REFERRALSSimon Thompson

12:10 - 12:20 CSF FLUID DYNAMICS IN CHIARI MALFORMATION: A MRI STUDY OF LONGITUTINAL IMPEDANCEMark Luciano

12:20 - 12:30 EARLY AND DELAYED QUANTITATIVE ASSESSMENTS ON TAP TEST FOR DIAGNOSIS OF IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUSMasatsune Ishikawa

12:30 - 14:00 Industry-sponsored Lunch Seminar Cartagena de Indias

Moderators: Daniele Rigamonti, Hernando Cifuentes

14:00 - 14:30 KEYNOTE SPEECHMRI OF HYDROCEPHALUS WITH THOUGHTS ON THE ETIOLOGY OF IDIOPATHIC NPHWilliam Guerin Bradley

14:30 - 14:40 ENDOSCOPIC THIRD VENTRICULOSTOMY IN NORMAL PRESSURE HYDROCEPHALUS PATIENTSKostas Fountas

14:40 - 14:50 EVALUATING BURDEN OF NORMAL PRESSURE HYDROCEPHALUS (NPH) IN THE MIDDLE EAST USING A POPULATION SCREENING METHODAtif Adam

14:50 - 15:00 EVALUATION OF HYDROCEPHALUS AFTER SEVERE OBSTRUCTIVE INTRAVENTRICULAR HEMORRHAGE AS A RISK FACTOR FOR POOR FUNCTIONAL OUTCOME IN THE CLEAR III TRIALWendy Ziai

15:00 - 15:10 IN VITRO COMPARISON OF ANTI-SIPHON MECHANISMS UNDER POSTURAL CHANGESManuel Gehlen

Detailed Program


13

15:10 - 15:20 INFLUENCE OF DIABETES MELLITUS ON CSF AND BRAIN CHARACTERISTICSEric Schmidt

15:20 - 15:30 NORMAL PRESSURE HYDROCEPHALUS – IS IT WORTHWHILE TO TREAT BEDRIDDEN PATIENTS?Uwe Kehler


Moderators: Carsten Wikkelsø, Carlos Hakim

16:00 - 16:30 KEYNOTE SPEECHMR ELASTOGRAPHY IN HYDROCEPHALUS: WHAT HAVE WE LEARNED FROM HUMAN AND ANIMAL STUDIES ABOUT ITS USEFULNESS AS A CLINICAL TOOL?Lynne Bilston

16:30 - 16:40 NORMAL PRESSURE HYDROCEPHALUS CLINICAL CARE PROGRAMMaría Fernanda Cárdenas

16:40 - 16:50 POTENTIAL MICRORNA BIOMARKERS FOR DIAGNOSIS OF IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUSMasakazu Miyajima

16:50 - 17:00 PROSA: THE ROLE IN THE MANAGEMENT OF INPHMichael J. Fritsch

17:00 - 17:10 REDUCING VENTRICULOPERITONEAL SHUNT MALFUNCTION IN THE ADULT PATIENTMark Hamilton

17:10 - 17:20 SIMULATION WORKSHOPS AND STANDARDISED CARE BUNDLES IMPROVE EXTERNAL VENTRICULAR DRAIN PLACEMENT AND DECREASE INFECTIONSDebayan Dasgupta

17:20 - 17:30 TELEMETRIC PRESSURE MONITORING: THE ROLE IN THE CLINICAL MANAGEMENT OF HYDROCEPHALUSMichael J. Fritsch

17:30 - 17:40 THE APOE GENOTYPE IN IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUSMats Tullberg

17:40 - 17:50 THE DISEASE STATE INDEX OUTPERFORMS CEREBROSPINAL FLUID TAP TEST IN SHUNT SURGERY OUTCOME PREDICTIONAntti Luikku

17:50 - 18:00 NUMERICAL MODELING OF THE CEREBROSPINAL SYSTEM: MRI AND SIMULATION TO DETERMINE HYDROCEPHALUS MECHANISMSOlivier Balédent

19:30 - 23:00 Colombian dinner

Detailed Program


14

Sunday, 9 October 2016


Moderators: Mark Hamilton, Hernando Cifuentes

08:00 - 08:30 KEYNOTE SPEECHPREVENT SHUNT INFECTIONS: HOW I DO IT?Richard Edwards

08:30 - 08:40 LOW-DOSE ACETAZOLAMIDE REVERSES PERIVENTRICULAR WHITE MATTER HYPERINTENSITIES IN INPHNoam Alperin

08:40 - 08:50 ANATOMIC FACTORS ASSOCIATED WITH POST-HEMORRHAGIC HYDROCEPHALUS AMONG PREMATURE INFANTS WITH INTRAVENTRICULAR HEMORRHAGEHannah Tully

08:50 - 09:00 CHANGES IN BRAIN TISSUE MECHANICAL PROPERTIES DURING HYDROCEPHALUS DEVELOPMENT IN ADULT AND YOUNG RATS ARE DIFFERENTLynne Bilston

09:00 - 09:10 CSF OUTFLOW ALONG ALL NERVES-A WIDELY UNEXPLORED ASPECT IN THE PATHOPHYSIOLOGY OF NEUROINFLAMMATIONKarl Bechter

09:10 - 09:20 ENCAPSULATION OF SUBCOMMISSURAL ORGAN (SCO) CELLS TO PROMOTE NEUROGENESIS IN FOETAL ONSET HYDROCEPHALUSMontserrat Guerra

09:20 - 09:30 EVALUATION OF A NEW TREATMENT PROTOCOL FOR HYDROCEPHALUS SECONDARY TO INTRAVENTRICULAR HAEMORRHAGE (IVH) IN PRETERM BABIESMagda Garzon

09:30 - 09:40 CSF DISTRIBUTION IN IDIOPATHIC NORMAL-PRESSURE HYDROCEPHALUS AND ALZHEIMER DISEASEShigeki Yamada

09:40 - 09:50 INTRACRANIAL VENOUS PULSATILITY IS REDUCED AFTER TRANSVERSE SINUS STENOSISEric Schmidt

09:50 -10:00 “I’M REFERRING A PATIENT WITH A SHUNT…”. DIAGNOSTIC COMPLEXITIES OF CSF SHUNT COMPLICATIONS IN CHILDRENRichard Edwards


Detailed Program


15

Moderators: William Cortes, Carlos Hakim

10:30 - 11:00 KEYNOTE SPEECHTHE TRIAD OF CLINICAL FINDINGS IN TETHERED CORDPetra Klinge

11:00 - 11:30 KEYNOTE SPEECHCSF BIOMARKERS OF INPH DIAGNOSE AND PREDICTIONCarsten Wikkelsø

11:30 - 11:40 MODELLING OF POSTURE-RELATED CHANGES IN CEREBROSPINAL FLUID DYNAMICSManuel Gehlen

11:40 - 11:50 RELATIONSHIP BETWEEN INTRA-ABDOMINAL PRESSURE AND OUTCOME OF SURGICALLY TREATED IDIOPATHIC INTRACRANIAL HYPERTENSION (IIH) PATIENTSSimon Thompson

11:50 - 12:00 ROLE OF ENDOSCOPIC THIRD VENTRICULOSTOMY IN THE MANAGEMENT OF MYELOMENINGOCELE RELATED HYDROCEPHALUS. 16 CASE SERIES IN CARTAGENA DE INDIAS - COLOMBIALeonardo Domínguez


ASSESSING WITHIN PATIENT IMPROVEMENT IN GAIT AND CLINICAL MEASURES IN RESPONSE TO ACTIVE SHUNT COMPARED TO PLACEBO (NON-ACTIVE SHUNT)Atif Adam

CEREBRAL VENOUS DRAINAGE DYNAMICS: INTRACRANIAL EXTRACRANIAL COMPARISON IN UPRIGHT AND SUPINEOlivier Balédent

CLINICAL OUTCOMES AFTER VENTRICULOATRIAL SHUNTING FOR IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUSBenjamin Elder

COMPARISON OF OUTCOMES BETWEEN PATIENTS WITH IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS WHO RECEIVED A PRIMARY VERSUS A SALVAGE SHUNTBenjamin Elder

PREDICTORS OF VENTRICULOPERITONEAL SHUNT REVISION IN PATIENTS WITH IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUSBenjamin Elder

IDENTICAL TWINS WITH IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUSAndreas Eleftheriou

Detailed Program


16

IMPACT OF A MANDATORY PERIOPERATIVE PROTOCOL IN PERMANENT CSF SHUNT OPERATIONSMagda Garzon

EFFICACY OF EARLY NEUROENDOSCOPIC INTERVENTION FOR VENTRICULITIS WITH RUPTURED BRAIN ABSCESS: TWO CASE REPORTSDaisuke Kawauchi

HIGH RISK OF DEMENTIA IN POSSIBLE IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS (INPH)Ville Leinonen

TWENTY-THREE ALZHEIMER’S DISEASE –RELATED SINGLE NUCLEOTIDE POLYMORPHISMS IN PATIENTS WITH SHUNT-RESPONSIVE INPH - A BRIEF CLINICAL STUDYVille Leinonen

12:30 - 14:00 Industry-sponsored Lunch Seminar Cartagena de Indias

Moderators: Juan Esteban Salas, George Chater

14:00 - 14:30 KEYNOTE SPEECHFOETAL ONSET HYDROCEPHALUS AS A NEURAL STEM CELLPATHOLOGY AND THE USE OF NEURAL STEM CELL GRAFTING AS A PROMISING THERAPYEsteban Martin Rodríguez

14:30 - 15:00 KEYNOTE SPEECHSHUNT PROGRAMING IN INPH: WHERE TO START, WHERE TO STOPRichard Edwards


Moderators: Harold Rekate, Juan Fernando Ramón

15:30 - 16:00 KEYNOTE SPEECHMRI OVER THE NEXT DECADE: QUO VADIS?William Guerin Bradley


Moderators: Harold Rekate, Juan Fernando Ramón

16:00 - 16:10 INTRACRANIAL COMPLIANCE AT REST AND AFTER INFUSION IN HYDROCEPHALUS PATIENTSArmelle Lokossou

16:10 - 16:20 MORPHOLOGY OF DURAL VENOUS SINUS STENOSIS IN IIHDebayan Dasgupta

16:20 - 16:30 PROGNOSTIC VALUE OF RADIOLOGICAL FINDINGS FOR MORTALITY IN IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUSMaria Kojoukhova

Detailed Program


17

16:30 - 16:40 ROSTRAL-CAUDAL CSF MARKERS OF INFLAMMATION AND INFECTION IN SAH PATIENTSClaudia Craven

16:40 - 16:50 THE EXPRESSION OF TRANSTHYRETIN AND AMYLOID-Β PRECURSOR PROTEIN IS ALTERED IN THE BRAIN OF IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS PATIENTSTiina Laiterä

16:50 - 17:00 VENTRICULAR T-TAU AND Aβ-42 LEVELS IN 78 SHUNTED INPH PATIENTSClaudia Craven


Moderators: Uwe Kehler, Carlos Hakim

17:00 - 17:10 ASSOCIATIONS OF INTRACRANIAL PRESSURE WITH BRAIN BIOPSY, RADIOLOGICAL FINDINGS, AND SHUNT SURGERY OUTCOME IN IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUSMaria Kojoukhova

17:10 - 17:20 BEHAVIOURAL VARIANT FRONTOTEMPORAL DEMENTIA HAS A POTENTIAL COMORBIDITY WITH POSSIBLE IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUSVille Korhonen

17:20 - 17:30 BIOMARKERS IN IIH: DOES CSF DRAINAGE INFLUENCE T-TAU AND Aβ-42 LEVELS?Claudia Craven

17:30 - 17:40 DELAYED SURGICAL TREATMENT FOR IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS WORSENS TREATMENT EFFICACY AND PROGNOSISBenjamin Elder

17:40 - 17:50 DOES GLYMPHATIC SOLUTE TRANSPORT NEED PARAVASCULAR BULK FLOW?Mahdi Asgari

17:50 - 18:00 HEALTH-RELATED QUALITY OF LIFE OUTCOME IN PATIENTS WITH IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS – A ONE-YEAR FOLLOW-UP STUDYAntti Junkkari

18:00 - 19:00 ISHCSF AGM

20:00 - 23:00 Gala dinner

Detailed Program


18

Monday, 10 October 2016

08:00 - 09:00 Experimental Hydrocephalus and Intracranial Pressure

Moderators: Harold Rekate, Mauricio Toscano

08:00 - 08:30 KEYNOTE SPEECHCEREBRAL VENOUS BED DYNAMICSCarlos Hakim

08:30 - 09:00 KEYNOTE SPEECHCRANIOSPINAL HYDRODYNAMICS: THEORETICAL AND PRACTICAL ISSUESRodolfo Hakim


Moderators: Laurence Watkins, Juan Esteban Salas

09:00 - 09:10 VENOUS SINUS STENTING FOR IDIOPATHIC INTRACRANIAL HYPERTENSION - 2 YEAR FOLLOW UP STUDY OF 40 PATIENTSSimon Thompson

09:10 - 09:20 VENTRICULAR VOLUMETRIC ANALYSIS DURING HYDROCEPHALUS DEVELOPMENT IN AN ANIMAL MODEL OF ADULT CHRONIC HYDROCEPHALUSTito Vivas-Buitrago

09:20 - 09:30 VENTRICULAR ZONE DISRUPTION IN PATIENTS WITH POST-HEMORRHAGIC HYDROCEPHALUS OF PREMATURITYMontserrat Guerra

09:30 - 09:40 VENTRICULOATRIAL SHUNT AS THE FIRST OPTION. OUR EXPERIENCE IN THE MANAGEMENT OF HYDROCEPHALUS IN ADULTSDiego Gomez

09:40 - 09:50 SURVIVAL OF GRAVITATIONAL VERSUS TRADITIONAL NON-GRAVITATIONAL VALVES IN PRIMARY SHUNT INSERTION IN CHILDREN: RETROSPECTIVE STUDYMagda Garzon

09:50 -10:00 ESTABLISHING A GERIATRIC REGISTRY IN THE MIDDLE EAST TO IDENTIFY RISK FACTORS AND MANIFESTATIONS OF NORMAL-PRESSURE HYDROCEPHALUSAtif Adam


Detailed Program


19

10:30 - 11:30 ROUND TABLEiNPH scales (Cartagena Consensus)Daniele Rigamonti, Carsten Wikkelsø , Masatsune Ishikawa, Fernando Hakim.


ANTITHROMBOTIC DRUGS OR NEUROLOGICAL COMORBIDITIES MIGHT NOT BE A CONTRAINDICATION FOR SHUNT SURGERY ON PATIENTS WITH IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUSHisayuki Murai

EFFECT OF LOW-LEVEL LASERTHERAPY IN PATIENTS WITH PAIN AMONG VENTRICULOPERITONEAL CATHETERFernando Campos Gomes Pinto

RESULTS OF VISION STUDY (VENOUS INTERVENTION VERSUS SHUNTING IN IIH FOR OPTIC DISC SWELLING) TRIAL PATIENT QUESTIONNAIRECatherine McMahon

SLEEP APNEA AND LEPTIN RESISTANCE IN IDIOPATHIC INTRACRANIAL HYPERTENSION SYNDROMEAruna Rao

ASSESSING THE BURDEN OF CARE OF THE ELDERLY IN THE KINGDOM OF SAUDI ARABIAKaren Rigamonti

VARIATIONS IN HEALTHCARE EXPENDITURES OF MEDICARE BENEFICIARIES WITH HYDROCEPHALUS OVER A DECADE: 1999 VERSUS 2008Alessandra Rigamonti

LUMBAR PUNCTURES MAY PREDICT THE QUANTITATIVE GAIT IMPROVEMENT EXPECTED POST-SHUNTING IN PATIENTS WITH INPHJamie Robison

DOPAMINERGIC LOSS IN PATIENTS SUSPECT OF HYDROCEPHALUSEric Schmidt

ANTHROPOMORPHIC IN VITRO SURVIVAL STUDY OF SHUNT VALVES WITH AND WITHOUT ANTI SIPHONING DEVICE USING POST SUBARACHNOID HEMORRHAGE CSFDavid Solomon

SUBCOMMISSURAL ORGAN INVOLVEMENT IN NIEMANN-PICK TYPE C DISEASEDavid Solomon

TWO-YEAR OUTCOME OF VA SHUNT FOR INPH EVALUATED BY MODIFIED RANKIN SCALEKiyoshi Takagi

Detailed Program


20

TELEMETRIC MONITORING OF ICP WITHIN A SHUNT SYSTEM. A SINGLE CENTRE EXPERIENCE INCLUDING THE FIRST IN VIVO COMPARISON VERSUS CONVENTIONAL INTRAPARENCHYMAL MONITORINGSimon Thompson

CEREBROSPINAL FLUID DISTURBANCE IN OVERWEIGHT WOMEN AFTER OCCIPITOCERVICAL DECOMPRESSION IN CHIARI MALFORMATION TYPE IMagnus Tisell

SUB-VENTRICULAR ZONE (SVZ) STEM CELL EXPLORATION IN A NOVEL ANIMAL MODEL OF ADULT CHRONIC COMMUNICATING HYDROCEPHALUSTito Vivas-Buitrago

VENTRICULAR-ATRIAL SHUNTING AS PRIMARY OPTION FOR THE TREATMENT OF NORMAL PRESSURE HYDROCEPHALUSTito Vivas-Buitrago

VENTRICULAR-ATRIAL SHUNTING COMPLICATIONS RATE IN NORMAL PRESSURE HYDROCEPHALUS. A SINGLE SURGEON PRACTICE EXPERIENCETito Vivas-Buitrago

12:30 - 14:00 Lunch break Jardines

Moderators: Richard Edwards, Rodolfo Hakim

14:00 - 14:30 KEYNOTE SPEECHPERSONAL QUESTIONS ABOUT CSF ABSORPTIONMasatsune Ishikawa

14:30 - 14:40 THE GAVCA STUDY – RANDOMIZED, PROSPECTIVE MULTICENTER TRIAL TO EVALUATE THE EFFECT OF A MOBILE HEALTH APPLICATION TO ASSIST VENTRICULAR CATHETER GUIDANCEUlrich Thomale

14:40 - 14:50 MPH IN NPH: HOW MUCH DOES WALKING SPEED INCREASE AFTER VP SHUNT INSERTION?Debayan Dasgupta

14:50 - 15:00 THE SYMPTOMS OF HAKIM’S TRIAD IN RELATION TO MORPHOLOGICAL FINDINGS IN NEURORADIOLOGYKarin Kockum


15:30 - 18:00 IHIWG Meeting

15:30 - 16:00 WORK OF THE ADULT HYDROCEPHALUS CLINICAL RESEARCH NETWORKMark Hamilton

16:00 - 16:30 THE ROLE OF DTI IN THE CONTEMPORARY IMAGING OF NPHEftichya Kapsalakis-Fountas

Detailed Program


21

16:30 - 17:00 CHANGES IN THE GLYMPHATIC SYSTEM WITH AGINGWilliam Guerin Bradley

17:00 - 17:30 BASIC RESEARCH IN HYDROCEPHALUSPat McAllister

17:30 - 18:00 TRANSLATIONAL RESEARCH IN COGNITIONPetra Klinge

Tuesday, 11 October 2016

IHIWG Meeting

09:00 - 11:00 Pulsatility

09:00 - 09:30 QUESTIONS TO BE ANSWERED THAT ARE NOT DEFINING A NEW SYNDROMEHarold Rekate

09:30 - 10:00 FLUIDS IN A VISCOELASTIC CONTAINERThomas Heldt

10:00 - 10:30 THE IMPORTANCE OF PULSE WAVE ANALYSISMark Luciano

10:30 - 11:00 DISCUSSION OF PULSATILITY SESSION WITH ANALYSISPat McAllister


11:30 - 13:30 CSF Flow and Solute Transport

11:30 - 12:00 THE PERIPHERAL CSF OUTFLOW PATHWAYS: ANATOMICAL AND PHYSIOLOGICAL ASPECTSKarl Bechter

12:00 - 12:30 DYNAMICS OF CEREBROSPINAL SOLUTE TRANSPORTMikahil Papisov

12:30 - 13:00 RELATION BETWEEN FLOW AND BIOCHEMICAL PARAMETERS IN THE CSFOlivier Balédent

13:00 - 13:30 FLOW VERSUS SOLUTE TRANSPORT IN THE CSFVartan Kurtcuoglu


14:30 - 16:30 Mixed Session

IHIWG Meeting Room: Salon Guacamayo

Detailed Program


22

14:30 - 15:00 TONSILAR MOVEMENT IN CHIARI I MALFORMATION WITH AND WITHOUT SYRINXLynne Bilston

15:00 - 15:30 ANATOMIC LOCALIZATION OF DYSAUTONOMIAHarold Rekate

15:30 - 16:00 MRI-MEASUREMENT AND NUMERICAL MODELING OF INTRATHECAL CSF DYNAMICS IN A CYNOMOLGUS MONKEYBryn Martin (online)

16:00 - 16:30 BRAIN WATER MOVEMENTAristotelis Filippidis (online)

16:30 - 16:35 INVITATION TO THE NEXT IHIWG SYMPOSIUM IN LONG BEACHWilliam Guerin Bradley

Abstracts




Abs

trac

ts

Abstracts


25

BARRIERS TO STANDARDIZING CARE FOR HYDROCEPHALUS IN THE MIDDLE EASTA Adam1, J Robison1, J Lu1, R Jose2, N Badran2, T Vivas-Buitrago1, D Rigamonti1

1Johns Hopkins University, Baltimore, USA2Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia

INTRODUCTION: Among the confirmed cases of Hydrocephalus in the Middle East, there is no standardization of care or differentiation between various types of Hydrocephalus. This is the first study in the Middle Eastern regions that aims at developing a Hydrocephalus clinical protocol for appropriate standard of care.

METHODS: We used a well-established clinical protocol from Johns Hopkins University and adapted it to a locally relevant clinical context with the help of an interdisciplinary panel of experts. The final protocol included diagnostic radiology studies, lumbar punctures (LP) as indication for surgery in hydrocephalus patients, and standardized times for follow-up visits were scheduled for optimal management of care. Baseline and follow-up testing protocol included gait assessment scales (Tinetti Gait and Balance Scale, Timed Up and Go task (TUG)) and ICIQ Urinary Incontinence short form.

RESULTS: Key highlights were cultural and language barriers which resulted in editing the testing and measures for use within the region (ex. translation into Arabic, religious beliefs, and education levels were incorporated to modify protocols). Gender roles and space constraints restricted feasibility of gait testing and required invasive procedures (ex. TUG times could not be assessed in a public hallway for women and women demanded inpatient stays for LP).

CONCLUSIONS: The study highlights the need to raise awareness and standardize clinical protocols for screening and treating NPH in the region. A critical analysis of issues related to the how and why of implementation, and in turn optimizing the appropriateness and relevance to the particular circumstances is essential.

Abstracts


26

EVALUATING BURDEN OF NORMAL PRESSURE HYDROCEPHALUS (NPH) IN THE MIDDLE EAST USING A POPULATION SCREENING METHODA Adam1, J Lu1, J Robison1, A Sattar3, O Omoush3, M Hammad3, M Dawood3, M Maghaslah3, T Belcher3, R Jose2, N Badran2, T Vivas-Buitrago1, D Rigamonti1

1Johns Hopkins University, Baltimore, USA2Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia3Johns Hopkins Aramco Healthcare, Ras Tanura, Saudi Arabia

INTRODUCTION: The burden of the geriatric population within Saudi Arabia is increasing rapidly and there is poor understanding of the prevalence of normal pressure hydrocephalus (NPH). This is the first study in the Middle Eastern regions that aims at diagnosing and increasing awareness of NPH through a population based screening approach.

METHODS: The team implemented a nurse-based screening clinic within primary care at four clinic sites over six months. Patients were screened using standard gait assessment measures. Patients with symptomology indicative of Hydrocephalus were then sent for CT and then MRI, if necessary.

RESULTS: The team screened over 300 patients in the first six months, of which, 31 were referred for head CT to confirm ventriculomegaly and diagnosis of NPH. Patient reluctance was high given the association between their symptoms and the progression of natural aging. Infrastructure to support screening (ex. radiological services) were also limited.

CONCLUSIONS: While the main focus of this study was in understanding the burden of NPH in the region, key areas were identified to encourage proactive screening of patients amongst primary care to raise awareness and further educate the country about Hydrocephalus. Education was expanded on both the provider level as well as to the patient and family. From these screening measures, the team was able to train nurses to integrate screening for Hydrocephalus within primary care. The team also raised awareness to physicians to refer patients with the triad to the new Hydrocephalus clinic.

Abstracts


27

COMPLICATIONS POST VENTRICULAR-ATRIAL AND VENTRICULAR-PERITONEAL SHUNT IN NORMAL PRESSURE HYDROCEPHALUS PATIENTS: RESULTS OVER A TWO-YEAR FOLLOW-UP FROM A RANDOMIZED CONTROL TRIALA Adam1, J Lu1, J Robison1, K Carson1, J Hoffberger1, I Jusué-Torres1, T Vivas-Buitrago1, S Foley2, S Yasar1, QA Thai1, J Wemmer1, P Klinge1, D Rigamonti1

1 Department of Neurosurgery, Johns Hopkins University, Baltimore, USA2 Department of Neurosurgery, Rhode Island Hospital, Providence, USA

INTRODUCTION: Ventricular-atrial and Ventricular-peritoneal shunt are commonly employed treatment of Normal Pressure Hydrocephalus (NPH). Few studies have focused on the complications at varied time points post-shunting surgery. This study aims to determine (1) Description of complications seen post-shunting procedures and (2) if complications are associated with worsening of gait or functional independence post-surgery.

METHODS: Between 2013 and 2016, 31 patients were enrolled at Rhode Island Hospital or Johns Hopkins Medical Institution for shunt surgery. Patients were eligible for the randomized, double blinded study if they were candidates for shunt surgery based on CSF drainage and radiological findings. They were followed up intermittently over a 2 year period for Primary outcomes: Tinetti Gait and Balance Scale and Timed Up and Go task (TUG), Clinical outcomes: European iNPH scale (E-iNPH), Kiefer Index and Kubo- INPH grading Scales and Functional independence using the Barthel Index (BI) and the Modified Rankin Scale (MRS).

RESULTS: i) In 2 years post shunting, 9 complications occurred amongst the 31 patients ii) Subdural Hematoma (SDH) was most common complication seen in 3 patients followed by 2 patients with headaches and hearing loss each iii) 63.64% of these complications occurred within 6 weeks post shunting. TUG and Tinetti were significantly different (p-value<0.01) in patients with SDH. Patients without SDH has significant improvements in TUG and Tinetti scores (p-value<0.001) while patients with SDH didn’t show significant improvements over the 2-year.

CONCLUSIONS: SDH is the most common complication seen post-shunting surgery and shows reduced and even worsening of gait improvements in NPH patients post-surgery.

Abstracts


28

ESTABLISHING A GERIATRIC REGISTRY IN THE MIDDLE EAST TO IDENTIFY RISK FACTORS AND MANIFESTATIONS OF NORMAL-PRESSURE HYDROCEPHALUSA Adam1, J Lu1, J Robison1, A Sattar3, O Omoush3, M Hammad3, M Dawood3, M Maghaslah3, T Belcher3, R Jose2, N Badran2, L Al-Mutawa4, H Al-Ghamdi5, T Vivas-Buitrago1, D Rigamonti1

1 Department of Neurosurgery, Johns Hopkins University, Baltimore, USA2 Department of Neurosurgery, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia3 Department of Primary Care, Johns Hopkins Aramco Healthcare, Ras Tanura, Saudi Arabia4 Department of Primary Care, Johns Hopkins Aramco Healthcare, Al Hasa, Saudi Arabia5 Department of Primary Care, Johns Hopkins Aramco Healthcare, Abqaiq, Saudi Arabia

INTRODUCTION: With rapid aging of the Saudi society, diagnosis of normal-pressure hydrocephalus (NPH) becomes relevant. Little is know about vascular risk factors in Saudi Arabia (KSA). This study looks at comorbidities identified through establishing a geriatric registry in the region.

METHODS: We collected and recorded from the medical record system demographics, medications, co-morbidities of every patient aged 65 or more. Then patients scheduled for a regular clinic visit were evaluated and entered into the Registry, after performing a baseline functional screen using Tinetti Gait and Balance Scale, Timed Up and Go task (TUG)), ICIQ Urinary Incontinence short form, and Picture Memory Impairment Screen.

RESULTS: The team screened 333 patients in the first six months. The mean age of the patient population was approximately 74.3 years old and 55.1% were male. 31.1% of the patients reported either being a current smoker or having smoked in the past and 58.8% having never smoked. Looking at clinical risk factors and comorbidities, 83.2% of the patients were either overweight or obese. 68.5% and 67.9% population reported being diagnosed with Diabetes or Hypertension respectively. 50.2% of the population reported being diagnosed with Hyperlipidemia as well. Coronary Artery Diseases (57.9%) was the most commonly reported in patients with either Diabetes, Hypertension or Hyperglycemia.

CONCLUSIONS: The study showcases the importance of setting a registry to measure the burden of co-morbidities in the elderly of Saudi Arabia. Proactively measuring the baseline degree of functional independence offers an optimal screening tool for the early diagnosis of NPH.

Abstracts


29

ASSESSING WITHIN PATIENT IMPROVEMENT IN GAIT AND CLINICAL MEASURES IN RESPONSE TO ACTIVE SHUNT COMPARED TO PLACEBO (NON-ACTIVE SHUNT)A Adam1, J Lu1, J Robison1, K Carson2, J Hoffberger1, I Jusué-Torres1, T Vivas-Buitrago1, S Foley3, S Yasar1, QA Thai1, J Wemmer1, P Klinge1, D Rigamonti1

1 Department of Neurosurgery, Johns Hopkins University, Baltimore, USA2 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA3 Department of Neurosurgery, Rhode Island Hospital, Providence, USA

INTRODUCTION: Normal Pressure Hydrocephalus (NPH) is a treatable cause of dementia, gait apraxia and urinary incontinence that results in significant disability if not identified and treated. However, response rates to shunting have been reported to vary between 31% to 89%. Furthermore, long term follow-up studies have shown loss of response to shunt which may be due to the natural history of disease, progression of comorbidities or a short term placebo effect following shunt surgery. In this abstract we look to determine within patient improvement in response to active shunt compared to placebo (non-active shunt).

METHODS: This study prospectively studies 32 eligible patients from shunt surgeries conducted between 2013 and 2016 and were evaluated pre-surgery and 6-months post-surgery. Primary outcomes were change in gait assessed by the Tinetti Gait and Balance Scale and Timed Up and Go task (TUG). Clinical outcomes were Kiefer Index and Kubo- INPH grading Scales. Linear fixed effects models were used for analysis using STATA 13.0.

RESULTS: Patients’ median age was 72 years (range: 64–83) and 63% were male. All measures showed significant statistical improvement (p-value <0.001) between baseline (no-shunt) versus 6-month (shunt). The largest improvement in gait measures were seen on the (Estimation: 1.8, p-value<0.001) and Kudo on the functional scale (Estimation: 1.3, p-value<0.001). In adjusting for pre-surgical characteristics, age at surgical procedure and BMI status were significantly associated with all measures (p-value<0.01) expect the Tinetti scale.

CONCLUSIONS: Active shunting shows significant improvements in gait and clinical outcomes measures in patients NPH.

Abstracts


30

ASSESSMENT OF COMMONLY USED SCALES TO EVALUATE NORMAL PRESSURE HYDROCEPHALUS (NPH) POST SHUNT SURGERYA Adam1, J Lu1, J Robison1, K Carson2, J Hoffberger1, I Jusué-Torres1, T Vivas-Buitrago1, S Foley3, S Yasar1, QA Thai1, J Wemmer1, P Klinge1, D Rigamonti1

1 Department of Neurosurgery, Johns Hopkins University, Baltimore, USA2 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA3 Department of Neurosurgery, Rhode Island Hospital, Providence, USA

INTRODUCTION: Gait improvement after shunt placement has been well documented in normal pressure hydrocephalus (NPH); however, there is no preferred test to evaluate the extent and pattern of postsurgical improvements. To lessen the clinician and patient burden and time, we aimed to determine the sensitivity of the European iNPH scale (E-iNPH) to capture multiple domains of clinical improvement in NPH patients.

METHODS: 30 eligible patients with diagnosed NPH, underwent shunting procedures and were evaluated pre-shunt and 6-month post-shunt. Gait was assessed by the Tinetti Gait and Balance Scale and Timed Up and Go task (TUG). Clinical outcomes were assessed using E-iNPH, Kudo iNPH scale and the Kiefer Index. McNemar’s test and Pearson’s Correlation were used to assess sensitivity between tests.

RESULTS: At 6 months post-shunting, 90% and 71% of patients showed improvements on the E-INPH and Keifer showed respectively. 67% and 73% of patients, using the TUG and Tinetti respectively, showed gait specific improvements. Improvements on E-INPH correlated closely with other tests: Kudo (0.70; p<0.001), Tinetti (0.67; p<0.001), TUG (0.78; p<0.001), and Kiefer (0.74; p<0.001). Comparisons on the McNemar’s test, the E-INPH scale is more sensitive in identifying NPH improvements at 6 months than other tests: Tinetti (X2=5; p=0.02), TUG (X2=7; p<0.001), and Kiefer (X2=4.5; p=0.02).

CONCLUSIONS: The results of this prospective multicenter study on patients with NPH supports the use of E-INPH scale in assessing improvements post shunt surgery. The E-INPH scale is more sensitive than other clinical tests in identifying improvement in patients 6-months post shunt surgery.

Abstracts


31

LOW-DOSE ACETAZOLAMIDE REVERSES PERIVENTRICULAR WHITE MATTER HYPERINTENSITIES IN INPHN Alperin1, N Relkin2

1 Department of Radiology, Miller School of Medicine, University of Miami, USA2 Department of Neurology, Weill Cornell Medical College, New York, USA

INTRODUCTION: The neuroimaging hallmark of iNPH is nonobstructive enlargement of the cerebral ventricles and in many cases, periventricular white matter hyperintensities (PVH). It has been noted that CSF diversion decreases PVH with symptom improvement. The current study assessed whether similar outcome can be archived pharmacologically.

METHODS: Serial MRI and gait measures were performed in 8 patients with iNPH who had been treated off-label with low dose acetazolamide (125–375 mg/day). MRI studies included fluid-attenuated inversion recovery and 3D T1-weighted high-resolution imaging. Automated analyses were employed to quantify each patient’s ventricular, global white matter hyperintensities (WMH), and periventricular WMH (PVH) volumes prior to and throughout treatment. Clinical outcome was based on gait changes assessed quantitatively using the Boon scale.

RESULTS: Five of 8 patients responded positively to treatment, with median gait improvement of 4 points on the Boon scale. A significant decrease in PVH volume (-6.1±1.9mL, p>0.002) was seen in these patients following treatment. One patient’s gait was unchanged and 2 patients demonstrated worsened gait and were referred for shunt surgery. No reduction in PVH volume was detected in the latter 2 patients. Non-periventricular WMH and lateral ventricle volumes remained largely unchanged in all patients.

CONCLUSIONS: These preliminary findings provide new evidence that low-dose acetazolamide can reduce PVH and may improve gait in iNPH. PVH volume, reflecting transependymal CSF, is shown to be a potential MRI indicator of pharmacologic intervention effectiveness. Further studies of pharmacologic treatment of iNPH are needed and may be enhanced by incorporating quantitative MRI outcomes.

Abstracts


32

DOES GLYMPHATIC SOLUTE TRANSPORT NEED PARAVASCULAR BULK FLOW?M Asgari, D de Zélicourt, V KurtcuogluThe Interface Group, Institute of Physiology, University of Zurich, Switzerland

INTRODUCTION: Experimental observations of fast transport of fluorescent tracers in the cerebral cortex have led to the hypothesis of bulk water flow directed from arterial to venous paravascular spaces (PVS) through the cortical interstitium. The corresponding overall transport pathway has been named ‘glymphatic system’. The hypothesized glymphatic pathway requires the presence of a net driving force between the arterial and venous PVS to enable bulk flow. While this force has not been identified so far, arterial pulsation has been suggested as its origin because unilateral ligation of the internal carotid artery has been shown to decrease the paravascular solute transport, presumably owing to reduced pulsation of cerebral arteries.

METHODS: We designed two distinct computational models 1) to assess the impact of arterial pulsation on water and solute dynamics in the para-arterial space and 2) to explore solute transport from para-arterial to the para-venous spaces through the cortical interstitium.

RESULTS: We show that arterial pulsation is an unlikely contributor to the hypothetical driving force for bulk flow in the PVS. However, we further show that such pulsation may still lead to fast para-arterial solute transport through dispersion and without directed bulk flow.

CONCLUSIONS: Rapid paravascular solute transport with rates faster than diffusion does not require bulk flow through the paravascular space. Instead, dispersion, which is the combined effect of diffusion and localized flow, may enable fast solute transport. Dispersion may reconcile a number of apparently conflicting experimental observations, notably bidirectional solute transport in the PVS, which are not explained by the glymphatic hypothesis.

Abstracts


33

NUMERICAL MODELING OF THE CEREBROSPINAL SYSTEM: MRI AND SIMULATION TO DETERMINE HYDROCEPHALUS MECHANISMSS Garnotel1,2,3, S Salmon2 , O Balédent1,3

1 BioFlowImage Laboratory, University of Picardie Jules Verne, Amiens, France2 Reims Mathematics Laboratory, University of Reims Champagne-Ardenne, Reims, France3 Image Processing Laboratory, University Hospital of Amiens-Picardie, Amiens, France

INTRODUCTION: Intracranial pressure (ICP) is an important clinical parameter for the proper functioning of the brain but this pressure is still difficult to measure in a non-invasive way and its regulation is quite hard to understand. Phase-contrast MRI (PC-MRI) provides arterial, venous and cerebrospinal fluid (CSF) cerebral flows in a noninvasive way that quantify most of the fluid exchanges in the cranium. Fluid-structure interactions are numerous in the cerebrospinal system and difficult to understand in the rigid skull , so this study focus on a numerical model of the cerebrospinal system taking into account CSF compartment, blood compartment and brain in fluid-structure interaction using PC-MRI measurements to approximate ICP.

METHODS: A fluid-structure interaction model is designed by coupling the fluid mechanics equations and the solid mechanics equations to obtain a global representation of the cerebrospinal system. The input of this model is the PC-MRI measured flows in arteries, in veins and in the CSF at the cervical level. This model allows quantification of velocity, pressure and displacement in the whole system. Different configurations of the model are tested to evaluate their impact on the system.

RESULTS: Ventricles stroke volume is widely impacted by heart rate and mechanical properties of the brain (Young modulus). Ventricles volume is modified under specific model configurations during a relatively sort time (few minutes).

CONCLUSIONS: The presented model allows a quantification of the system variables and highlights significants variations of the stroke volume in the ventricles under parameters variations that can be an origin of hydrocephalus.

Abstracts


34

ASSESSMENT OF THE DYNAMIC OF THE CEREBROSPINAL FLUID IN THE SPINAL CANAL OF HYDROCEPHALUS PATIENTSO Balédent1, A Lokossou1, S Garnotel1, G Page1, L Balardy², Z Czosnyka3, P Payoux4, E Schmidt5,6

1 Departments of Medical Image Processing, BioFlowImage Laboratory, University Hospital of Picardie Jules Verne, Amiens, France

² Departments of Geriatric, University Hospital of Toulouse, France3 Neurosciences department, University of Cambridge, UK4 Departments of Nuclear Medicine, University Hospital of Toulouse, France5 UMR 1214 – INSERM/UPS – TONIC Toulouse Neuro-Imaging Center, Toulouse, France6 Departments of Neurosurgery, University Hospital of Toulouse, France

INTRODUCTION: During cardiac cycle (CC), the vascular brain expansion is quickly compensated by cerebrospinal fluid (CSF) volume flush, also called the stroke volume (SVcsf ), toward the spinal compartment. Change in this flush resulting from the modification of biomechanical properties of the spinal canal could alter the main compliance of the system. We aimed to calculate the SVcsf.

METHODS: 83 subjects (74±7years) suspected of hydrocephalus underwent an infusion test. The change in intracranial pressure (ICP) at rest over the CC (ΔP_rest) was assessed from ICP monitoring before infusion using ICM+. After infusion, resistance to CSF outflow (R

out)

was calculated and was used to classify the patients in normal or pathological group. The day before the infusion, at the cervical level, the patients underwent a phase contrast MRI for the quantification of the spinal CSF flow oscillations. Then, SV

CSF was calculated and represents the

CSF volume moving outside and inside the cranium during CC.

RESULTS: 32 patients with a normal Rout (9±2mmHg/ml/min) were included in the Normal_inf_group. 51 others whose R

out was elevated (23±14mmHg/ml/min) were included in the

Patho_inf_group. SVcsf was higher (p=0.04) in the Normal_inf_group (0.62±0.22ml) than in the Patho_inf_group (0.52±0.19ml). ΔP_rest was smaller (p=0.04) in the Normal_inf_group (1.92±1.03mmHg) than in the Patho_inf_group (2.46±1.34mmHg).

CONCLUSIONS: We found that the increase of Rout

is associated with a decrease of the SVcsf combined with an increase of ΔP_rest. This decrease of SVcsf could be explained by: a spinal canal compliance decrease, a vascular brain expansion decrease or an increase of subarachnoid spaces resistance to CSF flow.

Abstracts


35

CEREBRAL VENOUS DRAINAGE DYNAMICS: INTRACRANIAL EXTRACRANIAL COMPARISON IN UPRIGHT AND SUPINEO Balédent1, M Zitoun1, A Lokossou1, MA Sevestre1, N Alperin2

1 University Hospital of Picardie Jules Verne, BioFlowImage, Amiens, France2 University of Miami Health System, USA

INTRODUCTION: It is well documented that venous drainage modulates intracranial pressure. It is less known how changes in body posture affect the link between intracranial and extracranial venous dynamics. This study combines velocity encoding MRI and Doppler ultrasound to characterize the relationship between intracranial and extracranial venous dynamics and postural influence on the venous drainage dynamics.

METHODS: 10 volunteers underwent Phase Contrast MRI study to measure venous drainage through the sagittal sinus as well as the extracranial drainage through the internal jugular veins. Flow waveform dynamics and mean flow rates were assessed to determine pulsatility ((flow_max-flow_min)/ mean_flow) differences between intra and extra cranial flows. B-mode Ultrasound study were used to asses the change of the internal jugular veins in the cross sectional area and Doppler ultrasound was used to asses flow velocities waveforms and estimated the mean flow.

RESULTS: Ultrasound-derived measurements demonstrated a significant reduction in the extracranial drainage through the internal jugular veins in the upright posture compared with supine posture (130±60 ml/min versus 20±30 ml/min for the left side and 290±380 ml/min versus 60±100 ml/min). Comparison between intracranial and extracranial venous flow dynamics demonstrated significantly larger magnitude of pulsatility in the internal jugular veins (0,41±0,13) than in the sagittal sinus (0,27±0,08). These differences were evident regardless of large inter-individual variability.

CONCLUSIONS: These results emphasize the complexity of the venous modulation of the intracranial physiology and a potential role for the right side of the heart and the jugular valves in the overall intracranial physiology and intracranial pressure dynamics.

Abstracts


36

BIOMARKERS IN IIH: DOES CSF DRAINAGE INFLUENCE T-TAU AND AΒ-42 LEVELS?I Baudracco, C Craven, S Matloob, S Thompson, LD Watkins, AK TomaVictor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, UK

INTRODUCTION: Little is known about cerebrospinal fluid (CSF) biomarkers in Idiopathic Intracranial Hypertension (IIH). T-tau and Aβ-42 have been studied in neurodegenerative diseases. This study aimed to determine if these biomarkers levels are influenced after shunting in IIH.

METHODS: Single-centre retrospective case series, who had CSF samples taken during either: ventriculoperitoneal (VP) shunt insertion or revision or during lumboperitoneal (LP) shunt insertion of revision. An unpaired T-test was used to compare the CSF biomarker levels.

RESULTS: Between January 2013 to March 2016, 34 IIH patients (33 F: 1M) mean age 36.5 years, were included. The mean follow-up was 51.2 ± 23.1 months. Nineteen samples were from lumbar CSF of which 11 were primary samples and 8 during revision. Sixteen samples were ventricular CSF, of which 4 were taken during a primary VP shunt insertion and 12 were taken during a revision. The mean ventricular CSF levels were: T-tau 1240 ng/l, Aβ-42 1240 ng/l and T-tau/Aβ1-42 ratio 7.1. Mean lumbar CSF levels were: T-tau 377 ng/, Aβ-42 1108 ng/l and T-tau/Aβ1-42 ratio 0.3. The mean ratio of T-tau/AB1-42 was significantly higher in CSF taken during shunt revision surgery compared to primary shunt insertion (p<0.05).

CONCLUSIONS: Patients with IIH appear to have normal lumbar CSF levels of T-tau and Aβ-42, suggesting neurodegeneration is not a major process in the pathophysiology of the disease. Samples taken during revision surgery had, on average, higher levels of neurodegenerative markers than those taken during primary surgery, suggesting the prescence of the shunt may influence the levels.

Abstracts


37

CSF OUTFLOW ALONG ALL NERVES-A WIDELY UNEXPLORED ASPECT IN THE PATHOPHYSIOLOGY OF NEUROINFLAMMATIONK BechterUlm University Department Psychiatry II/ Bezirkskliniken Günzburg, Germany

INTRODUCTION: Although first described by HI Quincke in 1872 (Bechter & Benveniste 2015 NPBR) the physiological outflow of CSF along all brain nerves and peripheral nerves remained unexplored with regard to a possible role in pathophysiology in general and specifically in neuroinflammation.

METHODS: Based on clinical observations during experimental treatments of therapy resistant psychiatric disorders with CSF filtration, shown effective for in autoimmune-neuroinflammatory disorder Guillain-Barre-syndrome, beyond the observed improvement of depression (associated with neuroinflammation) also minor peripheral neurological symptoms improved in parallel (Bechter et al 2004, Bechter 2007). On this background and extensive literature the Peripheral CSF Outflow (PCOP)-Hypothesis was developed, suggesting a broad role for CSF signaling at the PCOP (Bechter 2011).

RESULTS: With MRI the CSF outflow at the PCOP can be easily visualized (Bechter &Schmitz Croat Med J 2014). With case analysis including histopathology after death from chronic leukemia, we for the first time demonstrated, that CSF cells follow the PCOP(Schmitt et al Anticancer Res 2011).These findings match with recent knowledge about the afferent and efferent immunological pathways of the brain (Carare et al BBI 2014). Beyond, CSF signaling at the PCOP may result in retrograde effects in neurons, eg synaptic stripping, but may also modulate neuronal guided immune responses (Bechter NPBR 2016).

CONCLUSIONS: The predictions of the PCOP-Hypothesis remain yet poorly explored as far as investigated were confirmed. Further research in clinical and experimental approaches is required.

Abstracts


38

CHANGES IN BRAIN TISSUE MECHANICAL PROPERTIES DURING HYDROCEPHALUS DEVELOPMENT IN ADULT AND YOUNG RATS ARE DIFFERENTAC Pong1,2, L Jugé1,2, LE Bilston1,3, S Cheng1,4

1 Neuroscience Research Australia, Randwick, Australia2 School of Medical Sciences, University of New South Wales, Kensington, Australia3 Prince of Wales Clinical School, University of New South Wales, Kensington, Australia4 Department of Engineering, Faculty of Science and Engineering, Macquarie University, Australia

INTRODUCTION: Brain stiffness increases during ventricular enlargement in juvenile animals with unfused cranial sutures (Jugé et al, 2016), however it is not clear whether this also occurs in adult animals with a fused skull. The aims of this study are to determine how brain tissue stiffness changes in adult hydrocephalic rats with a fused skull, and how these changes are related to tissue deformation.

METHODS: Hydrocephalus was induced in 9 adult Sprague-Dawley rats by injecting a kaolin suspension into the cisterna magna. 6 sham-injected rats were used as controls. Anatomical MR images and MR elastograms (800Hz) were acquired 1 day before and 3 days post injection (9.4T, Bruker). Results were also compared with existing data from young hydrocephalic rats.

RESULTS: When the ventricles enlarged in adult hydrocephalic rats, brain tissue area decreased (GEE, P<0.01) while the cranial area and cortical stiffness did not change (GEE, P=0.40, P=0.24, respectively). However, while the ventricles enlarged more in young hydrocephalic rats than in adult hydrocephalic rats (t-test, P=0.01), brain tissue area normalized to baseline was significantly lower (t-test, P=0.0002) in the adult hydrocephalic rats than in young hydrocephalic rats, suggesting higher brain compression in adults. Plotting stiffness against changes in normalised brain cross sectional area for both adult and young hydrocephalic rats, cortical stiffness was higher when normalized brain tissue area was lower (Spearman, P=0.001).

CONCLUSIONS: This study showed that brain stiffness was higher in the more compressed adult hydrocephalic brains than the less compressed juvenile brains.

Abstracts


39

LATE ADULT ONSET AQUEDUCTAL STENOSIS MAY BECOME SYMPTOMATIC DUE TO DEEP WHITE MATTER ISCHEMIAW BradleyDepartment of Radiology, University of California San Diego Health System, USA

INTRODUCTION: While most aqueductal stenosis (AS) presents in infancy, some presents in late adulthood with a similar clinical triad as NPH – plus chronic headaches. The goal of this study was to consider a possible mechanism for a late adult onset presentation. Specifically, we believe that AS forces some CSF to exit via the extracellular space (ECS) of the brain via the glymphatic system – similar to children with tectal gliomas. With aging comes deep white matter ischemia (DWMI) which consists of myelin pallor and greater attraction between the exiting polar water molecules and the bare myelin protein, increasing resistance to CSF outflow, leading to back up of CSF both in NPH and AS.

METHODS: Retrospective review of medical records revealed 15 elderly patients referred for possible NPH who had aqueductal webs on midsagittal, bright CSF, submillimeter CISS or FIESTA sequences. Routine MRI including DWI with ADC was performed. Age matched controls were imaged using the same routine technique.

RESULTS: The apparent diffusion coefficient (ADC) was significantly higher for a given degree of DWMI for the AS patients (p<.018 for mild DWMI; p<.001 for moderate to severe DWMI) than the controls implying a higher water content in the ECS of the former.

CONCLUSIONS: The greater resistance to egress of CSF via the extracellular space of the brain (glymphatic system) due to DWMI may contribute to symptom onset in late adult onset AS.

Abstracts


40

ATROPHY OR NORMAL PRESSURE HYDROCEPHALUS?F Hakim1, JF Ramón1, MF Cárdenas1, JS Davidson1, C García1, D González1, S Bermúdez2, N Useche2

1 Department of Surgery, Section of Neurosurgery, Fundación Santa Fe de Bogotá, Colombia2 Department of Diagnostic Imaging, Section of Neuroradiology, Fundación Santa Fe de Bogotá,

Colombia

INTRODUCTION: The proper diagnosis of Normal Pressure Hydrocephalus has been a matter of debate since Dr Hakim first described it in 1964. Along with the clinical triad and the tap test, the diagnostic confirmation has been achieved with radiological findings suggesting NPH. The current radiological tools, namely CT and MRI has permitted a clearer approximation to NPH, and enabled better differentiation from other disease processes coursing with ventriculomegaly, by showing a disproportionate ventricular system size, as compared to peripheral cortical subarachnoid space. NPH tends to be subdiagnosed, with an ensuing unfavorable management strategy. This is probably due to the shared clinical and imaging characteristics between NPH and dementias, principally of the Alzheimer’s type.

METHODS: We compared pre-operative and post-operative head CT scan cuts of 5 patients with NPH, treated with ventriculo-atrial shunt placement, in order to determine changes in depth, antero-posterior segment length, and area of the Sylvian Fissure.

RESULTS: Analysis showed a bilateral, statistically significant reduction in the antero-posterior segment length and area of the Sylvian Fissure after shunt placement. Depth also decreased, but the difference was not statistically significant.

CONCLUSIONS: These post-operative changes are an indirect index of parenchymal recuperation not previously measured in an objective manner. These findings support the hypothesis that at least a proportion of patients diagnosed with cerebral atrophy, could be coursing with reversible subarachnoid space augmentation associated with NPH.

Abstracts


41

NORMAL PRESSURE HYDROCEPHALUS CLINICAL CARE PROGRAMF Hakim, JF Ramón, MF Cárdenas, JS Davidson, JA Mejía, P Mayorga, F Cruz, M Mora, C Martinez, MC Matiz, M Vallejo, K Ghotme, HA Soto, D Riveros, A Buitrago, M Mora, L Murcia, S Bermúdez, N Useche, D CohenGrupo de Hidrocefalia con Presión Normal, Hospital Universitario Fundación Santa Fe de Bogotá, Colombia

SUMMARY: Despite Normal Pressure Hydrocephalus (NPH) was described in 1964, its physiopathology has not yet been completely elucidated. Additionally, NPH diagnostic criteria and management clinical guidelines currently rely on epidemiological evidence and clinical experience. Unfortunately, epidemiological data display high variability due to the heterogeneity of diagnostic techniques and management approaches in different studies. This appears to lead to misdiagnosis and consequently to inaccurate treatment, as well as to underestimation of the number of NPH cases. There is as yet no consensus on the NPH patient´s interdisciplinary care protocol. In order to approach this limitation, a NPH Clinical Care Program was established at Hospital Universitario Fundación Santa Fe de Bogotá (FSFB) in 2014. The main objective of the program is to identify aspects that can be intervened in order to modify the course of the disease. This program consists as an interdisciplinary group of health care professionals, led by the Neurosurgery Department, and aims at designing and establishing of an assertive and early NPH detection for an optimal case management. The current approach of the FSB NPH-Program consists in offering early diagnosis; prompt treatment and initially a one-year of patient´s follow up The program has the final goal of improving the quality of NPH attention that may allow patients to be comfortable and confident in daily life with their families and in the community, and consequently a more effective health care. We will present the experience of the FSB NPH-Program and the importance of an accurate diagnose and treatment.

Abstracts


42

VENTRICULAR T-TAU AND AΒ-42 LEVELS IN 78 SHUNTED INPH PATIENTSC Craven, I Baudracco, S Matloob, S Thompson, AK Toma, LD WatkinsVictor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, UK

INTRODUCTION: Idiopathic normal-pressure hydrocephalus (INPH) has no reliable biomarkers that assist in the selection of patients for a ventriculoperitoneal (VP) shunt. T-tau and Aβ-42 have been implicated as biomarkers in other neurodegenerative diseases and in INPH. The aim of this study was to review their ability to predict outcome after VP shunting.

METHODS: Single-centre retrospective analysis of probable INPH patients with ventricular CSF samples. Samples were sent for ELISA analysis. Clinical documentation was reviewed for outcome. An unpaired T-test was used to compare the CSF biomarker levels. Negative and Positive predictive values (NPV and PPV) for shunt-responsiveness were calculated.

RESULTS: August 2006 to July 2015, 78 (31 F: 47 M) INPH patients, mean age 75.3 (R 55-94) had ventricular CSF analysed during shunt insertion or revision. Mean follow-up was 959 ± 657 days. Mean CSF levels for T-tau, Aβ-42 535 and T-tau/Aβ1-42 ratio were 669 ng/l, 471 ng/l and 2.00 respectively. There was no significant difference in levels between the shunt responsive and non-responsive group (p>0.05). The markers demonstrated poor predictive value for shunt responsiveness (PPV 59% and NPV 41%). There was no significant difference in T-tau/Aβ1-42 ratio between those with INPH and a neurodegenerative diagnosis (mainly Alzheimer’s and Parkinson’s disease) compared to those with probable INPH alone. Eleven of fourteen with a neurodegenerative diagnosis were still shunt responsive.

CONCLUSIONS: Neither T-tau nor Aβ-42 were effective at predicting shunt responsiveness in this group. Biomarkers more specific to INPH, with an ability to predict shunt responsiveness, still need to be identified.

Abstracts


43

MORPHOLOGY OF DURAL VENOUS SINUS STENOSIS IN IIHC Craven, S Matloob, S Thompson, I Baudracco, AK Toma, LD WatkinsVictor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, UK

INTRODUCTION: Idiopathic intracranial hypertension (IIH) is commonly associated with venous sinus stenosis and dural venous sinus stenting (DVSS) is becoming an increasingly used treatment option. Dural venous stenosis can be broadly classified into extrinsic (extra-luminal) or intrinsic (intra-luminal due to a thrombus or arachnoid granulation). We aimed to determine if morphological differences in sinus stenosis affected clinical or radiological outcome.

METHODS: A single centre case series. Clinical outcomes were assigned using degree of papilleodema on fundoscopy as a surrogate measure. Angiographic and manometry data before stenting and at 3 months after stent placement were reviewed. Differences in clinical outcomes, development of re-stenosis the two groups were assessed using Wilcoxon matched-pairs signed rank test and Fisher’s exact test (Chi squared) respectively.

RESULTS: Between September 2010 and March 2016, 41 patients (2 M: 39 F), mean age of 35.7 underwent DVSS, of whom 24 had an extrinsic and 17 had an intrinsic stenosis within the 3-month follow-up period. Sixteen of the 24 patients with an extrinsic stenosis developed a further morphological stenosis, compared to 3 within the intrinsic stenosis group (p<0.05). There was no significant difference in development of re-stenosis with a significant pressure gradient (p=0.12).

CONCLUSIONS: Extrinsic venous sinus stenosis is more common radiologically and more likely to result in a re-stenosis post stenting. However there was no increase in re-stenosis with a significant pressure gradient, nor difference in outcome on fundoscopy. The high proportion of re-stenosis occurring those with extrinsic stenosis may provide further insight into the pathophysiology of IIH.

Abstracts


44

ROSTRAL-CAUDAL CSF MARKERS OF INFLAMMATION AND INFECTION IN SAH PATIENTSC Craven, I Baudracco, S Matloob, S Thompson, LD Watkins, AK TomaVictor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, UK

INTRODUCTION: Acute hydrocephalus is a common complication of subarachnoid haemorrhage (SAH). Sampling of cerebrospinal fluid (CSF) from a pre-existing drain (external ventricular drain (EVD) or lumbar drain (LD)) is commonly performed to rule out infection prior to ventriculoperitoneal (VP) shunt insertion. Study aims to determine (1) if lumbar CSF infection markers reflects that of ventricular CSF (2) if abnormal WCC in LD correlated with a subsequent shunt infection.

METHODS: Single centre analysis of CSF from lumbar and ventricular CSF, sampled during the removal of LD and insertion of an EVD or VP shunt. Simultaneous CSF samples were sent for culture, WCC and biochemical analysis. A paired T-test was performed to determine if levels were significantly different in lumbar and ventricular samples. An F-test compared the variances.

RESULTS: Five patients (4M: 1F), aged 67 ± 13.44 (mean ± SD), had hydrocephalus secondary to SAH. Lumbar CSF samples had a mean WCC of 939 ± 1894 cu/mm, ventricular CSF had a mean 57.0 ± 105 cu/mm. Lumbar samples had a total protein of 3.80 ± 3.41 g/l, greater than ventricular samples level of 1.76 ± 2.09 g/l. Lumbar WCC levels had a significantly higher variance (p<0.05). No patients developed a subsequent VP shunt infection.

CONCLUSIONS: There is a rostral-caudal disparity in WCC and total protein levels, with Lumbar CSF having greater WCC and total protein levels than ventricular CSF taken simultaneously. Decision to proceed to shunt insertion should be guided by clinical picture rather than cell count on thecal CSF.

Abstracts


45

SIMULATION WORKSHOPS AND STANDARDISED CARE BUNDLES IMPROVE EXTERNAL VENTRICULAR DRAIN PLACEMENT AND DECREASE INFECTIONSD Dasgupta1, AK Toma1, C Curtis2, AA Khan1, LD Watkins1, L Thorne1

1 Victor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, UK

2 Department of Microbiology, University College London Hospital NHS Foundation Trust, UK

INTRODUCTION: Temporary cerebrospinal fluid (CSF) diversion through an external ventricular drain (EVD) comes with the risk of EVD-related infections (ERIs) – incidence varies from 0.8% to 22%1,2,3. ERIs increase mortality, length of stay, costs, prolonged courses of antibiotics, and increase subsequent permanent CSF diversion4,5. The rationale for this quality improvement project was therefore to reduce infection rates and improve placement via simulation training and a standardised perioperative care bundle.

METHODS: A best practice standardised perioperative approach and care bundle was peer-agreed amongst the senior neurosurgeons at the National Hospital for Neurology and Neurosurgery, Queen Square, London, and a standardised operation note was designed to improve documentation, and involve carers in positive decision-making. This was adapted from the bundle by Kubilay et al6. Targeted simulation workshops included safe access, administration of intrathecal drugs, and demonstration of safe operative technique using a perpendicular trajectory7 using the Rowena head8. Standardised aspects of care included choice of catheter, length of tunnelling, and method of securing the drain.

RESULTS: The infection rate before implementation was 5% (n=17), placement was satisfactory in 50% (n=16), and mean length of drainage was 8 days. In the 6 months following the interventions, preliminary results suggest the infection rate was 1.4% (n=70), placement was satisfactory in 86.7% (n=60), and mean length of drainage was 9 days.

CONCLUSIONS: This demonstrates that simulation training and standardising perioperative care of patients requiring EVDs dramatically reduces infection rates and accuracy of placement, resulting in improving patient outcomes and reducing length of stay.

Abstracts


46

ROLE OF ENDOSCOPIC THIRD VENTRICULOSTOMY IN THE MANAGEMENT OF MYELOMENINGOCELE RELATED HYDROCEPHALUS. 16 CASE SERIES IN CARTAGENA DE INDIAS - COLOMBIAL Domínguez1, AJ Remolina2, MA Grijalba2

1 Neurosurgery Department, Cartagena University, Cartagena de Indias, Colombia2 Neurosurgery Department, Cartagena University, Cartagena de Indias, Colombia

INTRODUCTION: Hydrocephalus (HC) treatment, related to Myelomeningocele, through Endoscopic third ventriculostomy (TVE) is controversial because of the fact that traditionally, ventriculoperitoneal shunt (VPS) represents a principal treatment for most of the patients. Consequently, our experience in the pathology treatment through TVE is presented.

MATERIAL – METHODS: a retrospective description was made to every patient, which were taken to TVE to treat hydrocephalus related to Myelomeningocele (MMC) since January 2013 to May 2016.

RESULTS: 15/16 patients had previous VPS, debuted with symptoms and signs of system dysfunctions and one case with intracranial hypertension syndrome (IHS) anew. 15/16 patients shown clinical and radiological improvement posterior TVE and just one case reappeared IHS symptoms.

CONCLUSIONS: Hydrocephalus is the principal problem for patients with MMC, which is developed in up to 80-90%, after spinal defect closure. The VPS is, at present, the principal option of treatment, however, is related to high morbility in this population. In spite of bad outcome few years ago, and the difficulties TVE represents, because of anatomical variations and neurological immaturity of the cerebrospinal fluid (CSF) in these patients, its realization by highly qualified personnel, in children after 6 month old, is a valuable option for HC treatment associated to MMC. In our experience, the TVE in pediatric patients with MMC has a high level of success (93,7%) made in well-chosen patients.

Abstracts


47

“I’M REFERRING A PATIENT WITH A SHUNT…”. DIAGNOSTIC COMPLEXITIES OF CSF SHUNT COMPLICATIONS IN CHILDRENKJ Whitehouse, R EdwardsDepartment of Paediatric Neurosurgery, Bristol Royal Hospital for Children, Bristol, UK

INTRODUCTION: CSF shunts have a high revision rate, but there is little in the literature about how patients referred with possible shunt failure are assessed and diagnosed.

METHODS: All children referred to a supra-regional paediatric neurosurgical centre with suspected CSF shunt failure over 6-month period were identified on a prospective database and a casenote review evaluating the diagnostic process was undertaken.

RESULTS: There were 100 emergency referrals for 61 children (mean age 6.4-years) with shunts, 46 of whom had never been revised, mean time since last shunt procedure was 3.3. years. 36 children required admission, 23 underwent revision (all requiring change of a part of the shunt at operation). 51% of referrals resulted in neurosurgical review, 9 required ventricular access and 6 required ICP monitoring. 5 patients required multiple shunt operations. A scale was developed to communicate the difficulty and level of invasiveness of investigation required to diagnose or exclude shunt failure, from 1 (not a query relating to potential blockage) to 5 (difficult to determine shunt issue requiring surgical exploration).

CONCLUSIONS: The proposed scale can help clinicians understand the referral patterns of patients with shunts; and convey the increasing complexity of this population and need to undertake invasive investigations to diagnose shunt blockage. It can also aid longitudinal analysis of neurosurgery unit data and identify the subgroup of patients for whom imaging studies are of low diagnostic utility, and where ventricular access device placement may useful to facilitate more invasive evaluation of shunt function such as CSF infusion studies or ICP monitoring.

Abstracts


48

DELAYED SURGICAL TREATMENT FOR IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS WORSENS TREATMENT EFFICACY AND PROGNOSISS Vakili1, D Moran1, A Hung1, B Elder1, L Jeon1, H Fialho1, EW Sankey1, I Jusué-Torres2, CR Goodwin1, J Lu1, J Robison1, D Rigamonti1

1 Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, USA2 Department of Neurosurgery, Miami University School of Medicine, Florida, USA

INTRODUCTION: Longer durations of preoperative symptoms may correlate with worse postoperative outcomes following treatment of idiopathic normal pressure hydrocephalus (iNPH). The aim of this study is to determine whether the duration of preoperative symptoms alters postoperative outcomes in patients treated for iNPH.

METHODS: A retrospective review of 393 iNPH patients treated with ventriculoperitoneal (VP) shunting was conducted. Symptom duration prior to operative intervention was recorded, and the following variables were assessed at baseline, six months postoperatively and at last follow-up: gait performance, urinary continence, and cognition.

RESULTS: Median age at shunting was 74 years. Increased symptom duration was significantly associated with worse gait outcomes (RR=1.055 per year of symptoms, p=0.037), and an overall absence of improvement in any of the classic triad symptomology (RR=1.053 per year of symptoms, p=0.033) at six months postoperatively. Additionally, there were trends towards significance for symptom duration increasing the risk of having no six month postoperative improvement in urinary incontinence (RR=1.049 per year of symptoms, p=0.069) or cognitive symptoms (RR=1.051 per year of symptoms, p=0.069). However, no statistically significant differences were noted in these outcomes at last follow-up (median 31 months).

CONCLUSIONS: iNPH patients with longer durations of preoperative symptoms may not receive the same short-term benefits of surgical intervention as patients with shorter durations of preoperative symptoms. However, with longer follow-up, the patients eventually reached the same endpoint. Therefore, when managing patients with iNPH, it may take longer to see the benefits of shunting when patients present with a longer duration of preoperative symptoms.

Abstracts


49

PREDICTORS OF VENTRICULOPERITONEAL SHUNT REVISION IN PATIENTS WITH IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUSA Hung1, D Moran1, S Vakili1, EW Sankey1, I Jusué-Torres2, B Elder1, CR Goodwin1, J Lu1, J Robison1, D Rigamonti1


INTRODUCTION: Few studies have focused on predictive factors of ventriculoperitoneal (VP) shunt revision in patients with idiopathic normal pressure hydrocephalus (iNPH). This study aims to determine whether comorbidities and baseline symptoms are associated with the need for shunt revision.

METHODS: A retrospective review of patients with iNPH treated with VP shunts by the senior author from 1993 to 2013 was conducted. Demographics and baseline symptoms were compared between patients with and without shunt revision. The need for revision, total number of revisions, and time to first revision, were examined. Statistical analysis was performed using simple logistic, linear, and Poisson regression, and a multivariate analysis was performed.

RESULTS: A total of 347 patients with iNPH who received VP shunts were included. One hundred patients (28.8%) required shunt revision, with an average of 1.38 ± 0.76 revisions per patient. Mean time to revision was 19.2 ± 31.7 months. Gait and cognitive symptoms were associated with fewer revisions (incidence rate ratio, 0.45 and 0.67; P = 0.03 and 0.004, respectively). Headaches and urinary incontinence showed a greater time to revision (32.0 and 12.0 months; P = 0.014 and <0.0005, respectively). Gait instability demonstrated decreased time to revision (P < 0.0005).

CONCLUSIONS: Preoperative symptoms, such as headaches, gait instability, cognitive decline, and urinary incontinence, were significantly correlated with number of revisions and time to first revision. These factors should be considered during the initial counseling of prognosis for patients with iNPH receiving VP shunts.

Abstracts


50

COMPARISON OF OUTCOMES BETWEEN PATIENTS WITH IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS WHO RECEIVED A PRIMARY VERSUS A SALVAGE SHUNTD Moran1, A Hung1, S Vakili1, B Elder1, H Fialho1, L Jeon1, EW Sankey1, I Jusué-Torres2, J Lu1, CR Goodwin1, D Rigamonti1


INTRODUCTION: Placement of a ventriculoperitoneal (VP) shunt is the treatment of choice for communicating hydrocephalus; however, the extent to which VP shunting is able to relieve symptoms in patients who had previously been treated with cerebrospinal fluid diverting therapy at an outside institution remains unclear.

METHODS: A retrospective review of patients with idiopathic normal pressure hydrocephalus treated with VP shunts at a single institution between 1993 and 2013 was conducted. Patients were classified as having a received a primary VP shunt if they had not been previously treated with a VP shunt, ventriculoatrial shunt, lumboperitoneal shunt, or endoscopic third ventriculostomy. Patients were classified as having received a salvage VP shunt if they had been previously treated by one of these four modalities at an outside institution prior their presentation to our institution.

RESULTS: There were 357 patients who received a primary shunt and 33 patients who received a salvage shunt. Patients who had a salvage shunt placed had significantly higher odds of requiring a future revision (54% versus 41%; OR=2.85; 95% confidence interval [CI]: 1.24–6.57; p=0.014). Patients who received a salvage shunt had statistically significantly lower rates of gait improvement at 6 months in comparison to patients who received a primary shunt (RR= 0.35; 95% CI: 0.14–0.87; p=0.025). Despite these findings, there was no significant difference at last follow-up in improvement in gait, continence, and cognition.

CONCLUSIONS: Despite increased risk of shunt revision, outcomes for patients requiring a salvage shunt were comparable to patients receiving a primary shunt.

Abstracts


51

CLINICAL OUTCOMES AFTER VENTRICULOATRIAL SHUNTING FOR IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUSA Liu1, EW Sankey1, I Jusué-Torres2, MA Patel1, B Elder1, CR Goodwin1, J Hoffberger1, J Lu1, J Robison1, D Rigamonti1


INTRODUCTION: Idiopathic normal pressure hydrocephalus (iNPH) is typically treated with ventriculoperitoneal (VP) shunting, but one alternative is ventriculoatrial (VA) shunting.

METHODS: A retrospective review of patients with iNPH who were treated with VA shunting at a single institution, from 2003 to 2013, was performed.

RESULTS: 58 patients with iNPH underwent primary VA shunting at a median age of 74 years. The most common comorbidities included hypertension (67%) and diabetes mellitus (19%).Median duration of symptoms prior to VA shunting was 24 months. All patients had gait impairment, 90% had cognitive decline, and 74% had urinary incontinence. 74% of patients had all three symptoms. At a median last follow-up of 16 months, median iNPH score improved from 6 to 3 (p<0.0001), mini mental status exam (MMSE) tended to increase from 26 to 29 (p=0.082), timed up-and-go (TUG) improved from 18 to 13 s (p<0.0001), and Tinetti score improved from 19 to 25 (p<0.0001) after VA shunting. 78% of patients had improvement in at least one of their symptoms with 66% of patients having improvement in gait, 53% having improvement in their cognition, and 52% having improved urinary incontinence. Finally, 21 patients had improvement in all 3 symptoms.

CONCLUSIONS: There were significant improvements in functional outcomes as evaluated via the iNPH score, TUG, and Tinetti score, while improvement in MMSE trended toward significance. Patients also had improvement of clinical symptoms related to gait, urinary function and cognition. Therefore, VA shunting can be an effective primary treatment alternative to VP shunting for iNPH.

Abstracts


52

IDENTICAL TWINS WITH IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUSA Eleftheriou1, F Lundin2

1 Department of Neurology, University Hospital, Linköping, Sweden2 Department of Clinical and Experimental Medicine (IKE), Division of Neuroscience, Linköping University,

Sweden

SUMMARY: Idiopathic normal pressure hydrocephalus (iNPH) is usually regarded as a sporadic disease with typical gait, cognitive and urinary symptoms caused by a disturbance of the cerebrospinal fluid dynamics. The pathophysiological mechanisms of iNPH are still poorly understood. In the literature there are a few reports of familial clustering of iNPH. We present the first case of iNPH in two adult identical twins. Both developed similar symptoms at approximately the same age. Their MRI showed enlargement of the ventricles, a disproportional narrowing of the subarachnoid space and cortical sulci at the high convexity of the cerebrum and sharp callosal angle. Both of them improved significantly after shunt surgery confirmed by a three month-postoperative examination. This indicates a possible genetic component involved in the pathogenesis. Further genetic studies are needed in this poorly explored area.

Abstracts


53

ENDOSCOPIC THIRD VENTRICULOSTOMY IN NORMAL PRESSURE HYDROCEPHALUS PATIENTSKN Fountas1, EZ Kapsalaki2, HF Smisson3, J Robinson3

1 Department of Neurosurgery, School of Medicine, University of Thessaly, Larisa, Greece2 Department of Diagnostic Radiology, School of Medicine, University of Thessaly, Larisa, Greece3 Department of Neurosurgery, Georgia Neurosurgical Institute, Macon, USA

INTRODUCTION: Surgical management of idiopathic Normal Pressure Hydrocephalus (iNPH) remains puzzling despite the wide clinical application of programmable CSF shunts. The shunt-associated complications, along with the increased cost of the shunt, constitute the major drawbacks for shunting as a treatment for iNPH patients. Endoscopic third ventriculostomy has been employed in several small series of selected iNPH patients with variable results.

MATERIAL – METHODS: Our prospective study included 23 patients (4 females, 19 males) with ages ranged between 63 and 76 years (mean: 70.4), suffering iNPH. All participants underwent preoperatively conventional and cine-MRI study, 40-50 ml CSF drainage via a spinal tap, and neurocognitive evaluation by employing the Frontal Assessment Battery (FAB) and the Montreal Cognitive Assessment (MOCA) tests. All patients underwent an endoscopic third ventriculostomy, while another MRI study and neuropsychological evaluations were obtained six months postoperatively, and then at six months interval for up to 2 years. The idiopathic normal pressure hydrocephalus grading system (INPHGS) was also employed pre- and post-operatively in all participants. The follow up time ranged in our cohort from 6 to 96 months (mean: 40.2).

RESULTS: The mean postoperative INPHGS score was 5.2, while the preoperative one was 6.8 in our current series. The mean postoperative FAB score was 14.3 from 12.5, while the mean postoperative MOCA score was 24.2 from 21.5 preoperatively. The mean postoperative CSF stroke volume was 33.2μL from 47.0 μL preoperatively.

CONCLUSIONS: Endoscopic third ventriculostomy seems to be a valid surgical alternative option in iNPH patients, with functional CSF obstruction.

Abstracts


54

TELEMETRIC PRESSURE MONITORING: THE ROLE IN THE CLINICAL MANAGEMENT OF HYDROCEPHALUSMJ Fritsch, W AroukKlinik für Neurochirurgie, Dietrich-Bonhoeffer-Klinikum, Neubrandenburg, Germany

INTRODUCTION: One indication for the application of Telemetric Pressure Monitoring (TPM) we see in patients (with or without shunt) presenting with unclear clinical symptoms (e.g. headaches), not explained by imaging studies or the patients history. The question we wanted to answer is: Does this patient need treatment? Our second indication is the optimization / adjustment of a preexisting (adjustable) shunt. Here the task is: How can we adjust the valve in the best possible way.

METHODS: Between November 2012 and October 2015 a total of 15 patients (11 male, 4 female) underwent TPM. A Raumedic sensor was implanted in 13 patients and a Miethke sensor reservoir in 2 patients. Age was between 4 and 35 years (mean 14 a) and the Follow up between 6 and 32 months (mean 18 mo). Our algorithm was: Implantation - Measurement at the hospital - Training (patient / family) - Measurement at home (2-4 weeks) - Evaluation of data - Decision.

RESULTS: In all patients’ pressure monitoring under daily conditions in the hospital and at home was helpful in guiding therapy decisions (implantation or revision of a shunt, decision against shunt / or any other surgery, valve adjustment, other surgeries like cranioplasty). We present several case examples.

CONCLUSIONS: Telemetric pressure monitoring is a helpful tool to guide clinical decision making in complex or difficult cases. TPM adds pressure data to clinical judgment and imaging studies and it provides new insight in the correlation between symptoms (e.g. headaches) and normal or pathologic ICP.

Abstracts


55

PROSA: THE ROLE IN THE MANAGEMENT OF INPHMJ Fritsch, ER LopezKlinik für Neurochirurgie, Dietrich-Bonhoeffer-Klinikum, Neubrandenburg, Germany

INTRODUCTION: Overdrainage is a common complication after VP-Shunt implantation in iNPH patients. According to the SVASONA study gravitational valves reduce the incidence of overdrainage significantly. One indication for the implantation of the adjustable gravitational valve proSA is the treatment of complications related to overdrainage (e. g. subdural hygroma) in patients who already have a shunt. Another indication is the prevention of overdrainage in patients who have large ventricles and receive a VP-Shunt. A further indication, which had not been evaluated and reported so far, is long-term adjustment of the proSA in patients with iNPH and a pre-existing VP Shunt. Three to five years after initial implantation patients treated for iNPH will likely experience worsening of their clinical symptoms and will benefit from lowering the opening pressure of their valve. Once the valve had been adjusted to the lowest possible opening pressure (zero cm of water column) we continue treatment by lowering the opening pressure oft the proSA in increments of 2 from 20 to 18, 16, 14 or 12 cm of water. The goal of this pilot study is to evaluate safety and clinical results of this protocol.

METHODS: Between September 2011 and August 2015 a total of 43 patients (22 female, 21 male) received a proSA at our institution. We divided the indication for proSA implantation retrospectively in three groups: treatment of overdrainage (n=11), prevention / risk reduction of possible overdrainage (n=4) and optimization of the iNPH adjustment (n=28). Follow up ranged from 6 to 62 months (mean 25 months). Patients had regular outpatient visits and received a clinical examination, including Kiefer score.

RESULTS: One of the 28 patients experienced overdrainage after adjusting the proSA to an opening pressure below 20 cm of water column and had to be readjusted. None of the other patients showed signs or symptoms of overdrainage. Two patients were adjusted to 12 cm, 6 patients to 14 cm, 14 patients to 16 cm and the remaining 5 patients to 18 cm. All of those patients had an opening pressure of the valve of zero cm of water column, draining in the horizontal position against an open shunt tube. In 12 out of 28 patients we could confirm clinical improvement by lowering the Kiefer score for 2 points or more. In the remaining 16 patients no such improvement was seen.

CONCLUSIONS: The implantation of an adjustable gravitational valve (proSA) presents a therapy option not only for patients with signs of overdrainage or for patients with high risk for overdrainage, proSA may also be a safe and reliable tool for the adjustment and clinical fine-tuning of patients with iNPH in long term follow up. Clinical improvement can be achieved by adjusting the proSA. Our empirical data show, that patients with iNPH may not need a conventional differential pressure valve and may be treated against an opening pressure of zero. Condition for that is, that an adjustable gravitational valve compensates for the hydrostatic pressure.

Abstracts


56

EVALUATION OF A NEW TREATMENT PROTOCOL FOR HYDROCEPHALUS SECONDARY TO INTRAVENTRICULAR HAEMORRHAGE (IVH) IN PRETERM BABIESM Garzon, M Kang, K Sandhu, D Baghawatti, K Aquilina, G James, D ThompsonGreat Ormond Street Hospital, London, UK

INTRODUCTION: IVH is the commonest neurosurgical presentation in preterm infants. In 2012, we introduced a new protocol for its management, using ventriculo-subgaleal shunts (VSGS) as the preferred temporising device.

METHODS: Retrospective case review on electronic records. All the preterm infants requiring VSGS between 01/12 and 01/14 were included.

RESULTS: During this period, 23 infants required VSGS; mean birth-weight was 897 gr. Nineteen (82.6%) presented with IVH Papile grade 3 or 4 IVH at the time of referral. At the time of VSGS insertion, mean gestational age was 31+1 weeks (range 26+4 - 36+4), and the weight was 1171 gr (range 758-1600g). Pre- and postsurgical ventricular indices (VI) demonstrated an average 7.6 mm reduction. Surgical complications occurred in 7 cases (30%), including 2 infections, 2 failures requiring revision, and 3 decompressive haemorrhages (managed conservatively). The mean follow up was 516 days (range 137- 1056). Twenty two infants (95.6%) underwent conversion to a permanent ventriculoperitoneal shunt, within a mean time of 79 days (range 24-349) after the VSGS insertion. Mortality was zero.

CONCLUSIONS: VSGS is a safe therapeutic option for preterm IVH with an acceptable morbidity profile in these complex patients. Despite its conceptual use as temporising device, all, except one patient required insertion of a permanent shunt. This may relate to the severe Papile-grade in our population.

Abstracts


57

IMPACT OF A MANDATORY PERIOPERATIVE PROTOCOL IN PERMANENT CSF SHUNT OPERATIONSO Omrani, J O’Connor, M Garzon, O Jeelani, G JamesDepartment of Paediatric Neurosurgery, Great Ormond Street Hospital, London, UK

INTRODUCTION: Infection remains a major source of morbidity in shunts. On 2012, we introduced a standardized perioperative protocol with the aim of reduce its rate.

METHODS: Retrospective study using electronic database interrogation. Consecutive patients undergoing permanent shunts between Jul/09 to Jun/15 were included and divided in 2 groups: 1) pre-protocol and 2) Post-protocol. Operations were classified in: 1) Primary insertion, 2) Revision, and 3) Internalization of external CSF drainage. Absolute and relative risk reduction (ARR/RRR) and chi square statistics were calculated.

RESULTS: 962 operations in 546 children were included (529 pre-protocol, 433 post). Mean age was 5.1 years group 1, and 4.2 years group 2. Overall infection rate for the whole cohort was 6.5% group 1 (32/529 cases) and 4.8% group 2 (21/433); p=0.14; ARR 1.7%; RRR 23.2%. For primary insertions, 4.1% group 1 (8/193), and 2.5% group 2 (4/160); p=0.26; ARR 1.6%; RRR 39.1%. For shunt revisions, 6.5% group 1 (16/247), 4.3% group 2(9/210; p=0.17; ARR 2.2%; RRR 34%). For internalizations, 10.4% group 1 (8/87), 12.7% group 2 (8/63; P = 0.6, ARR -2.3%, RRR -22%).

CONCLUSIONS: Although there was no impact on the internalization group, there was a decrease in the rate of infections in primary shunts and revisions. We support the introduction of shunt protocols for those procedures in paediatric neurosurgical units.

Abstracts


58

SURVIVAL OF GRAVITATIONAL VERSUS TRADITIONAL NON-GRAVITATIONAL VALVES IN PRIMARY SHUNT INSERTION IN CHILDREN: A RETROSPECTIVE COHORT STUDYT Grainger, J O’Connor, M Garzon, O Jeelani, G JamesDepartment of Paediatric Neurosurgery, Great Ormond Street Hospital, London, UK

INTRODUCTION: Gravitational valves are increasingly used for primary shunts in children. Its long-term theoretical advantage is tempered by the suspicion that complex valve designs are more prone to early failure.

METHODS: Retrospective analysis of electronic records of patients undergoing primary shunt insertion (2007-2014). Using Chi-square statistical analysis, we compared the failure rate and time of a gravitational valve (GV; Miethke/PaediGAV) versus a non-gravitational valve (NGV; Codman/Precision). Early failure was a shunt revision within 30 days of surgery and late failure was a revision after that point.

RESULTS: 207 primary shunts inserted (36 GV and 171 NGV). Mean age 8.7mo in GV and 26mo in NGV (p= 0.013). There were 5/36 (14%) early failures in the GV group and 10/171 (6%) in the NGV group (p = 0.091). For late failures, there were 4/31 (14%) events in the GV group with 45/161 (28%) in the NGV group (p= 0.078). 1 year shunt survival in the GV group was 77.8% vs 79.5% in the NGV group.

CONCLUSIONS: 1 year overall survival was almost identical between the 2 groups. There was a trend for more early failures in the GV group which was balanced by less late failures. There was no evident superiority of one valve over another for primary shunts in children.

Abstracts


59

MODELLING OF POSTURE-RELATED CHANGES IN CEREBROSPINAL FLUID DYNAMICSM Gehlen1,2, V Kurtcuoglu2,3, M Schmid-Daners1

1 Department of Mechanical and Process Engineering, ETH Zurich, Switzerland2 Institute of Physiology, University of Zurich, Switzerland3 Neuroscience Center Zurich, and the Zurich Center for Integrative Human Physiology, University of

Zurich, Switzerland

INTRODUCTION: Postural changes lead to changes in intracranial pressure, but also to a shift in the cranio-spinal compliance distribution of the cerebrospinal fluid (CSF) system. We hypothesize that this shift is caused by the collapse of the jugular veins and aim to test the hypothesis with a lumped-parameter model of CSF dynamics.

METHODS: An exponential function was used to describe the relationship between CSF pressure – relative to venous pressure – and volume. 63% of this CSF-to-venous compliance was assumed to be located spinally. The hydrostatic pressure column in the CSF system was assumed uninterrupted in upright posture, while the one in the veins was assumed to be interrupted at the jugular veins. The venous pressure at the spinal level was modelled as posture independent.

RESULTS: Reaching the same overall compliance in supine and upright equilibrium required 22% of the CSF absorption to be located spinally. With this, the overall CSF volume in upright equilibrium was increased by 1.6 mL. Sitting up caused an immediate caudal CSF shift of 2.5 mL and a spinal compliance decrease from 63 to 22% of the overall value. Due to this shift in compliance, the ability to compensate for cerebral arterial volume pulsations was reduced and the cranio-spinal CSF flow pulsations decreased from 328 to 61 mL/min peak-to-peak amplitude.

CONCLUSIONS: The good accordance of the here modelled changes with values observed in vivo lead us to the conclusion that the jugular collapse is a major contributor to the posture-related changes in CSF dynamics.

Abstracts


60

IN VITRO COMPARISON OF ANTI-SIPHON MECHANISMS UNDER POSTURAL CHANGESM Gehlen1,2, A Eklund3, V Kurtcuoglu2,4, J Malm5, M Schmid-Daners1

1 Department of Mechanical and Process Engineering, ETH Zurich, Switzerland2 Institute of Physiology, University of Zurich, Switzerland3 Department of Radiation Sciences, Umeå University, Sweden4 Neuroscience Center Zurich, and the Zurich Center for Integrative Human Physiology, University of

Zurich, Switzerland5 Department of Pharmacology and Clinical Neuroscience, Umeå University, Sweden

INTRODUCTION: Flow-regulated, gravitational, and membrane-controlled anti-siphon devices (ASD) have been developed to counteract siphoning-induced overdrainage in upright posture through cerebrospinal fluid (CSF) shunts. We aimed to elucidate how these three types of ASDs interact with the CSF system under postural changes.

METHODS: Three shunts each of Codman Hakim with SiphonGuard (flow-regulated), Miethke miniNAV with proSA (gravitational), and Medtronic Delta (membrane-controlled) were tested. The pressure-flow characteristic of each shunt was quantified in terms of opening pressure, closing pressure, and resistance. CSF drainage rates, resulting CSF volume change and intracranial pressure (ICP) were measured in supine, sitting, and standing posture. The measurements were performed on a robotic test bench that models the in vivo environment of the shunt based on a mathematical description of CSF dynamics.

RESULTS: The flow-regulated ASDs avoided increased drainage in sitting posture, but reopening of the ASD was observed while standing. This reopening may be problematic for short patients and patients with increased IPP. The gravitational ASDs allowed setting the opening pressures in horizontal and vertical orientation independently. However, as their drainage rate changes with IPP, uniform drainage in upright posture is impossible and adaptation to the patient is critical. The membrane-controlled ASDs eliminated overdrainage by stopping drainage in upright posture at the expense of CSF accumulation.

CONCLUSIONS: All tested ASDs reduced overdrainage, but their effects on CSF dynamics varied greatly: While membrane-controlled ASDs are a robust means of siphon-prevention, flow-controlled devices provide continuous drainage, and gravitational ASDs allow patient-specific adaptation, but precise adjustment is required.

Abstracts


61

VENTRICULOATRIAL SHUNT AS THE FIRST OPTION. OUR EXPERIENCE IN THE MANAGEMENT OF HYDROCEPHALUS IN ADULTS.F Hakim, JF Ramón, D GomezNeurosurgery Department, “Hospital Universitario, Fundación Santafe de Bogota”, Bogota, Colombia

INTRODUCTION: Ventricular shunts represent the axis of treatment of disorders of the cerebrospinal fluid (CSF). The literature shows that the preferred technique around the world is the ventricular peritoneal shunt (VP), which is technically more simple , reproducible and represents a permanent and lasting CSF drainage. In our institution ventriculoatrial derivation is the first choice in the treatment of hydrocephalus in adults, results are equivalent to the technique of choice or even better.

METHODS: A retrospective review of patients with hydrocephalus who were treated with ventriculoatrial shunting at a single institution, from 2007 to 2015, was performed.

RESULTS: The results will be show at the meeting.

CONCLUSIONS: Ventriculoatrial shunt is a valid option in the management of hydrocephalus, in our experience is a safe, reproducible and effective technique. We consider that a DVA shunt is more phisiologycal than traditional technic and less shunt malfunction in the follow up.

Abstracts


62

ENCAPSULATION OF SUBCOMMISSURAL ORGAN (SCO) CELLS TO PROMOTE NEUROGENESIS IN FOETAL ONSET HYDROCEPHALUSM Guerra1, M Jara1, M Flores2, K Vío1, I Moreno2, S Rodríguez1, E Ortega3, EM Rodriguez1

1 Instituto de Anatomía, Histología y Patología, Facultad de Medicina, UACh, Chile2 Laboratorio de Polímeros, Facultad de Ciencias, UACh, Chile3 Instituto de Neurociencias Clínicas, Facultad de Medicina, UACh, Chile

INTRODUCTION: Prenatal and adult neurogenesis is impaired in hydrocephalus. The aim of the present investigation was to encapsulate cells of the subcommissural organ (SCO) in order to develop a neurotrophic therapy for hydrocephalic children. SCO cells secrete SCO-spondin, transthyretin, fibroblast growth factor, and S100β. These compounds have neurotrophic, neuroprotective and immunomodulatory functions [ref.1].

METHODS: SCO explants from bovine were maintained in organ culture for thirty days, a time when they become secretory ependymospheres. These spheres were encapsulated by using different polymeric semipermeable membranes. Encapsulated ependymospheres were cultured for six months with complete culture medium containing DMEM/F12HAM supplemented with 10% fetal calf serum and 5% bovine serum. Double immunofluorescence was used to analyze the phenotype of SCO-cells after encapsulation and a long term in culture. Western blotting analyses were performed to study the presence of SCO-secretory compounds in the conditioned medium. Culture of rat neural stem cells (NSC) or human SH-SY5Y cells in the presence of encapsulated ependymospheres or of their condition medium was used as an assay to evaluate neurogenetic properties of SCO.

RESULTS: (I) SCO-encapsulated cells maintained their phenotype and they keep on secreting neurotrophic factors to the conditioned media for at least six months; (II) SCO-spondin was detected in the conditioned media of encapsulated cells; (III) In the differentiation assay, NSCs and SH-SY5Y cells differentiated into neurons.

CONCLUSIONS: Encapsulated-SCO may become a useful tool to promote neuronal differentiation in the brain. Since xenografting of encapsulated tissue does not trigger a host-versus-graft reaction, grafting of encapsulated bovine SCO into the hydrocephalic cerebrospinal fluid may become a fruitful clinical tool. This would provide an opportunity for the early treatment of the neurological impairment associated with the onset fetal hydrocephalus.

Abstracts


63

VENTRICULAR ZONE DISRUPTION IN PATIENTS WITH POST-HEMORRHAGIC HYDROCEPHALUS OF PREMATURITYP McAllister1, M Guerra3, EM Rodriguez3, DM Morales1, D Sival4, A Jimenez5, DD Limbrick1,2

1 Department of Neurosurgery, St. Louis Children’s Hospital, St. Louis, Missouri, USA2 Department of Pediatrics, St. Louis Children’s Hospital, St. Louis, Missouri, USA3 Instituto de Histologia y Patologia, Facultad de Medicina, Universidad Austral de Chile, Valdivia, Chile4 Departments of Pediatrics Pathology and Medical Biology, University Medical Center Groningen,

University of Groningen, The Netherlands5 Departamento de Biología Celular, Genética y Fisiología Facultad de Ciencias, Universidad de Malaga,

Malaga, Spain

INTRODUCTION: Experimental and clinical studies have documented disruption of the ventricular (VZ) and subependymal (SVZ) zones in fetal-onset congenital hydrocephalus[1-3], but no studies have included patients with hydrocephalus following intraventricular hemorrhage (IVH). To test the hypothesis that VZ and SVZ alterations are associated with IVH, immunohistochemistry was performed on tissue from neonates with this condition.

METHODS: IVH cases (n=15) were classified using Papile’s ultrasound-based grading system[4] and compared to controls (n=4) with no hemorrhage or ventriculomegaly who expired from non-neurological causes. Specimens were matched by estimated gestational age (EGA). Postmortem tissue from frontal cortical and subcortical regions was processed by routine histology and immunohistochemistry for glial fibrillary acidic protein (GFAP for stem cells and mature astrocytes), β-3 tubulin (for neural progenitors), β-4 tubulin (for ciliated ependymal cells), aquaporin-4 (AQP4 for ependyma and astrocytes), and L1-cell adhesion molecule.

RESULTS: The ranges of patient birth and expiration age were 23.0-39.1 and 23.7-44.1 weeks EGA, respectively; survival was 0-42 days (median 2.0 days). IVH grade did not correlate with ventricular size. All control cases exhibited normal VZ/SVZ cytology, i.e. GFAP-positive and β-4 tubulin-positive cells lining the ventricles and abundant β-3 tubulin-positive neural progenitors. All IVH cases exhibited multiple sites of parenchymal hemorrhage (including the ganglionic eminence), patchy loss of ciliated ependymal cells and stem cell processes, and periventricular heterotopias that were not correlated with IVH grade. AQP4 appeared in the plasma membrane of neural stem cells, ependyma cells and on SVZ astrocytes. GFAP-positive cells appeared to replace ependymal cell gaps in longer-term survivors.

CONCLUSIONS: These findings indicate that VZ/SVZ disruption occurs consistently in neonates with IVH and hydrocephalus and increases understanding of the pathogenesis of this disorder.

Abstracts


64

REDUCING VENTRICULOPERITONEAL SHUNT MALFUNCTION IN THE ADULT PATIENTM Hamilton1, G Urbaneja1, A Hockley1, R Holubkov2, A Isaacs1

1 Department of Clinical Neurosciences, University of Calgary, Foothills Hospital, Calgary, Canada2 Department of Pediatrics, University of Utah, Salt Lake City, Utah, USA

INTRODUCTION: Treatment of adult patients with hydrocephalus is often undertaken with a ventriculoperitoneal shunt (VPS). Failure rates have been reported as high as 50% in the first year.

METHODS: A Quality (Continuous) Improvement (QI) model was used to evaluate and modify VPS-insertion and revision techniques to improve outcome. Malfunction was defined as a change in neurological shunt-related function with correlated diagnostic imaging studies. Infection was defined by standard HCRN criteria. Prospectively collected data from January 2012-December 2015 was reviewed.

RESULTS: 141 patients underwent a new VPS insertion. Diagnoses were: normal pressure hydrocephalus 98 patients, acquired hydrocephalus 24 patients, chronic-congenital hydrocephalus 17 patients and 2 transitional patients. 103 patients had traditional insertion of a ventricular catheter using surface landmarks with 2 catheter misplacements requiring surgery. Image guidance with electromagnetic tracking was instituted with 0 catheter misplacements in 43 consecutive patients. 116 patients had traditional minilaparotomy or trocar placement of the peritoneal catheter with 59/121 (49%) experiencing shunt malfunction and 35/59 (59%) experiencing a 2nd malfunction requiring surgery. Laparoscopic insertion of the peritoneal catheter was instituted in 25 consecutive patients with 3 (12%) experiencing distal obstructions. Laparoscopy was also used in 27 patients undergoing ventriculoperitoneal shunt revision with 2 (7.4%) experiencing subsequent malfunction. Shunt surgery related infection rates decreased from 6% to 3.5%.

CONCLUSIONS: Changes to standard VPS surgical treatment including the addition of image-guidance and laparoscopic surgical techniques and a shunt infection prevention bundle were associated with a significant decrease in shunt malfunction and shunt infection.

Abstracts


65

EARLY AND DELAYED QUANTITATIVE ASSESSMENTS ON TAP TEST FOR DIAGNOSIS OF IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUSM Ishikawa1,2, S Yamada2,3, K Yamamoto3

1 Rakuwa Villa Ilios, Kyoto, Japan2 Normal Pressure Hydrocephalus Center, Otowa Hospital, Kyoto, Japan3 Department of Neurosurgery, Otowa Hospital, Kyoto, Japan

INTRODUCTION: Idiopathic normal pressure hydrocephalus (iNPH) is a disorder of gait, cognition and urination in the aged population. Cerebrospinal fluid (CSF) tap test is useful for diagnosis of iNPH, but its diagnostic accuracy was relatively low. To improve the accuracy, we performed early and delayed quantitative assessments for gait on day 1 and day 4.

METHODS: Fifty-seven patients who were treated with CSF shunt surgery were subjected in this study. Assessments included 3-meter timed up and go test (TUG) and 10-meter walk by time and step. The values of area under the curve (AUC), sensitivity, specificity and cutoff were computed using receiver-operating curves.

RESULTS: On all three examinations, improvement of gait on day 4 was same as or more frequent than that on day 1. High AUC values above 0.75 were noted in TUG and TUG (%) on day1, and 10-meter walk (step) and 10-meter walk (% time) on day 4. Among them, percent change of TUG on day 1 showed highest AUC of 0.784 and cutoff was 9.3% (sensitivity 83%, specificity 78%). On day 4, AUC values on TUG and 10-meter walk were comparable to those on day 1, but statistical differences were not noted. We made a subgroup of better values of variables between day 1 and day 4. They showed high AUC values, but no statistical differences were noted.

CONCLUSIONS: Percent change of TUG on day 1 would be favorable for predicting the effectiveness of shunt surgery.

Abstracts


66

HEALTH-RELATED QUALITY OF LIFE OUTCOME IN PATIENTS WITH IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS – A ONE-YEAR FOLLOW-UP STUDYA Junkkari1, A Häyrinen1, T Rauramaa2, H Sintonen3, O Nerg4, AM Koivisto4, RP Roine5, H Viinamäki6, H Soininen7, A Luikku4, JE Jääskeläinen1, V Leinonen1

1 Neurosurgery of NeuroCenter, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland

2 Department of Pathology, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland3 Department of Public Health, University of Helsinki, Helsinki, Finland4 Neurology of NeuroCenter, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland5 University of Eastern Finland, Kuopio Finland and Helsinki and Uusimaa Hospital District, Group

Administration, Helsinki, Finland6 Department of Psychiatry, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland7 Department of Neurology, University of Eastern Finland, Kuopio, Finland

INTRODUCTION: This prospective study explored the factors affecting the health-related quality of life (HRQoL) outcome in patients with idiopathic normal pressure hydrocephalus (iNPH) one year after the installation of the cerebrospinal fluid (CSF) shunt.

METHODS: HRQoL outcome was evaluated using 15D instrument, in which the minimum clinically significant change/difference has been estimated to be ± 0.015. The follow-up data (15D, Mini-Mental State Examination, Beck Depression Inventory, iNPH Grading Scale), frontal cortical biopsy, Charlson Age Comorbidity Index and body mass index (BMI) of 145 patients diagnosed with iNPH by clinical and radiological examination were analyzed.

RESULTS: At one year follow-up 63 (43%) patients had experienced a clinically significant improvement in HRQoL. Multivariate binary logistic regression analysis indicated that the absence of Aβ and HPτ pathology in the frontal cortical biopsy (53 vs. 33%, absolute risk difference, 20%; adjusted OR=2.27, 95% CI 1.07 – 4.84; p < 0.05) and lower BMI (adjusted OR=0.90, 95% CI 0.82 - 0.98; p < 0.05) predicted favorable HRQoL outcome one year after the shunting.

CONCLUSIONS: Less than half of the patients with iNPH experienced clinically significant favorable HRQoL outcome, partly explained by the patient’s characteristics and comorbidities. The HRQoL approach reveals aspects that are important for the patient’s well-being, but may also improve the quality of the outcome assessment of CSF shunting. Study results may help clinicians to estimate which patient will benefit shunt surgery.

Abstracts


67

EFFICACY OF EARLY NEUROENDOSCOPIC INTERVENTION FOR VENTRICULITIS WITH RUPTURED BRAIN ABSCESS: TWO CASE REPORTSD Kawauchi, T Shin, T Matsutani, H MuraiDepartment of Neurological Surgery, Chiba University Graduate School of Medicine, Japan

INTRODUCTION: Despite advances in antimicrobial treatments and surgical interventions, brain abscess is still a life-threatening disease with mortality rate of 15%. When abscess ruptures into the ventricular system and leads ventriculitis and hydrocephalus, mortality rate further increases (ranging from 27 to 85%). These two cases we experienced exemplify the efficacy of early neuroendoscopic intervention for ventriculitis with ruptured brain abscess.

METHODS: The first case was an eleven year old man who was admitted with headache, fever and altered mental status. Brain magnetic resonance imaging (MRI) showed two independent abscesses at right frontal and left parietal lobes, and a right abscess ruptured into ventricular system. The second patient was a 72 year old woman who was admitted with fever and altered mental status. Brain MRI showed an abscess at right occipital lobe that ruptured into ventricular system. For these two patients, we performed abscess drainage and ventricular lavage with flexible neuroendoscope. Soon after the surgery, their physical and mental status dramatically improved. They received two months of additional antimicrobial treatment and were discharged without shunting or any disability.

CONCLUSIONS: We presented two cases of brain abscess and ventriculitis treated by early neuroendoscopic intervention. Our clinical strategy not only enables drastic elimination of causative pathogen, but also prevents hydrocephalus that complicates patient’s clinical management. We believe with further clinical experience the early neuroendoscopic intervention will be a promising clinical strategy to ventriculitis with ruptured brain abscess.

Abstracts


68

NORMAL PRESSURE HYDROCEPHALUS – IS IT WORTHWHILE TO TREAT BEDRIDDEN PATIENTS?U KehlerNeurosurgical Department, Asklepios Klinik Hamburg Altona, Hamburg, Germany

INTRODUCTION: Normal pressure hydrocephalus (NPH) is a progressive disease. If not treated in time, patients end bedridden with total incontinence and severe dementia. The more advanced the disease is the worse the outcome of shunting. This is often the reason to refuse surgery in bedridden patients. The aim of this work is to show if bedridden patients with NPH still can benefit from surgery.

METHODS: We treated 5 bedridden patients with NPH in the last 3 years. They had all the diagnostic standard work-up with clinical examination, MRI-imaging and repeated spinal tap test. The evaluation of STT was done by clinical impression of the movement improvement: the bedridden patients were asked to sit at the bedside. The effectiveness to realize this position change was evaluated as well as video-recorded in the last patients.

RESULTS: Five bedridden patients with strong suspicion of NPH were evaluated with STT. All showed slight improvement although none was able to get to the sitting position by himself. However, all patients got back to ambulating stage (1 independent, 4 with walking aids) after shunting.

CONCLUSIONS: These five cases prove that despite the advanced stages of NPH, treatment can be effective and can improve substantially quality of life This means that bedridden patients should not be excluded from NPH-therapy. However, evaluation criteria should be developed to help in the decision making of shunting these patients. Video recording of patient´s movements before and after spinal tap test or lumbar drainage may be helpful to detect improvements, and can be discussed with the treatment team as well as relatives to indicate shunt surgery.

Abstracts


69

THE SYMPTOMS OF HAKIM’S TRIAD IN RELATION TO MORPHOLOGICAL FINDINGS IN NEURORADIOLOGYO Lilja-Lund1, K Kockum1, EM Larsson2, K Riklund3, L Söderström1, P Hellström4, K Laurell1

1 Department of Pharmacology and Clinical Neuroscience, Unit of Neurology, Östersund, Umeå University, Sweden

2 Department of Radiology, Uppsala University, Sweden3 Department of Radiation Sciences, Umeå University, Sweden4 Hydrocephalus Research Unit, Institute of Neuroscience and Physiology, The Sahlgrenska Academy,

University of Gothenburg, Sweden

INTRODUCTION: Idiopathic normal pressure hydrocephalus (iNPH) is characterized by Hakim’s triad, i.e. impairment of gait and balance, dementia and incontinence. We aimed to describe the relation between Hakim’s triad symptoms and easy accessible radiological markers associated with three cerebral regions hypothesized to contribute to the specific symptomatology i.e. caudate nucleus, hippocampus, and cingulate gyrus.

METHODS: The material consisted of 168 individuals from the general population (93 females, median age 75, range 66-92 years) with and without signs of iNPH. The triad symptoms were assessed using gait and balance test (TUG), NPH-sensitive neuropsychological tests (Pegboard, Stroop interference, RAVLT), and urinary symptoms (yes/no). The radiological markers Evan’s index (EI), mean size of the temporal horns, and Callosal angle (CA) were measured on CT scans.

RESULTS: Relating the three cerebral regions in a multivariate regression analysis to the different symptoms, showed that for TUG, Pegboard and RAVLT, only the size of temporal horns was significantly contributing (p < 0.001 for all three), for Stroop interference CA contributed as well (p = 0.022). Those with urinary symptoms had significantly larger temporal horns (mean=3.8 mm) than those without (mean=3.2 mm) (t=-2.38, p=0.019), whereas no differences were found for EI or CA.

CONCLUSIONS: More pronounced triad symptoms were related to wider temporal horns on CT. This was not limited to memory impairment. The findings support that wide temporal horns are an important radiological marker of iNPH. However, functional methods are probably needed to link the different symptoms of Hakim’s triad to specific brain regions.

Abstracts


70

PROGNOSTIC VALUE OF RADIOLOGICAL FINDINGS FOR MORTALITY IN IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUSM Kojoukhova1, A Sutela2, AM Koivisto3,4, R Vanninen2, JE Jääskeläinen1, V Leinonen1


2 Department of Radiology, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland3 Unit of Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland4 Neurology of NeuroCenter, Kuopio University Hospital, Kuopio, Finland

INTRODUCTION: Little is known about relationship between radiological markers and mortality in idiopathic normal pressure hydrocephalus (iNPH).

METHODS: We used data from Kuopio University Hospital’s NPH register of 477 patients with suspected iNPH. A total of 305 (64%) patients underwent shunt surgery and 294 (62%) died during the mean follow-up time of 6.4 years. We used Cox regression model adjusted for BMI, age, gender and imaging method (CT [n=295] or MRI [n=182]) to investigate the associations between radiological markers and mortality.

RESULTS: White matter changes in brain stem (P<0.001), periventricular area (P<0.001) and deep white matter (P=0.001) were associated with high mortality. Wide temporal horns (P<0.001) and high Scheltens scores (P<0.001) were also associated with high mortality. The disproportional sylvian and suprasylvian subarachnoid spaces (P=0.026) and decreased superior medial subarachnoid spaces (P=0.048) were associated with better prognosis. Evans’ index, focally dilated sulci, superior convexity subarachnoid spaces, lateral ventricles, sylvian fissures, basal cisterns, flow void, callosal angle and modified cella media index were not associated with mortality. In shunted patients the disproportional sylvian and suprasylvian subarachnoid spaces and decreased superior medial subarachnoid spaces were no longer associated with mortality, while the other associations remained similar.

CONCLUSIONS: Radiological findings related to Alzheimer’s disease and vascular degeneration were associated with high mortality. However, iNPH related markers were only weakly associated with better survival. Our findings suggest that in the treatment of iNPH patients, we should focus more on vascular degeneration.

Abstracts


71

ASSOCIATIONS OF INTRACRANIAL PRESSURE WITH BRAIN BIOPSY, RADIOLOGICAL FINDINGS, AND SHUNT SURGERY OUTCOME IN IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUSM Kojoukhova1, KI Vanha1, M Timonen1, AM Koivisto3,4, J Rummukainen5, T Rauramaa5,6, R Vanninen2, JE Jääskeläinen1, A Sutela2, V Leinonen1


2 Department of Radiology, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland3 Unit of Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland4 Neurology of NeuroCenter, Kuopio University Hospital, Kuopio, Finland5 Department of Pathology, Kuopio University Hospital, Kuopio, Finland6 Institute of Clinical Medicine - Pathology, University of Eastern Finland, Kuopio, Finland

INTRODUCTION: It remains unclear how intracranial pressure (ICP) measures are associated with brain biopsies and radiological markers. Here, we aim to investigate associations between ICP and radiological findings, brain biopsies, and shunt surgery outcome in patients with suspected idiopathic normal pressure hydrocephalus (iNPH).

METHODS: We analyzed data from 73 patients admitted with suspected iNPH to Kuopio University Hospital. Of these patients, 71% underwent shunt surgery. The NPH registry included data on clinical and radiological examinations, 24-h intraventricular pressure monitoring, and frontal cortical biopsy.

RESULTS: The mean ICP and mean ICP pulse wave amplitude were not associated with the shunt response. Aggregations of Alzheimer’s disease (AD) related proteins (amyloid-β, hyperphosphorylated tau) in frontal cortical biopsies were associated with a poor shunt response (P=0.014). High mean ICP was associated with Evans’ index (EI; P=0.025), disproportional sylvian and suprasylvian subarachnoid spaces (P=0.014), and focally dilated sulci (P=0.047). Interestingly, a high pulse wave amplitude was associated with AD-related biopsy findings (P=0.032), but the mean ICP was not associated with the brain biopsy. The ICP was not associated with medial temporal lobe atrophy, temporal horn widths, or white matter changes.

CONCLUSIONS: The EI and disproportional sylvian and suprasylvian subarachnoid spaces were associated with mean ICP. Their ability, although limited, to predict elevated ICP in 24-h measurements, underlined their value in iNPH diagnostics. Interestingly, our results suggested that elevated pulse wave amplitude might be associated with brain amyloid accumulation.

Abstracts


72

BEHAVIOURAL VARIANT FRONTOTEMPORAL DEMENTIA HAS A POTENTIAL COMORBIDITY WITH POSSIBLE IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUSV Korhonen1, S Helisalmi2, E Solje2, T Rauramaa3, R Vanninen4, AM Remes2, V Leinonen1

1 Department of Neurosurgery, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland

2 Institute of Clinical Medicine - Neurology, University of Eastern Finland, Kuopio, Finland and Department of Neurology, Kuopio University Hospital, Kuopio, Finland

3 Department of Pathology, Kuopio University Hospital, Kuopio, Finland4 Department of Radiology, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland

INTRODUCTION: Differential diagnosis between idiopathic normal pressure hydrocephalus (iNPH) and other neurodegenerative diseases can be challenging. The C9ORF72 repeat expansion has been associated with frontotemporal lobar degeneration (FTLD) and the penetrance of the C9ORF72 mutation is considered complete. We aim to determine the prevalence of the pathological C9ORF72 repeat expansion in Kuopio University hospital (KUH) NPH-register.

METHODS: We genotyped the repeat region of C9ORF72 by using repeat primed polymerase chain reaction (RP-PCR) in a cohort of 551 shunted patients who were all diagnosed with NPH. Frontal cortical biopsy was available for 347 patients. We cross-referenced the C9ORF72 expansion to neuropathological findings that included beta-amyloid-protein, tau-protein, p62 and TDP-43. All C9ORF72 expansion positive patients were clinically evaluated after laboratory analysis by a neurologist specialised in FTLD. All results were also read through using amplicon length analysis and positive ones were verified in collaborator´s laboratory.

RESULTS: The prevalence of the C9ORF72 repeat expansion was determined to be 1.1 % (6/551). Cortical biopsy was available for five expansion positive patients.

CONCLUSIONS: Prevalence of the C9ORF72 expansion in KUH NPH-register is greater than expected and there may be a possible comorbidity between FTLD and iNPH.

Abstracts


73

THE EXPRESSION OF TRANSTHYRETIN AND AMYLOID-Β PRECURSOR PROTEIN IS ALTERED IN THE BRAIN OF IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS PATIENTST Laiterä1,2, MI Kurki2, J-P Pursiheimo3, H Zetterberg4, S Helisalmi1, T Rauramaa5,6, I Alafuzoff7, AM Remes1, H Soininen1, A Haapasalo1, JE Jääskeläinen2, M Hiltunen1,8*, V Leinonen2*1 Institute of Clinical Medicine – Neurology, University of Eastern Finland and Department of Neurology,

Kuopio University Hospital, Kuopio, Finland2 Institute of Clinical Medicine – Neurosurgery, University of Eastern Finland and Neurosurgery of

NeuroCenter, Kuopio University Hospital, Kuopio, Finland3 Institute of Biomedicine, University of Turku, Turku, Finland4 Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry, The Sahlgrenska

Academy, University of Gothenburg, Gothenburg, Sweden5 Institute of Clinical Medicine - Pathology, University of Eastern Finland and Department of Pathology,

Kuopio University Hospital, Kuopio, Finland6 Department of Pathology, Kuopio University Hospital, Kuopio, Finland7 Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden8 Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland

INTRODUCTION: Idiopathic normal pressure hydrocephalus (iNPH) is a dementing condition in which Alzheimer’s disease (AD)-related amyloid-β (Aβ) plaques are frequently observed in the neocortex. iNPH patients with prominent Aβ pathology show alterations in amyloid precursor protein (APP) processing resulting from increased γ-secretase activity. We assessed potential alterations in the global gene expression profile in the brain of iNPH patients as compared to non-demented controls and evaluated the levels of the identified targets in the cerebrospinal fluid (CSF) of iNPH patients.

METHODS: The genome-wide expression profile of ~35000 probes was assessed in the RNA samples obtained from 22 iNPH patients and eight non-demented control subjects using a microarray chip. The levels of sAPPα, sAPPβ and transthyretin (TTR) were measured from the CSF of 102 iNPH patients using ELISA.

RESULTS: After correcting for multiple testing, significant differences in the expression of TTR and APP were observed between iNPH and control subjects. The mRNA levels of TTR were on average 17-fold lower in iNPH samples compared to control samples. Conversely, the expression level of APP was on average three times higher in iNPH samples as compared to control samples. The expression of α-secretase (ADAM10) was also increased in iNPH patients. In the lumbar CSF samples, soluble TTR levels showed a significant positive correlation with sAPPα and sAPPβ but TTR levels did not predict the brain pathology or the shunt response.

CONCLUSIONS: These findings suggest differences in the expression profile of key factors involved in AD-related cellular events in the brain of iNPH patients.

Abstracts


74

HIGH RISK OF DEMENTIA IN POSSIBLE IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS (INPH)AM Koivisto1, MI Kurki2, I Alafuzoff3, A Sutela4, J Rummukainen5, T Rauramaa5, S Savolainen2, R Vanninen4, JE Jääskeläinen2, H Soininen1, V Korhonen2, O Nerg1, AM Remes1, V Leinonen2

1 Department of Neurology, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland2 Department of Neurosurgery, University of Eastern Finland and Kuopio University Hospital, Kuopio,

Finland3 Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University and

Pathology and Cytology, Uppsala University Hospital, Uppsala, Sweden4 Department of Radiology, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland5 Department of Pathology, Kuopio University Hospital, Kuopio, Finland

INTRODUCTION: Differential diagnosis of idiopathic normal pressure hydrocephalus (iNPH) related symptoms is challenging. Patients with enlarged ventricles often manifest cognitive deterioration but their long-term outcome is not well known. We aim to evaluate long-term cognitive outcome in patients with enlarged ventricles and clinically suspected iNPH.

METHODS: A neurologist and a neurosurgeon clinically evaluated 468 patients with enlarged ventricles and possible NPH using radiological methods, intraventricular pressure monitoring, and frontal cortical brain biopsy. Eventually 236 patients were shunted. The neurologist confirmed final diagnoses after a median follow-up interval of 4.8 years.

RESULTS: The incidence of dementia among patients with enlarged ventricles, and at least one NPH-related symptom with adequate follow-up data (n=446) was high, varying from 77 (iNPH, shunt responders) to 141/1000 person-years (non-shunted patients with enlarged ventricles). At the end of the follow-up, 59% of all these patients were demented. The demented population comprised 73% of non-shunted patients with enlarged ventricles, 63% of shunted iNPH patients that did not respond to treatment, and 46% of iNPH patients that were initially responsive to shunting. The most common causes of dementia were Alzheimer’s disease (n=94, 36%) and vascular dementia (n=68, 26%). Along with wide range of specific causes of dementia also hydrocephalic dementia without any signs of other known causes of dementia was detected.

CONCLUSIONS: Dementia caused by various neurodegenerative diseases was frequently seen in patients with ventricular enlargement. Thus, careful diagnostic evaluation in collaboration with neurologists and neurosurgeons is emphasized.

Abstracts


75

TWENTY-THREE ALZHEIMER’S DISEASE –RELATED SINGLE NUCLEOTIDE POLYMORPHISMS IN PATIENTS WITH SHUNT-RESPONSIVE INPH - A BRIEF CLINICAL STUDYJ Huovinen1, S Helisalmi2, J Paananen2,3, AM Koivisto2, AM Remes2, H Soininen2, M Hiltunen2,3, MI Kurki1,4, JE Jääskeläinen1, V Leinonen1

1 Department of Neurosurgery, Kuopio University Hospital, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland

2 Unit of Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland and Department of Neurology, Kuopio University Hospital, Kuopio, Finland

3 Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland4 Analytical and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital,

USA, Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, USA Stanley Center for Psychiatric Research, Broad Institute for Harvard and MIT, USA

INTRODUCTION: Idiopathic normal pressure hydrocephalus (iNPH) is late onset, surgically treated progressive neurodegenerative disease caused by inadequate cerebrospinal fluid (CSF) dynamics and ventriculomegaly. Comorbid Alzheimer’s disease (AD) seems to be more prevalent in patients with iNPH, yet no overexpression of APOE epsilon 4 allele has been discovered in patients with iNPH.

MATERIAL – METHODS: Overall 188 shunt-responsive iNPH-patients and 688 age-matched controls without diagnosed neurodegenerative disease were included into analysis. 23 single-nucleotide polymorphisms (SNP:s) were analysed between groups [FRMD4A (rs7081208_A, rs2446581_A, rs17314229_T), CR1, BIN, CD2AP, CLU, MS4A6A, MS4A4E, PICALM, ABCA7, CD33, INPP5D, HLA_DRB5, NME8, EPHA1, PTK2B, CELF1, SORL1, FERMT2, SLC24A, DSG2, CASS4] between groups. Analyses were performed with SPSS statistics software (version 22.0, SPSS Inc., Chicago, Illinois). Using binary logistic regression analysis, each SNP was analysed with adjustments to age, sex and APOE-genotype.

RESULTS: NME8 AG-genotype was more common in iNPH-patients than no demented controls (p=0.044). With respect to other SNP:s, no other significant differences were discovered between groups.

CONCLUSIONS: Our findings support iNPH to have independent genetic and pathophysiological mechanisms independent from Alzheimer’s disease. Considering the fact NME8 plays a role in ciliary function and has SNP-related diversity in MRI-volumetry and CSF-biomarkers, the plausible ciliopathic dimension of iNPH as well as further genetic studies are required.

Abstracts


76

INTRACRANIAL COMPLIANCE AT REST AND AFTER INFUSION IN HYDROCEPHALUS PATIENTSA Lokossou1, O Balédent1, S Garnotel1, G Page1, L Balardy², Z Czosnyka3, P Payoux4, E Schmidt5,6

1 Departments of Medical Image Processing, BioFlowImage Laboratory, University Hospital of Picardie Jules Verne, Amiens, France

2 Departments of Geriatric, University Hospital of Toulouse, France3 Neurosciences Department, University of Cambridge, UK4 Departments of Nuclear Medicine, University Hospital of Toulouse, France5 UMR 1214 – INSERM/UPS – TONIC Toulouse Neuro-Imaging Center, France6 Departments of Neurosurgery, University Hospital of Toulouse, France

INTRODUCTION: Conventionally, intracranial compliance is assessed considering change in intracranial pressure (ICP) in response to a known volume change injected during the infusion tests (C_stress). We propose a new method to assess the physiological intracranial compliance at rest (C_rest) without any injection.

METHODS: 83 subjects (74 ± 7 years) suspected of hydrocephalus underwent a phase contrast magnetic resonance imaging for the quantification of the intracranial liquid volume change (ΔV) during cardiac cycle (blood and cerebrospinal fluid (CSF)). ICP amplitude at rest over the cardiac cycle (ΔP) was assessed from ICP monitoring before infusion to calculate C_rest=ΔV/ΔP. C_stress was calculated as usual by dividing the known injected volume by the pressure amplitude obtained by considering the end and the beginning of the injection. After infusion, resistance to CSF outflow (R

out) was calculated. Based on their R

out, the patients were affected in

a normal (Normal_inf) or a pathological group (Patho_inf).

RESULTS: In the Normal_inf group, C_stress=0.93±0.4 ml/mmHg and C_rest=0.28±0.21 ml/mmHg. In the Patho_inf group, C_stress=0.62±0.34 ml/mmHg and C_rest=0.19±0.13 ml/mmHg. For all the patients, C_stress was significantly higher than C_rest. These two compliance parameters were significantly lower in Patho_inf group than in Normal_inf group.

CONCLUSIONS: We have shown the possibility to assess the physiological intracranial compliance at rest. The values calculated were paradoxically smaller during this short period than during the long period of an infusion test. Nevertheless, because the C_rest values were different between both groups, C_rest could be used as a complementary biomarker to better select the patients who need shunt surgery care.

Abstracts


77

CSF FLUID DYNAMICS IN CHIARI MALFORMATION: A MRI STUDY OF LONGITUDINAL IMPEDANCEB Martin1, F Loth2, M Luciano3

1 Biological Engineering, University of Idaho, Moscow, USA2 Mechanical Engineering, University of Akron, USA3 Neurosurgery, Johns Hopkins University, Baltimore, USA

INTRODUCTION: Chiari Malformation 1 is defined as a herniation of the cerebellar tonsils below the foramen magnum and into the spinal canal. Although initially considered a congenital malformation it is increasingly understood as a CSF dynamic disorder where fluid differential pressures and cardiac pulsation may play a role in the pathophysiology. While the degree of descent of the tonsils into the spinal canal has been used as an index of symptom likelihood and candidacy for surgical decompression it has been found to unreliable and fluid dynamic parameters are being investigated.

METHODS: In this study we investigate the measurement of fluid impedance in the area of the cervicomedulary junction (longitudinal impedance, LI) using quantified phase-contrast MRI imaging in fifteen adult Chiari patients and eight normal controls.

RESULTS: Longitudinal Impedance was found to be increased in Chiari patients compared to normal controls and was variably decreased by decompressive surgery. The effect of this increased impedance on pulsatile brain tissue movement will also be discussed.

CONCLUSIONS: Chiari pathophysiology demonstrates an increased impedance to flow at the cervicomedullary junction that may be related to pathophysiology and symptoms, and that is variably reduced in surgery. The assessment of the cardiac-dynamic fluid-brain interaction in Chiari malformation may provide insights into the pathophysiology, symptom generation, and appropriate surgical treatment.

Abstracts


78

THE DISEASE STATE INDEX OUTPERFORMS CEREBROSPINAL FLUID TAP TEST IN SHUNT SURGERY OUTCOME PREDICTIONA Luikku1,2, A Hall1, O Nerg1,3, AM Koivisto1,3, M Hiltunen1,3,4, S Helisalmi1, A Junkkari2, SK Herukka1,3, A Sutela5, M Kojoukhova2,5, J Mattila6,7, J Lötjönen6,7, J Rummukainen8, I Alafuzoff1,9, JE Jääskeläinen2, AM Remes1,3, H Soininen1,3, V Leinonen2

1 Institute of Clinical Medicine - Neurology, University of Eastern Finland, Kuopio, Finland2 Neurosurgery of NeuroCenter, Kuopio University Hospital, Kuopio, Finland3 Neurology of NeuroCenter, Kuopio University Hospital, Kuopio, Finland4 Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland5 Department of Radiology, Kuopio University Hospital, Kuopio, Finland6 VTT Technical Research Centre of Finland, Tampere, Finland7 Combinostics Ltd, Tampere, Finland8 Department of Pathology, Kuopio University Hospital, Kuopio, Finland9 Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University and

Department of Pathology and Cytology, Uppsala University Hospital, Uppsala, Sweden

INTRODUCTION: Optimal selection of idiopathic normal pressure hydrocephalus (iNPH) patients for shunt surgery is challenging. Cerebrospinal fluid tap test (CSF-TT) is often used as a prognostic test for shunt surgery outcome evaluation, but its negative predictive value (NPV) is poor. Disease State Index (DSI) is a statistical method that merges multimodal data to assist clinical decision-making. In this study we predict shunt surgery response measured with iNPH Grading Scale (iNPH-GS) for patients with iNPH.

METHODS: 93 patients (42 shunt responders and 51 non-responders) for 3-month outcome and 97 patients (44 shunt responders and 53 non-responders) for 1-year outcome were analyzed with the DSI. iNPH-GS score and subscores, status of first and present symptoms, previous cerebrovascular disease and mean walking speed after CSF-TT were significant in our analysis. Statistical significance between groups was not observed with MMSE, ADCS-ADL –questionnaire, CT/MRI imaging, APOE-genotyping and CSF AD-biomarkers. Prognostic power for both DSI and CSF-TT were evaluated with Receiver Operating Characteristic (ROC) Curve analysis.

RESULTS: DSI was able to predict shunt surgery outcome effectively both for 3 months (ACC 65.9 %, SEN 66.8 %, SPE 65.1 %, PPV 61.2 %, NPV 70.5 %) and 1 year (ACC 68.6 %, SEN 66.6 %, SPE 70.2 %, PPV 65.0 %, NPV 71.7 %). CSF-TT was not useful for outcome prediction neither for 3 months (ACC 47.3 %, SEN 50.0 %, SPE 45.1 %, PPV 42.9 %, NPV 52.3 %) nor 1 year (ACC 47.4 %, SEN 47.7 %, SPE 47.2 %, PPV 42.9 %, NPV 52.1 %). Merging CSF-TT and DSI did not improve predictive value.

CONCLUSIONS: DSI can be used reliably to predict shunt surgery outcome, even for 1 year.

Abstracts


79

RELATIONSHIP BETWEEN INTRA-ABDOMINAL PRESSURE AND OUTCOME IN IDIOPATHIC INTRACRANIAL HYPERTENSIONS Matloob, C Craven, S Thompson, I Baudracco, AK Toma, LD WatkinsVictor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, UK

INTRODUCTION: IIH is more common in patients with a raised BMI. Increased intra-peritoneal pressure is likely to affect the functioning of CSF shunts. We aimed to investigate the relationship between intra-abdominal pressure and outcomes in patients with IIH. Idiopathic intracranial hypertension (IIH) is a difficult to treat condition. In a subset of patients, this condition results from venous stenosis. Stenosis can be primary or secondary to another cause. One theory is increased abdominal mass compresses the IVC giving rise to increased venous pressures resulting in a similar picture to IIH. We aimed to investigate the relationship between BMI and outcomes in patients with IIH.

METHODS: Case notes and radiological reports were reviewed. BMI for each patient was recorded as well as what interventions each patient had. Inferior vena cavae pressures (IVCP) measured during venography were recorded. The outcome in clinic was also recorded.

RESULTS: We identified 27 patients who had undergone venography as part of their assessment for IIH. IVCP ranged from 3-19mmHg (10.7+/- 5.04). 21/27 patients had IVCP > 8mmHg. BMI ranged from 25.9 - 63.4. Mean follow up was 9.4 months. Of these 27 patients 15 had undergone CSF drainage into the peritoneum. 60% of these patients had a BMI >30. We found a positive correlation between BMI and need to re-operate. These patients were advised to have bariatric surgery or pleural shunts.

CONCLUSIONS: Outcome was less likely to resolve symptoms in patients with an increased BMI. For patients with CSF drainage into the peritoneum the need for re-intervention was higher and the outcome in clinic was worse. Therefore patients with a raised BMI and evidence of IIH should be considered for atrial or pleural shunt or be considered for bariatric intervention.

Abstracts


80

VENOUS SINUS STENTING FOR IDIOPATHIC INTRACRANIAL HYPERTENSION - 2 YEAR FOLLOW UP STUDY OF 40 PATIENTSS Matloob, C Craven, S Thompson, I Baudracco, AK Toma, LD WatkinsVictor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, UK

INTRODUCTION: Venous sinus stenting is increasingly being used as a treatment option in patients with idiopathic intracranial hypertension. Venous hypertension is frequently observed in patients with IIH, and the pathophysiology behind this remains poorly understood. Pressure gradients across focal points of stenosis in the venous sinuses has been demonstrated and this pressure gradient has been shown to be obliterated once a stent is inserted. Furthermore we have been able to demonstrate a significant reduction in the ICP within 24 hours after stenting. We aim to present the follow up findings for these difficult to treat patients from our unit.

METHODS: A case note review was carried out for all patients with idiopathic intracranial hypertension that had undergone venous sinus stenting. Length of follow up was recorded and clinical outcome as well as ICP was noted.

RESULTS: 40 patients who had undergone venous sinus stenting were identified. Mean length of follow up was 24.1months (range 8-60months). 1 patient had a clinically silent intracerebral bleed during the stent insertion. 95% (38/40) of our patient cohort were female. On follow up venography 97.5% (39/40) of our patients demonstrated a significant reduction in their pressure gradient. Mean intracranial pressure was recorded following stenting in 27 patients, and of these 27 patients a significant reduction in ICP was recorded in 23 patients. Clinical improvement was recorded in 42.5% (17/40) of patients.

CONCLUSIONS: Venous sinus stenting is associated with a significant reduction in intracranial pressure and is effective in obliterating a pressure gradient across the venous sinus. This however does not correlate with clinical improvement, particularly with regards to improving symptoms of headache.

Abstracts


81

RESULTS OF VISION STUDY (VENOUS INTERVENTION VERSUS SHUNTING IN IIH FOR OPTIC DISC SWELLING) TRIAL PATIENT QUESTIONNAIREH Pulhorn1, A Chandran2, C McMahon1

1 Department of Neurosurgery, The Walton Centre, Liverpool, UK2 Department of Neuroradiology, The Walton Centre, Liverpool, UK

INTRODUCTION: Headaches, visual problems and tinnitus are symptoms of Idiopathic Intracranial Hypertension (IIH) which resolve with reduction of CSF pressure. Impaired cranial venous outflow has been implicated in the pathogenesis and there is evidence of good treatment results in IIH using venous sinus stenting. We are currently initiating a multi-centre randomised controlled trial, the VISION study (Venous Intervention versus Shunting in IIH for Optic Disc Swelling) comparing radiological (venous sinus stenting) to surgical intervention (CSF shunting).As part of the preparation for VISION we made a basic questionnaire available to members of the website IIH UK (www.iih.org.uk).

METHODS: 10-point questionnaire pertaining to IIH diagnosis, symptoms and management using www.surveymonkey.com.

RESULTS: 250 questionnaires were returned. 95.6% of respondents were female, mostly ≤ 40 years of age. 70% were diagnosed in the last 5 years, but only 35% were diagnosed less than a year after onset of symptoms. 59.4% of patients had not undergone any radiological/surgical intervention, 34.9% had had CSF diversion, 3.6% venous stenting and 2.0% had stent plus shunt. 16.8% indicated their lives were most affected by tinnitus and 18.1% by visual problems, but 49.6% said they were most affected by their headaches. 81% of patients indicated they would be happy to participate in a randomised trial comparing the two treatment options of venous stenting and CSF shunting.

CONCLUSIONS: IIH patients want to be actively involved in their treatment and are favourably disposed towards clinical research. Variation exists in treatment modalities offered. There are individual differences regarding impact of symptoms.

Abstracts


82

POTENTIAL MICRORNA BIOMARKERS FOR DIAGNOSIS OF IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUSI Jurjević1,2, M Miyajima1, M Nakajima1

1 Department of Neurosurgery, Juntendo University Graduate School of Medicine, Tokyo, Japan2 Department of Pharmacology and Department of Neurology, University of Zagreb School of Medicine,

Croatia

INTRODUCTION: Patients presenting with idiopathic normal pressure hydrocephalus (iNPH) triad often show some additional symptoms from the parkinsonian spectrum (PS) including progressive supranuclear palsy (PSP), or symptoms typical for Alzheimer’s disease (AD). Making the correct initial diagnosis is challenging, but it also strongly influences the long-term outcome of shunting procedures. The aim of this study was to find potential cerebrospinal fluid (CSF) microRNA biomarkers to distinguish patients with iNPH from PS and AD.

METHODS: Records of 55 patients with iNPH that were treated between the year 2011 and 2014 were retrospectively reviewed. CSF samples were obtained from patients clinically diagnosed with definite iNPH (n=21), possible iNPH with PS (n=18), and possible iNPH with AD (n=16). A two-step qRT-PCR analysis of the CSF samples was done to detect miRNAs that were differently expressed in the definite iNPH group.

RESULTS: From 1008 miRNAs, miR-1280 and miR-4274 showed most promising results, both distinguishing definite iNPH versus possible iNPH with PS (AUC = 0.997 and 0.913), and miR-1280 distinguishing definite iNPH versus possible iNPH with AD (AUC = 0.949) with high accuracy. Furthermore, the combination of these microRNA biomarkers and p-Tau clearly separated iNPH from PS and AD patients.

CONCLUSIONS: Potential microRNA biomarkers were identified in CSF of definite iNPH patients that could differentiate them from patients presenting with symptoms that are overlaping with other neurodegenerative disorders. Further investigations on larger number of patients would be useful to confirm these preliminary results.

Abstracts


83

ANTITHROMBOTIC DRUGS OR NEUROLOGICAL COMORBIDITIES MIGHT NOT BE A CONTRAINDICATION FOR SHUNT SURGERY ON PATIENTS WITH IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUSH Murai, T Shin, D KawauchiDepartment of Neurosurgery, Chiba University Graduate School of Medicine, Chiba, Japan

INTRODUCTION: Idiopathic normal pressure hydrocephalus (iNPH) is a disease of the elderly, there is a possibility that the number of complications are coexist. Shunt surgery if it is properly indicated and performed improves the patient’s QOL, but it might increase the risk of subdural hematoma (SDH). So we examined the effects of antithrombotic drugs or neurological comorbidities on the outcome.

METHODS: From July 2002 to May 2015, 290 cases of iNPH were diagnosed. In the 171 patients who underwent shunt surgery, comorbidities, preoperative cognitive function and the effects of antithrombotic drugs on SDH were examined.

RESULTS: Of the 171 patients subjected to surgery, neurological comoridities with dementia coexisted in 45 patients (26%), oral antithrombotic drugs were taken in 59 cases (34%). A median observation period was 3 years and 10 months. Chronic subdural hematoma was observed in 29 patients (17%, 4% per year), with non-surgical treatments the surgery was needed in only 7 patients (4.1%, 0.96% per year). Antithrombotic agents have the trend to increase the incidence, but it was not significant. There was no correlation between the outcome and preoperative cognitive function. Even if there is coexistence of other neurological disorders, most cases had some better period before deterioration.

CONCLUSIONS: 1) In case of coexistence with dementia, we recommend doing tap test even if the MRI image is typical and informing and negotiating well with the patients and their family. 2) The use of antithrombotic drugs did not appear to be a contraindication for shunt surgery.

Abstracts


84

COMPARISON OF LUMBOPERITONEAL SHUNT SYSTEMS USING SMALL LUMEN ABDOMINAL CATHETER VERSUS GRAVITAIONAL ADD-ON VALVE IN IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUSM Nakajima, M Miyajima, C Akiba, I Ogino, K Karagiozov, H AraiDepartment of Neurosurgery, Juntendo University School of Medicine, Tokyo, Japan

INTRODUCTION: Cerebrospinal fluid (CSF) shunt also has a role of improving clearance of CSF in addition to the role of adjusting intracranial pressure. Neurotoxic proteins in CSF is excreted by shunt treatment. As for lumboperitoneal shunt (LPS) that is used for treatment of iNPH, complications arising from CSF over-drainage (OD) are perceived as problematic. The objective of treatment is to avoid complications caused by OD, while maintaining the amount of CSF drained. For that it is necessary to create a shunt system that can avoid OD and also safely facilitate excretion of neurotoxic proteins such as Aβ42. To establish whether LPS by a shunt system that has gravitational add-on valves (GV) installed tandem in programmable pressure valve could reduce complications arising from OD due to iNPH and improve the condition of patients.

METHODS: The peritoneal catheter has a small (0.7 mm) inner lumen (SL) to preserve distal shunt resistance. GV, enables the surgeon to use different opening pressure for supine and standing positions, managing over drainage complications and patient discomfort. We compared two settings of Strata NSC valve shunt systems: one with attached GV and one with SL, under different performance levels. We analyzed 62 cases of iNPH patients (average age of 75.0yo) to whom LPS was implanted using GV + programmable pressure valves tandem from March 2013 through June 2015, and 54 cases (74.7yo) of treatment of iNPH from July 2010 through April 2012. By shunt systems with programmable pressure valves + SL with regard to OD complications one year after commencement of treatment, evaluating mRS, Japan NPH grading scale score, MMSE and CSF biomarkers; amyloid beta (Aβ) 42, p-tau.

RESULTS: As for complications due to OD, on the other hand, the rate of postoperative headache was 13.2% and that of chronic subdural hematoma that required surgery was 2.2%, showing a decreasing trend. mRS scores improved from 2.8 to 2.2, total JNPHGS decreased from 5.9 to 4.5. MMSE scores improved from 21.9 to 24.8. Aβ42, p-tau concentration were changed from 483 to 480 (pg/mL), 31.3 to 71.9 (pg/mL) respectively.

CONCLUSIONS: It was found that the complications of low CSF pressure syndrome peculiar to LP shunt tended to be decreased by the use of the add-on valve system. In the case where GV was used in tandem, the effect of insufficient excretion of CSF was assumed.

Abstracts


85

EFFECT OF LOW-LEVEL LASERTHERAPY IN PATIENTS WITH PAIN AMONG VENTRICULOPERITONEAL CATHETERRC Reis1, MJ Teixeira1, CG Valêncio1, D da Vigua1, L Almeida-Lopes2, MW Mancini2, FCG Pinto1

1 Group of Cerebral Hydrodynamics, Division of Functional Neurosurgery, Institute of Psychiatry, Hospital das Clínicas, University of São Paulo, Brazil

2 Núcleo de Pesquisa e Ensino de Fototerapia nas Ciências da Saúde (NUPEN), São Carlos, Brazil

INTRODUCTION: Pain among catheter is a common complaint in patients with ventriculoperitoneal shunt. Low-level lasertherapy (LLLT) has been applied in the treatment of different types of pain. We sought to evaluate LLLT efficiency in treating ventriculoperitoneal catheter pain.

METHODS: Randomized, placebo-controlled, double-blind study with patients treated in a clinics of a tertiary referral hospital complaining of pain among catheter. They were randomized in two groups: one treated with LLLT (infrared diode laser, Therapy XT EC: 808nm) and the other received sham-laser. Applications were done twice a week, through 4 weeks. Patients evaluated pain intensity before first session of lasertherapy and after 2, 4 and 8 weeks of treatment, using pain visual analog scale (VAS) and McGill questionnaire.

RESULTS: Until now, 2 patients were randomized to LLLT group and 2 to sham-laser group. Patients submitted to LLLT had an initial score of 7 in VAS, turning to a mean score of 3 in 4 weeks. When submitted to McGuill questionnaire, pain score also decreased from 24 to 5. One month after treatment, though, both scores increased: mean of 6 in VAS and 20 in McGuill. Patients treated with sham-laser did not get better during treatment: VAS score decreased from 8 to 7 and McGuill decreased from 19 to 18. There were no side effects of LLLT in this study.

CONCLUSIONS: Our results showed important analgesic action of LLLT in patients complaining of ventriculoperitoneal catheter pain, without side effects. This effect seems to be temporary and dependent of multiple applications.

Abstracts


86

APPLICATION OF A 980-NANOMETER DIODE LASER IN NEUROENDOSCOPY: A CASE SERIESRC Reis1, MJ Teixeira1, MW Mancini2, L Almeida-Lopes2, MF de Oliveira1, FCG Pinto1

1 Group of Cerebral Hydrodynamics, Division of Functional Neurosurgery, Institute of Psychiatry, Hospital das Clínicas, University of São Paulo, Brazil

2 Núcleo de Pesquisa e Ensino de Fototerapia nas Ciências da Saúde (NUPEN), São Carlos, Brazil

INTRODUCTION: Ventricular neuroendoscopy represents an important advance in the treatment of hydrocephalus. High-power (surgical) Nd:YAG laser and low-level laser therapy (using 685-nm-wavelength diode laser) have been used in conjunction with neuroendoscopy with favorable results. This study evaluated the use of surgical 980-nm-wavelength diode laser for the neuroendoscopic treatment of ventricular diseases.

METHODS: Nine patients underwent a neuroendoscopic procedure with 980-nm diode laser. Complications and follow-up were recorded.

RESULTS: Three in-hospital complications were recorded (1 intraventricular hemorrhage and 2 meningitis cases). The remaining 6 patients had symptom improvement after endoscopic surgery and were discharged from the hospital within 24–48 hours after surgery. Patients were followed for an average of 14 months: 1 patient developed meningitis and another died suddenly at home. The other patients did well and were asymptomatic until the last follow-up consultation.

CONCLUSIONS: The 980-nm diode laser is considered an important therapeutic tool for endoscopic neurological surgeries. This study showed its application in different ventricular diseases.

Abstracts


87

DIAGNOSIS AND TREATMENT OF NORMAL PRESSURE HYDROCEPHALUS BY A MULTIDISCIPLINARY TEAMRH Maykot, G Calia, J Tornai, SSS Silvestre, G Mendes, V Sousa, B Bezerra, P Dutra, P Modesto, MF Oliveira, RC Reis, CE Petitto, FCG PintoGroup of Cerebral Hydrodynamics, Division of Functional Neurosurgery, Institute of Psychiatry, Hospital das Clínicas, University of São Paulo, Brazil

INTRODUCTION: Normal pressure hydrocephalus (NPH) is characterized by gait apraxia, urinary incontinence and several degrees of dementia. Usual diagnosis is based in classic triad and neurological image and advocated treatment needs a shunt placement. Nevertheless, there are few reports of a full multidisciplinary team evaluation, in order to maximize diagnosis and outcomes, including neuropsychologists, nutritionist, music therapists and physical therapists

METHODS: From 2014 to 2015, a pilot evaluation of 25 patients with NPH was performed, according to specific music therapy evaluation, neuropsychologic tests and physical therapy in addition to neurological and neurosurgical approach. Patients were evaluated before and after surgery of ventriculoperitoneal shunt, with a follow-up of 1 year. We evaluated pre and post operative body mass index, Mini-Mental State Examination, Timed Up and Go and a music therapy assessing tool.

RESULTS: The evaluation in a multidisciplinary approach increased sensibility for diagnosing NPH. We did not perform VPS only with clinical and radiological patterns, but also with positive results in multidisciplinary evaluation. Additionally, the presence of neuropsychologist improved cognitive rehabilitation and motor rehabilitation improved by physical therapist.

CONCLUSIONS: A multidisciplinary team is able to increase sensibility in diagnosing and following patients with NPH before and after surgery, detecting subtle alterations and allowing maximal functional rehabilitation.

Abstracts


88

SLEEP APNEA AND LEPTIN RESISTANCE IN IDIOPATHIC INTRACRANIAL HYPERTENSION SYNDROME.AS Rao, M Jumaly, D Solomon, A MoghekarThe Johns Hopkins Hospital, Baltimore, USA

INTRODUCTION: Obesity is a risk factor for both Idiopathic intracranial hypertension syndrome (IIHS) and sleep apnea( SA). Studies have demonstrated the relationship between elevations in intracerebral pressure and sleep apnea (1) as well as shown a relationship between papilledema and OSA. (2) In our sample 39% of patients with IIHS were shown to have SA. Thus far, there are no human studies on neurochemical factor that may play a role in the susceptibility of this population to sleep disordered breathing. Current literature has shown low leptin levels in obese patients with SA. In addition leptin is well known for it’s adipogenic properties (3). Animal studies have demonstrated a role for the adipocytokines especially Leptin which is deficient in the cerebrospinal fluid (CSF) leptin in obese animals, a phenomenon is known as of “leptin resistance” (4). However, this has not been tested in patients with IIHS. Our hypothesis is that patients with IIHS are more susceptible to OSA due to obesity and/or leptin resistance. Through this study we plan to explore further the anthropometric characteristics that make subjects with IIHS more susceptible to sleep disordered breathing. We also plan to analyze the CSF from these subjects for evidence of leptin resistance as well as other possible neurohumoral factors which may play a role in the pathophysiology. Objectives: 1. To identify the underlying clinical characteristics of Obstructive Sleep Apnea (OSA) in patients diagnosed with Idiopathic intracranial hypertension syndrome (IIHS). 2. To characterize the relationship between obesity and leptin levels in patients with both IIHS and OSA.

METHODS: Adults ≥ 18 years of age in The Johns Hopkins center for CSF Disorders with a confirmed diagnosis of IIHS who provided informed consent were selected for the study. These patients undergo an evaluation that includes a history (including a sleep and headache questionnaire) and physical exam, lumbar puncture to measure opening pressure and a detailed examination for visual abnormalities. Neuroimaging is obtained as part of the diagnostic workup. For our project we will included a detailed sleep history administered by the Sleep Fellow (including The Epworth sleepiness score and the Hopkins sleep survey) and examination relevant to sleep disordered breathing (including BMI, neck circumference and examination of the oropharynx) to identify those with SA risk factors. Patients who were identified as high probability of having sleep apnea underwent an overnight polysomnogram. The sleep studies were scored using standard AASM scoring criteria. CSF and blood which is obtained as part of routine care was tested for leptin levels in all subjects. Independent variables: Opening pressure, CSF leptin, Plasma leptin, Apnea-Hypopnea index, oxygen desaturations, arousals, and carbon dioxide recordings where available. Covariates: We recorded demographic and anthropometric measurements, medical comorbidities and medications.

RESULTS: Data from a total of 18 patients was collected. Higher opening pressures were found in subjects with with higher BMI (p=0.03) and SA (p=0.05). Leptin concentrations in CSF were not correlated to the plasma level (r = 0.5; P = 0.216). CSF leptin levels were not correlated to body mass index (r = 0.14; P = 0.567). Opening pressure did not correlate with CSF leptin levels (r =0.96; P=0.732)

CONCLUSIONS: Obesity is a risk factor for both PTC and OSA and is characterised by leptin resistance due to poor penetration through the blood- brain barrier. Leptin has been shown to be protective against OSA (5). Our pilot data demonstrates that in subjects with IIHS those with higher BMI and SA had higher opening pressures. Our analysis of leptin levels in subjects with IIHS and SA did not demonstrate a correlation between CSF and serum leptin as is seen in obesity and SA, ie “leptin resistance”. There was also no correlation with BMI which was a surprising finding. This suggests that the neurochemical pathways associated with leptin in IIHS are unique and distinct from its role in adiposity.

Abstracts


89

A COMPARISON OF FOUR ETIOLOGIC SUBTYPES OF ADULT HYDROCEPHALUS FROM THE AHCRN PATIENT REGISTRYN Relkin1, M Hamilton2, H Katzen3, M Williams4, T Bach5, S Zuspan5, R Holubkov5

1 Weill Cornell Medical College, Department of Neurology, New York, USA2 University of Calgary, Department of Neurosurgery, Alberta, Canada3 University of Miami, Department of Neurology, Miami, USA4 Washington University, Department of Neurosurgery, Seattle, USA5 University of Utah, Utah Data Collection Center (DCC), Salt Lake City, USA

INTRODUCTION: This is the first multicenter observational study to compare four different etiologic subtypes of hydrocephalus in adults: idiopathic (iNPH), acquired (aNPH), transitional (t-Hydro) and congenital (c-Hydro). This interim analysis was triggered by accrual of 200 subjects from five sites in the US and Canada in the Adult Hydrocephalus Clinical Research Network (AHCRN).

METHODS: Informed consent was obtained under IRB-approved protocols from subjects >=18 years who met pre-specified clinical and imaging criteria. This study examined baseline demographics, co-morbidities and selected clinical measures. Analyses included descriptive statistics and t-tests to evaluate the significance of group differences.

RESULTS: Subjects ranged in age from 18-88 years of age with a slight predominance of males. The iNPH group was the oldest and tHydro the youngest. Percentages of subjects with the respective subtypes of hydrocephalus varied significantly across sites. All t-Hydro subjects were treated by shunt or ETV, whereas the majority of others were untreated. Hypertension was most common in iNPH and relatively rare in t-Hydro and c-Hydro. Epilepsy was over-represented in tHydro. Increased frequencies of hypertension, diabetes, coronary artery disease, spinal stenosis, obesity and sleep apnea were observed in iNPH. Gait, urinary and cognitive measures showed the greatest impairment in iNPH.

CONCLUSIONS: This pilot study highlights important group differences exist among adults with four hydrocephalus etiologies. Differences in rates of enrollment by etiologic subtype across sites may have contributed ascertainment bias. Age and treatment status are possible co-variates. A possible association between sleep apnea and iNPH has not been widely reported and deserves further study.

Abstracts


90

VARIATIONS IN HEALTHCARE EXPENDITURES OF MEDICARE BENEFICIARIES WITH HYDROCEPHALUS OVER A DECADE: 1999 VERSUS 2008A Rigamonti1, J Lu2, J Robison2, A Adam2, G Clemens3, P Sharkey4, K Carson3, A Sanyal3, T Vivas-Buitrago2, I Jusué-Torres2, J Hoffberger2, E Sankey2, D Rigamonti2

1 Cornell University, Ithaca, NY USA2 Department of Neurosurgery, Johns Hopkins University, Baltimore, USA3 Bloomberg School of Public Health, Johns Hopkins University, Baltimore, USA4 School of Business, Loyola University Maryland, USA

INTRODUCTION: In 2007 Williams et al published an analysis of total Medicare costs for patients with a diagnosis of Hydrocephalus using Medicare data from 1999. Costs significantly changed over the last decade. This study’s goal was to determine whether Hydrocephalus diagnosis prevalence and surgical treatment (including associated costs) of Medicare patients have changed over time. The impact of costs averted from Hydrocephalus due to these interventions was reviewed.

METHODS: This retrospective cost analysis, mirroring Williams et al, 2007 study was performed using the standard analysis files of paid claims for beneficiaries enrolled in both part A (inpatient) and part B (outpatient) of the Medicare program for 2008. Some outcome measures were Hydrocephalus prevalence, five-year total direct medical payment and costs by specific service-types.

RESULTS: In 2008 alone, 2,378 patients, 0.2% of the Medicare beneficiaries were diagnosed with Hydrocephalus (a 1.65-fold increase from 0.12% in 1999). Of these, 637 patients, 26.8%, underwent shunt surgery (an increase from the 25.1% in 1999). 2008 data suggests on average shunted patients spend $10,256 ($2,051/year) more over five years than patients without shunts. This is dramatically different than 1999 data, which showed patients saved on average $25,477 ($5,095/year) over a 5-year span. The majority of this change comes from hospital costs, which shifted from $18,565 cheaper to $10,737 more expensive for shunted patients over 5 years.

CONCLUSIONS: From 1999 to 2008 the rate of Hydrocephalus diagnosis increased 1.65 fold. Besides the increase of confirmed cases, both surgical intervention and subsequent hospitalization costs have significantly increased.

Abstracts


91

ASSESSING THE BURDEN OF CARE OF THE ELDERLY IN THE KINGDOM OF SAUDI ARABIAK Rigamonti1, J Robison1, J Lu1, A Adam1, A Sattar2, O Omoush2, S Naqvi3, T Vivas-Buitrago1, D Rigamonti1

1 Department of Neurosurgery, Johns Hopkins University, Baltimore, USA2 Primary Care, Johns Hopkins Aramco Healthcare, Ras Tanura, Saudi Arabia3 Primary Care, Johns Hopkins Aramco Healthcare, Abqaiq, Saudi Arabia

SUMMARY: Stress of caring for an elderly person can have a negative impact on a caregiver’s health and well-being. Lack of functional independence in the elderly has been shown to increase caregiver’s burden, both in the quantity of time and resources needed as well as changes in personal health relationships of the caregiver in charge. But establishing associations in caregiver’s burden across different culture and regions in the world is unclear and less studied. Given the lack of knowledge on the caregiver-patient structures seen within Johns Hopkins Aramco Healthcare (JHAH), the primary aims of this exploratory study are to (1) define caregiver-patient demographics for the region and (2) identify the relationship between aspects of caring context and caregiver health as measured by quality of life. This study involves prospective data collection of geriatric patients seen at JHAH who will be assessed on their ability to carry out their activities of daily living by administering the Barthel Index. Eligible patients and their primary caregivers will be asked to participate in the voluntary survey. The caregivers will be assessed on their quality of life (SF-36) and burden from caregiving role (Zarit burden questionnaire). The patients will be assessed on their quality of life (SF-36). This study clarifies the type of caregiver and caregiver duties specific to JHAH, the effect of the burden on the caregiver and ways to improve caregiver well-being.

Abstracts


92

LUMBAR PUNCTURES MAY PREDICT THE QUANTITATIVE GAIT IMPROVEMENT EXPECTED POST-SHUNTING IN PATIENTS WITH INPHJ Lu, J Robison, A Adam, T Vivas-Buitrago, A Hung, D RigamontiDepartment of Neurosurgery, Johns Hopkins University, Baltimore, USA

INTRODUCTION: Lumbar punctures (LP) are often used as a diagnostic measure in patients with idiopathic normal pressure hydrocephalus (iNPH) as they mimic the effects of ventricular shunting. Gait improvement after an LP is used to determine which patients could benefit from undergoing surgical treatment for iNPH. In this abstract, we seek to correlate the quantitative improvements in post-LP gait assessment with the improvements in post-shunt gait assessments.

METHODS: All patient records of shunt procedures by the senior author at Johns Hopkins Medical Institution, from 1993 to 2014, were reviewed (n=150). All patients completed gait evaluation at baseline, post-LP, and again six months post shunt surgery. Clinical outcomes measured were Tinetti Gait and Balance Scale and Timed Up and Go test (TUG). Wilcoxon signed rank tests were performed using STATA 13.0.

RESULTS: The mean improvement at post-LP and six-month from baseline TUG was 4.6 (2.0–7.2) and 5.8 (0-11.7) seconds respectively and 2.9 (2.3–3.6) and 4.2 (2.6–5.8) points respectively on baseline Tinetti. While both tests show significant statistical improvement from baseline at post-LP and 6 months (p-value<0.001), only the TUG showed statistical improvement in the post-LP to 6-month period (p-value <0.001).

CONCLUSIONS: Patients showed as much improvement in all gait parameters at six months as they did after the diagnostic LP. For the TUG test, patients can actually expect to see even more improvement post-surgery than they saw after the initial LP.

Abstracts


93

DOPAMINERGIC LOSS IN PATIENTS SUSPECT OF HYDROCEPHALUSE Schmidt1,5, F Ory-Magne2,5, L Balardy3, P Gantet4, P Payoux4,5

Departments of Neurosurgery1, Neurology2, Geriatry3 and Nuclear Medicine4, University Hospital Toulouse, France, INSER TONIC 10145

INTRODUCTION: Dementia with Lewy bodies (DLB) is the third most common cause of dementia after Alzheimer’s disease and vascular dementia. Diagnosis of probable DLB can be made by fluctuating mental status, visual hallucinations, and mild parkinsonism with hypokinetic gait. DLB is associated with a significant loss of dopaminergic cell. This loss can be confirmed in vivo with DaTcan, a brain imaging of the dopamine transporter. Hydrocephalus if often associated with a Parkinsonism. The aim of this work is to assess the dopaminergic denervation in a group of patient suspected of NPH.

METHODS: A prospective cohort of 86 patients suspected of NPH has been included. For every patient, a lumbar infusion study has been performed with calculation of hydrodynamic parameters. DaTscan has been performed with image analysis by DaTsoft3D software for quantification of the dopaminergic neurons activity. We quantified the left and right activities of the caudate nucleus and putamen. We also calculate the putaminal index (PI=min of putamen − 0.5 × |right putamen – left putamen|. This index allows below 2 indicates an dopaminergic cell loss vs healthy controls.

RESULTS: In our group, the mean activities were: right caudate: 3,54 ± 0,94, right putamen: 2,48 ± 0,89, left caudate: 3,45 ± 0,98, left caudate: 2,38 ± 0,89 and putaminal index: 1,88 ± 0,91 that indicates a clear dopaminergic denervation. There was no correlation between the hydrodynamic parameters and the dopaminergic activity.

CONCLUSIONS: We demonstrate a dopaminergic denervation in our patient suspected of NPH but did not identify in a preliminary analysis any subgroups of patients.

Abstracts


94

INTRACRANIAL VENOUS PULSATILITY IS REDUCED AFTER TRANSVERSE SINUS STENOSISA Guenego1,2, AC Januel1, P Tall1, N Fabre3, L Mahieu4, Z Czosnyka5, C Cognard1, E Schmidt2

Departments of Neuroradiology1, Neurosurgery2, Neurology3 and Ophtalmology4, University Hospital Toulouse, France, 5Brain physics lab, Academic Neurosurgery, University of Cambridge, UK

INTRODUCTION: Transverse sinus stenosis is seen in the majority of patients with idiopathic intra-cranial hypertension (IIH). In case of a significant pressure gradient, transverse sinus is stented to reduce cerebral venous pressure, improve CSF resorption, reduce ICP and papilledema. However the pathogenesis of sinus stenosis and its effect on the cerebral venous system remain controversial. We hypothesize that transverse sinus stenosis stenting modifies the dynamic component of venous pressure.

METHODS: 10 IIH patients were prospectively enrolled. Under general anesthesia, a microcatheter was navigated into cerebral veins and sinuses. Intra sinus pressure was measured and recorded upstream and downstream the stenosis with a pressure transducer connected to the micro catheter. A stent was placed if a significant pressure gradient (>10 mmHg) was found across the stenosis. Finally pressure was measured upstream and downstream the stented stenosis. Off line mean venous pressure (VP) was calculated and waveform analyses were performed to extract fundamental harmonic A1 (heart-rate), second harmonic A2 (2*heart-rate), and respiratory component (Resp). Parameters are presented before and after stenting (mean±SD) upstream and downstream the stenosis with p value (Kruskal-Wallis test).

RESULTS: Stenting significantly reduces mean venous pressure upstream the stenosis, which is expected. Stenting also significantly reduces fundamental harmonic A1 upstream with a trend in A1 decrease downstream the stenosis.

CONCLUSIONS: Transverse sinus stenosis stenting reduces mean venous pressure and venous pressure pulsatility. This might have indirect effect on CSF dynamics and ICP amplitude. Sinus stenting yields complex venous pressure profile changes and possibly in brain biomechanics.

Abstracts


95

INFLUENCE OF DIABETES MELLITUS ON CSF AND BRAIN CHARACTERISTICSE Schmidt1, Z Czosnyka2, L Balardy3

1 Department of Neurosurgery, University Hospital Toulouse, France2 Brain physics lab, Academic Neurosurgery, University of Cambridge, UK3 Department of Geriatry, University Hospital Toulouse, France

INTRODUCTION: Diabetes mellitus (DM) represents a major cause of morbidity and mortality worldwide. DM is an independent risk factor for cerebrovascular disease. DM is associated with an increase in the risk of brain atrophy and dementia. The WHO diagnostic criteria for DM is fasting plasma glucose ≥ 7.0 mmol/L. As well, glycated haemoglobin (HbA1c) reflects average plasma glucose over the previous 2–3 months. An HbA1c of 6.5 % is recommended as the cut off point for diagnosing diabetes. DM is considered as a co morbidity of normal pressure hydrocephalus (NPH). We hypothesize that DM has an influence on ICP, CSF circulation and brain biophysical characteristics.

METHODS: In a prospective cohort of 91 patients suspected of NPH, we performed lumbar infusion tests and measured at the same time plasma glucose and HbA1C. To understand the influence of DM on ICP and CSF/brain characteristics we dichotomized our cohort into 2 sub-groups: one diabetic and one non-diabetic. According the WHO, we characterized our 2 sub-groups with glycemia and HbA1C: patients with normal glycemia (i.e. < 7.0 mmol/L) or high glycemia (i.e. ≥ 7.0 mmol/L) and patients with normal HbA1c (i.e. < 6.5 %) or high HbA1c (i.e. ≥ 6.5 %). Then we compared the data in the diabetic and non-diabetic subgroups with Student test.

RESULTS: The table below gives mean±sd values of various parameters in each diabetic and non-diabetic subgroup.

CONCLUSIONS: Our data suggest that patients with DM have stiffer brain with less CSF production rate and more resistive CSF outflow.

Abstracts


96

SUBCOMMISSURAL ORGAN INVOLVEMENT IN NIEMANN-PICK TYPE C DISEASED Solomon1, L Gray2, JA Buttner-Ennever3

1 Neurology, Johns Hopkins Hospital, Baltimore, USA2 Deceased3 Anatomy and Cell Biology, Ludwig-Maximilians-University, Munich, Germany

INTRODUCTION: The subcommissural organ has been implicated in the development of congenital hydrocephalus, and some genetic models of hydrocephalus involve disrupting the development or function of this structure located along the ependyma of the caudal third ventricular at the posterior commissure. Ocular motor pathways important in vertical gaze traverse the posterior commissure; deficits in downward saccadic eye movement is a hallmark of Niemann-Pick Type C (NPC), an autosomal recessive neurodegenerative condition that interferes with trafficking and transport of cholesterol and glycolipids.

METHODS: EM first manifest ataxia in her teens, with progressive neurologic symptoms of dysarthria, psychosis, inability to voluntarily initiate downward eye movements and hepatosplenomegaly.

RESULTS: MRI brain showed atrophy, low signal abnormality in the thalamus, globus pallidus, putamen and external capsule bilaterally. Post-mortem examination showed glial plaque displacing the posterior commissure anteriorly, originating in the subcommissural organ (SCO, also called the subnucleus dorsalis or nucleus subcommissuralis of Carpenter). This structure is composed mainly of glia with fenestrated capillaries abutting the ventricle.

CONCLUSIONS: Alterations in secretory function, blood brain barrier and or glycoproteins (Reisner’s fiber) may contribute to hydrocephalus during development and metabolic neurodegeneration in adulthood.

Abstracts


97

ANTHROPOMORPHIC IN VITRO SURVIVAL STUDY OF SHUNT VALVES WITH AND WITHOUT ANTI SIPHONING DEVICE USING POST SUBARACHNOID HEMORRHAGE CSFD Solomon2, M Luciano1

1 Department of Neurosurgery, Johns Hopkins Hospital, Baltimore, USA2 Department of Neurology, Johns Hopkins Bayview Medical Center, Baltimore, USA

INTRODUCTION: Devices have been developed to limit drainage of CSF in the upright posture using gravitational, membrane controlled and flow limiting designs. We chose to study the Codman SiphonGuard flow-regulated anti-siphoning device, to determine if the extra fluid channel makes it susceptible to blockage from elevated CSF protein.

METHODS: Human CSF is collected and stored from patients in Johns Hopkins Neuroscience Critical Care Unit with an IVC following intraventricular or subarachnoid hemorrhage. Red blood cell count is reduced <1000 cc by freezing and centrifugation. Pooled CSF preserved with sodium azide (0.08%) is analyzed daily for desired protein concentration (5g/L) and adjusted using sediment or dilution. Fluid, intraventricular catheters and shunts are maintained at body temperature (37 C) in a shaking, thermal controlled water bath. Collection chamber height re: shunt valve is changed to mimic daily upright and recumbent postures. Gravitational flow is used, and physiologic pulsatility mimicked by shaking water bath oscillations at 1 Hz. Testing lasts 30 days, after which valves will be pressure-flow tested per ISO-7197.

RESULTS: Initial flow studies are currently underway; results will be available at the time of presentation.

CONCLUSIONS: We present an in vitro method for testing shunt survival in patients requiring CSF diversion after subarachnoid or intraventricular hemorrhage, taking into account effects of abnormal CSF contents, orthostatic postural changes and concomitant use of anti-siphoning devices with programmable shunt valves. Findings should help with the selection and timing of shunt systems in survivors of intracranial hemorrhage.

Abstracts


98

TWO-YEAR OUTCOME OF VA SHUNT FOR INPH EVALUATED BYMODIFIED RANKIN SCALEK Takagi1, K Onouchi2

1 Normal Pressure Hydrocephalus Center, Kashiwa-Tanaka Hospital, Kashiwa, Japan2 Department of Neurology, Kashiwa-Tanaka Hospital, Kashiwa, Japan

INTRODUCTION: Shunt surgery is the only treatment for iNPH. Although VA shunt has been almost abandoned, it has many advantages. We have selected VA shunt as a first choice surgery for iNPH. The purpose of this study is to report the 2-year outcome of VA shunt evaluate by mRS..

METHODS: Between January 2012 to December 2013, 137 VA shunts were performed for NPH. From these patients, those less than 60 yo, with secondary NPH, and with advanced Alzheimer’s disease were excluded. Patients with Evans Index less than 0.3 were included. Eighty-nine cases were the candidate for this study. The mRS was evaluated before the surgery (pre), 6 moths (6m), 1 year (1y), and 2 years (2y) after the surgery. The data was shown in mean (SD). The outcome at each time point was compared with preoperative condition. Statistic analysis was carried out with Dunnett’s multiple comparison test. Statistic significant level was set at p < 0.05.

RESULTS: Mean age at the surgery was 78.08 (5.38) years old (male : female = 43 : 28). Mean mRSs for pre, 6m, 1y, and 2y were 2.68 (0.99), 1.72 (1.19) (p < 0.0001), 1.71 (1.19) (p < 0.0001), and 1.90 (1.20) (p < 0.0001) respectively.

CONCLUSIONS: Although the patients were old at the surgery and those with Evans Index less than 0.3 were include, the VA shunt significantly improved the mRS of iNPH patients up to 2 years after surgery. This study suggests that VA shunt should be the first line for iNPH.

Abstracts


99

THE GAVCA STUDY – RANDOMIZED, PROSPECTIVE MULTICENTER TRIAL TO EVALUATE THE EFFECT OF A MOBILE HEALTH APPLICATION TO ASSIST VENTRICULAR CATHETER GUIDANCEUW Thomale1, A Schaumann1, F Stockhammer2, H Giese3, D Schuster4, S Kästner5, S Ahmadi6, S Szeöke7, M Polemikos8, HC Bock2, L Gölz9, J Lemcke9, E Herrmann8, M Schuhmann7, T Beez6, MJ Fritsch4, B Orakciouglu3, P Vajkoczy1, V Rohde2, G Bohner10

1 Pediatric Neurosurgery and Department of Neurosurgery, Campus Virchow Klinikum, Charité Universitatsmedizin Berlin, Germany

2 Pediatric Neurosurgery and Department of Neurosurgery, Universitatsmedizin Göttingen, Germany3 Department of Neurosurgery, Universitatsklinikum, Heidelberg, Germany4 Department of Neurosurgery, Dietrich-Bonhoeffer-Klinikum, Neubrandenburg, Germany5 Department of Neurosurgery, Klinikum Kassel, Germany6 Department of Neurosurgery, Universitatsklinikum Düsseldorf, Germany7 Department of Neurosurgery, Universitatsklinikum Tübingen, Germany8 Department of Neurosurgery, Medizinische Hochschule Hannover, Germany9 Department of Neurosurgery, Unfallkrankenhaus, Berlin Marzahn, Germany10 Department of Neuroradiology, Campus Virchow Klinikum, Universitatsmedizin Berlin, Germany

INTRODUCTION: Freehand ventricular catheter placement was reported to be inaccurate up to a relevant proportion. Guidance technologies such as ultrasound imaging, neuronavigation or endoscopy are technically sophisticated relative to the short surgical procedure. The GAVCA study investigates the accuracy of a ventricular catheter guide assisted by a simple mobile health application (mhealth app) in a multicenter randomized controlled simple blinded study.

METHODS: In total, 139 eligible patients were enrolled in 9 study centers. Optimal catheter placement was evaluated by three components: a grading scale (I-IV), an anatomical position scale of the catheter tip and the rate of primary successful CSF draining puncture. The primary endpoint was defined as primary puncture with grade I ventricular catheter tip position in the ipsilateral ventricle being analyzed by a blinded neuroradiologist. The rate of intraventricular position of the perforated part of the catheter, early ventricular catheter failure and complications were analyzed as secondary endpoints.

RESULTS: The primary endpoint was reached in 70% of cases in the guided group versus 56.5% in the freehand group (p=0.099). The rate of incorrect catheter placement (non-primary, grade III+IV placement) was 10% versus 31.9% (p=0.001) respectively. The primary successful puncture rate was 100% versus 91.3% (p=0.012). Catheter perforations located completely inside the ventricle were achieved significantly more often in the guided treatment group (81.4%) compared to the freehand group (65.2%; p=0.031). No differences were seen in early ventricular catheter failure, complication rate or duration of surgery or hospital stay.

CONCLUSIONS: The guided application of a ventricular catheter enables a simple and safe method of catheter placement. The primary endpoint did show a non-significant difference, while the quality of catheter placement was shown by significantly avoiding incorrect placements and increasing the rate of completely intraventricular location of catheter perforations. Long-term follow-up is needed in order to evaluate differences in catheter survival in shunted patients.

Abstracts


100

TELEMETRIC MONITORING OF ICP WITHIN A SHUNT SYSTEM. A SINGLE CENTRE EXPERIENCE INCLUDING THE FIRST IN VIVO COMPARISON VERSUS CONVENTIONAL INTRAPARENCHYMAL MONITORING.S Thompson, LD Thorne, AK Toma, LD WatkinsThe National Hospital for Neurology and Neurosurgery, Queen Square, London, UK

INTRODUCTION: Recent technological advances have allowed for telemetric, non-invasive monitoring of ICP. This allows clinicians to measure ICP non-invasively, once implanted, and assess for possible shunt dysfunction. Most ICP monitors show some drift in the accuracy in readings over time, however both the Spiegelberg intraparenchymal ICP bolt system and Miethke Sensor reservoir systems are reported to have zero and low drift respectfully.

METHODS: The Miethke Sensor Reservoir® allows telemetric ICP reading once implanted as part of a shunt system. A retrospective case series of a single unit’s experience with the Miethke Sensor Reservoir® over a 4 year period was undertaken. This included the world’s first in vivo comparison between Sensor Reservoir® and Spiegelberg intraparenchymal bolt.

RESULTS: 13 Sensor Reservoirs® have been inserted between February 2012 and June 2016, mean follow-up 14.5months. There have been no reported complications. One patient has undergone measuring of ICP concurrently using Sensor Reservoir® and via a Spiegelberg intraparenchymal bolt 2.5 years after Sensor Reservoir® implantation. Miethke Sensor Reservoir® was within 1mmHg when compared against the spiegelberg bolt.

CONCLUSIONS: The Miethke Sensor Reservoir® has been a reliable clinical tool in the measurement of ICP 2.5 years after implantation. Patients have had their symptoms managed in accordance with ICP, resulting in improved outcomes and less surgical interventions.

Abstracts


101

CREATING AN NPH PATHWAY FOR NEW REFERRALSS Thompson, LD Thorne, LD Watkins, AK TomaThe National Hospital for Neurology and Neurosurgery, Queen Square, London, UK

INTRODUCTION: The NPH population are elderly, commonly suffering from multi-morbidities and are frail. Current practice at our hospital involves several out-patient appointments pre surgical admission, including initial surgeon review, anaesthetic assessment and baseline neuropsychological testing. We have commenced a one-stop polyclinic where patients can see all specialities in one day as well as being reviewed by an occupational therapist.

METHODS: iNPH patients traveling from long distances to central London has proved difficult for some of these elderly patients. Therefore we have developed a one-stop NPH polyclinic, allowing patients to see neurosurgeons, specialist nursing, occupational therapy, anaesthetics and neuropsychology in one day. Here we undertake a prospective cohort observational study to review its impact.

RESULTS: In the trial group, patients who attended the clinic were discharged, on average, day 4. This is compared against an average of day 5.6 for patients that did not pass through the clinic over the same period.

CONCLUSIONS: The one-stop clinic allowed for patients to be screened appropriately prior to admission. The input from Occupational therapists assessing patients and putting adequate resources in place where needed pre admission, proved essential in reducing the length of admission for these patients.

Abstracts


102

CEREBROSPINAL FLUID DISTURBANCE IN OVERWEIGHT WOMEN AFTER OCCIPITOCERVICAL DECOMPRESSION IN CHIARI MALFORMATION TYPE IF Almotairi, M TisellDepartment of Neurosurgery, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Sweden

INTRODUCTION: Cerebrospinal fluid disturbance (CSFD) is a well-known complication after occipitocervical decompression (OCD) in patients with Chiari malformation type I (CMI). There is scarce data focusing on preoperative patients’ factors predisposing to development of CSF disturbance. The aim of this study is to evaluate a prognostic value of some patients’ factors in the prediction of CSFD after OCD in CMI patients.

METHODS: We undertook a 10-year (2003-2013) retrospective study of all OCD in patients with CMI performed at Sahlgrenska IC, Sahlgrenska University Hospital, Sweden. A total of 52 consecutive patients were obtained from the operation database and we excluded one patient who was previously diagnosed with normal-pressure hydrocephalus. Data regarding preoperative age, body mass index, gender, degree of tonsillar herniation and syrinx were registered. Development of CSFD after OCD was noted.

RESULTS: Of the 51 patients reviewed, six had CSFD after OCD and were managed using a form of CSF diversion procedure. All of the patients who developed CSFD were females. They had a mean body mass index of 32.3 compared to a mean of 24.3 in patients without CSFD (p = 0.0011). There was no difference between the two groups with regard to the other examined patient factors.

CONCLUSIONS: CSF diversion was needed in six consecutive adult Chiari malformation type I patients who underwent occipitocervical decompression. All patients with postoperative CSFD were female and their mean BMI was significantly higher than patients without this complication.

Abstracts


103

THE APOE GENOTYPE IN IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUSY Yang1, M Tullberg1, K Mehlig2, A Rosengren3, K Torén4,5, H Zetterberg6,7, C Wikkelsø1

1 Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Sweden2 Department of Public Health and Community Medicine, Sahlgrenska Academy, University of

Gothenburg, Sweden3 Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg,

Sweden4 Section of Occupational and Environmental Medicine, Institute of Medicine, Sahlgrenska Academy,

University of Gothenburg, Sweden5 Occupational Medicine, Respiratory Diseases and Toxicology, University of Perugia, Italy6 Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the

Sahlgrenska Academy at the University of Gothenburg, Sweden7 UCL Institute of Neurology, Queen Square, London, UK

INTRODUCTION: Amyloid plaque has been reported in brain biopsies from patients with idiopathic normal pressure hydrocephalus (iNPH) and proposed as a significant feature of the pathophysiology. Presence of the apolipoprotein E ε4 (APOE ε4) allele is associated with increased risk of Alzheimer’s disease (AD). Aims: To compare the distribution of APOE genotype in iNPH patients with an age-matched control population and with Alzheimer’s disease (AD) patients.

METHODS: APOE genotype frequencies were determined in 77 iNPH patients (50 men and 27 women, mean age 71.7 years) diagnosed with iNPH, a sample of 691 AD patients and 638 age-matched population controls (299 men and 339 women) from the INTERGENE cohort.

RESULTS: The APOE distribution did not differ significantly between the iNPH patients and the control population. The per e4-allele odds-ratio (OR) of iNPH was given by OR = 0.90, 95% confidence interval (CI) = (0.50, 1.60) that was considerably smaller than the per-allele OR of AD, OR = 5.34 (4.10, 7.00).

CONCLUSIONS: The APOE genotype of iNPH patients reveals no APOE associated increased risk of developing AD.

Abstracts


104

ANATOMIC FACTORS ASSOCIATED WITH POST-HEMORRHAGIC HYDROCEPHALUS AMONG PREMATURE INFANTS WITH INTRAVENTRICULAR HEMORRHAGEHM Tully1, TL Wenger, WA Kukull, D Doherty, WB Dobyns1 Department of Neurology, University of Washington, Seattle, USA2 Department of Pediatrics, University of Washington, Seattle, USA3 Department of Epidemiology, University of Washington, Seattle, USA4 Department of Pediatrics, University of Washington, Seattle, USA5 Department of Pediatrics, University of Washington, Seattle, USA

INTRODUCTION: Intraventricular hemorrhage (IVH) is a complication of prematurity often associated with ventricular dilatation, which may resolve over time or progress to post-hemorrhagic hydrocephalus (PHH). We investigated anatomic factors that could predispose infants with IVH to PHH.

METHODS: We analyzed a cohort of premature infants diagnosed with Grade III-IV IVH between 2004 and 2014. Using ultrasounds and MRIs, we determined CSF obstruction pattern, skull shape and brain:skull ratios, comparing children with PHH to those with resolved ventricular dilatation (RVD), and comparing both groups to a set of healthy controls.

RESULTS: Among 110 premature infants with Grade III-IV IVH, 65 (59%) developed PHH. Infants with PHH had more severe ventricular dilatation compared to those with RVD, though ranges overlapped. Intraventicular CSF obstruction was observed in 36/42 infants (86%) with PHH and 0/18 (0%) with RVD (p<0.001). The distribution of skull shapes found among infants with PHH was similar to that of infants with RVD, though markedly different from controls. No significant differences in supratentorial brain:skull ratio were observed; however, the mean infratentorial brain:skull ratio of infants with PHH was 5% greater (more crowded) than controls (p=0.006), whereas the mean infratentorial brain:skull ratio of infants with RVD was 8% smaller (less crowded) than controls (p=0.004).

CONCLUSIONS: Among premature infants with IVH, intraventricular obstruction and infratentorial crowding are strongly associated with PHH. Prospective studies are required to determine how these anatomic factors relate to the disease process and whether they can be used to predict the need for surgical intervention.

Abstracts


105

VENTRICULAR-ATRIAL SHUNTING AS PRIMARY OPTION FOR THE TREATMENT OF NORMAL PRESSURE HYDROCEPHALUST Vivas-Buitrago1, J Lu1, J Robison1, A Hung1, A Adam2, E Sankey1, D Moran1, S Vakili1, MA Patel1, I Jusué-Torres1, B Elder1, CR Goodwin1, D Rigamonti1,3

1 Department of Neurosurgery, Johns Hopkins University, School of Medicine, Baltimore, USA2 Johns Hopkins Biostatistics Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA3 Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia

INTRODUCTION: Ventricular-peritoneal(VP) and ventricular-atrial(VA) shunting are the primary procedures for NPH. Given the invasiveness of the VA placement into the cardiovascular system and its possible complications, most surgeons have reserved this technique for cases with history of VP failure, intra-abdominal scaring/infection, and obese patients. This study aims to compare the complication rates between these two techniques.

METHODS: A retrospective chart review was conducted on all patients undergoing primary shunt-placement treatment for NPH by the senior author between 1993-2014. Analysis includes any complication related to the procedure.

RESULTS: 150 patients underwent VA shunt-surgery, while 435 patients underwent VP. Age ranged from 48 to 87 years for VA and 35 to 87 years for VP with an age-average of 74 years and 70 years respectively. 26% of VA patients had post-surgical complications vs a 25% of VP population. Subdural-Hematoma (SDH) was most common VA complication (17%) without need of surgical-evacuation vs 7% of SDH in VP shunt with surgical-evacuation needed in 19 % of these cases. Shunt-obstruction: (VA:7%) vs (VP:19%). Overdrainage: (VA:9%) vs (VP:7%). CSF infection (VA:1%) vs (VP:5%). Malpositioned-catheter: (VA:0.71% vs VP:1.31%). Shunt surgical revisions were needed in 11% of VAs vs 29% for VPs.

CONCLUSIONS: Our study suggests that VA compares favorably to VP shunting in regards to postsurgical complications. Furthermore, no cardiopulmonary complications related to VA placement were found. Given these facts, in our experience, we can conclude that in the absence of contraindications, ventricular-atrial shunting should be consider as the primary option for the treatment of NPH.

Abstracts


106

VENTRICULAR VOLUMETRIC ANALYSIS DURING HYDROCEPHALUS DEVELOPMENT IN AN ANIMAL MODEL OF ADULT CHRONIC HYDROCEPHALUST Vivas-Buitrago1, I Jusué-Torres1, J Lu1, J Robison1, A Adam8, JA Crawford3, MV Pletnikov3, J Xu4, A Blitz5, DA Herzka6, H Guerrero-Cazares1, A Quiñones-Hinojosa1,7, S Mori2, D Rigamonti1,9

1 Department of Neurosurgery, Johns Hopkins University, School of Medicine, Baltimore, USA2 Department of Radiology-Magnetic Resonance Research, Johns Hopkins University, School of Medicine,

Baltimore, USA3 Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, School of Medicine,

Baltimore, USA4 F. M. Kirby Research Center for Functional Brain Imaging at the Kennedy Krieger Institute, Johns Hopkins

University, School of Medicine, Baltimore, USA5 Department of Radiology and Radiological Science, Johns Hopkins University, School of Medicine,

Baltimore, USA6 Department of Biomedical Engineering, Johns Hopkins University, Baltimore, USA7 Department of Oncology, Johns Hopkins University, School of Medicine, Baltimore, USA8 Johns Hopkins Bloomberg School of Public Health, Baltimore, USA9 Johns Hopkins Hopkins Aramco Healthcare, Dhahran, Saudi Arabia

INTRODUCTION: The pathogenesis of ventricular enlargement and its correlation to symptomatology is not entirely understood. We correlated the temporal enlargement of the ventricular system(VS) with symptomatology.

METHODS: Kaolin was injected bilaterally into the subarachnoid space overlying the cranial convexities in 18 adult rats. MRI was performed on an 11.7-T scanner at 14, 60, 90 and 120 days post-injection. Volumes of the VS were measured and correlated with behavioral results biweekly.

RESULTS: Right and left ventricles showed non-linear trajectories, with the highest increase at 60 days, (p=<0.001, and, p=0.001, respectively). 3rd ventricle had a linear change volume,(p=0.002), synchronous with lateral ventricular enlargement. No significant change occurred in the 4th ventricle (p=0.086). No symptoms occurred in the first 68 days. Median time to first symptom:92 days. Most common symptom was anxiety=(83.3%), while the most common first symptom was gait change=(50%). There was a significant increase in odds for all clinical symptoms over time(p<0.001). Significant relationship was only observed between MRI volume and locomotor symptoms at any time point during the follow-up. Additionally, the odds of locomotor symptoms increase by 3% for every 1 additional mm3 of volume in left ventricle,(p=< 0.001). Similar estimate for the right ventricle at 1% increase per 1 mm3,(p=0.023) and slightly lower for the total MRI volume at 2%,(p=0.013).

CONCLUSIONS: Periodic ventricular volumetric measurement is feasible in this model given the slow progressive development of hydrocephalus. Late symptomatology presentation in this model allows a continuous in-vivo monitoring of the dynamics between ventricular enlargement and symptomatology.

Abstracts


107

SUB-VENTRICULAR ZONE (SVZ) STEM CELL EXPLORATION IN A NOVEL ANIMAL MODEL OF ADULT CHRONIC COMMUNICATING HYDROCEPHALUST Vivas-Buitrago1, I Jusué-Torres1, J Lu1, J Robison1, A Adam7, JA Crawford3, MV Pletnikov3, P Saavedra1, H Treviño1, K Maitani1,8, J Xu4, A Quiñones-Hinojosa1,6, H Guerrero-Cazares1, D Rigamonti1,2

1 Department of Neurosurgery, Johns Hopkins University, School of Medicine, Baltimore, USA2 Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia3 Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, School of Medicine,

Baltimore, USA4 F. M. Kirby Research Center for Functional Brain Imaging at the Kennedy Krieger Institute, Johns Hopkins

University, School of Medicine, Baltimore, USA5 Department of Radiology and Radiological Science, Johns Hopkins University, School of Medicine,

Baltimore, USA6 Department of Oncology, Johns Hopkins University, School of Medicine, Baltimore, USA7 Johns Hopkins Biostatistics Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA8 Tohoku University School of Medicine, Japan

INTRODUCTION: Normal Pressure Hydrocephalus (NPH) is a communicating form of hydrocephalus with slow-onset ventriculomegaly and late symptomatology. The Subventricular Zone (SVZ) of the lateral ventricles has been established as the primary site for adult neurogenesis. Few studies have focused on the potential impact on the SVZ throughout the course of NPH. We studied the SVZ stem cell population in a novel animal model of adult chronic communicating hydrocephalus.

METHODS: We injected Kaolin bilaterally into the subarachnoid space overlying the cranial convexities in 15 adult rats. We performed sham surgery (saline_injection) in 5 animals, and used 5 additional not-injected animals as controls. We obtained MRI using a 11.7T scanner at 15, 60, 90 and 120 days post kaolin injection (KI). Behavioral evaluations were performed independently every two weeks. KI animals were sacrificed at 15, 90 and 120 days after the injection. Immunofluorescence staining against neural progenitor markers, Nestin and GFAP, as well as proliferation markers, Ki67, was utilized to identify proliferating SVZ cells.

RESULTS: 86% of the KI animals demonstrated radiological evidence of ventricular enlargement (VE). Evans Index showed a linear VE progression over time. Initial clinical presentation was locomotor activity decline at one month, followed by balance, coordination, and memory deficits at 3 months. SVZ stem cell proliferation rate remained similar between experimental and control groups throughout the study.

CONCLUSIONS: Chronic communicating hydrocephalus in our model eventually leads to locomotor and cognitive changes without affecting the proliferation rate of the SVZ stem cells.

Abstracts


108

VENTRICULAR-ATRIAL SHUNTING COMPLICATIONS RATE IN NORMAL PRESSURE HYDROCEPHALUS. A SINGLE SURGEON PRACTICE EXPERIENCE.T Vivas-Buitrago1, J Lu1, J Robison1, A Hung1, A Adam2, E Sankey1, D Moran1, S Vakili1, MA Patel1, I Jusué-Torres1, B Elder1, CR Goodwin1, D Rigamonti1,3

1 Department of Neurosurgery, Johns Hopkins University, School of Medicine, Baltimore, USA2 Johns Hopkins Biostatistics Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA3 Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia

INTRODUCTION: Cerebrospinal fluid diversion has been the gold-standard treatment for normal pressure hydrocephalus (NPH). Ventriculoatrial shunting (VAS) is one of these diversion strategies. VAS is thought to be an invasive procedure associated with high risk of severe cardiopulmonary complications. However, few studies have focused on this topic, being the majority out of date considering the recent surgical and technological advances. Further research is required to better understand the current rate of complications associated to the VAS.

METHODS: A retrospective chart review was conducted on all patient undergoing a VA shunt placement as primary treatment for NPH by the senior author between 1993 to 2014 at the Johns Hopkins Medical Institution. Analysis includes any complication related to the procedure within the period immediately after surgery until last follow-up.

RESULTS: 150 patients underwent VA shunt-surgery. 87 were male. Age ranged from 48 to 87 years. 26% of the patients had post-surgical complications. Most common complication was Subdural-Hematoma/Hygroma (SDH) presented in 17% of all VAS patients, with no need of surgical evacuation. Shunt-obstruction occurred in 7% of patients, over-drainage in 9%. Surgical revisions were needed in 11% of all cases.

CONCLUSIONS: No cardio-pulmonary complications occurred in this study. Further analysis and comparison with our ventriculoperitoneal shunted patient’s data will be done to compare the complication rates between these two techniques.

Abstracts


109

CSF DISTRIBUTION IN IDIOPATHIC NORMAL-PRESSURE HYDROCEPHALUS AND ALZHEIMER DISEASES Yamada1, M Ishikawa1, Y Iwamuro2, K Yamamoto2

1 Normal Pressure Hydrocephalus center, Rakuwakai Otowa Hospital, Kyoto, Japan2 Department of Neurosurgery and Stroke center, Rakuwakai Otowa Hospital, Kyoto, Japan

INTRODUCTION: The differences in intracranial CSF volume and distribution between iNPH and AD have not been well described. Using CSF segmentation and volume quantification, we compared the distribution of CSF in iNPH and AD.

METHODS: CSF volumes were extracted from T2-weighted 3-dimensional spin-echo sequence on 3-Tesla MRI and quantified semiautomatically. We compared the volumes of the ventricles and subarachnoid spaces after classification in 30 patients diagnosed with iNPH, 10 concurrently with iNPH and AD, 18 with AD, and 26 control subjects aged ≥ 60 years old.

RESULTS: The mean ventricular volumes in iNPH, iNPH with AD, AD and the controls were 162 mL, 148 mL, 119 mL and 62 mL, respectively. Although the mean volumes of the total subarachnoid spaces were not significantly different among the four groups, the convexity part of subarachnoid spaces in the iNPH and iNPH with AD groups was significantly smaller than that in the AD and control groups. The basal cistern and Sylvian fissure in the iNPH, iNPH with AD, and AD groups had similar mean volumes that were significantly larger (>30 mL) than that in the control group. The z-axial expansion of the lateral ventricle in iNPH was significantly associated with the enlargement of the basal cistern and Sylvian fissure.

CONCLUSIONS: The most distinct morphological characteristics in iNPH and iNPH with AD were z-axial expansion of the bilateral ventricles in concurrence with enlargement of the basal cistern and Sylvian fissure and diminishment of the convexity part of the subarachnoid spaces.

Abstracts


110

EVALUATION OF HYDROCEPHALUS AFTER SEVERE OBSTRUCTIVE INTRAVENTRICULAR HEMORRHAGE AS A RISK FACTOR FOR POOR FUNCTIONAL OUTCOME IN THE CLEAR III TRIALWC Ziai1, V Eslami1, S Nekoovaght-Tak1, R Dlugash1, G Yenokyan2, N McBee1, DF Hanley1

1 Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, USA2 Department of Biostatistics, The Johns Hopkins University Bloomberg School of Public Health, Baltimore,

USA

INTRODUCTION: The impact of acute hydrocephalus on outcomes in adult spontaneous intraventricular hemorrhage is unstudied. We explore association between imaging biomarkers of hydrocephalus and functional outcomes in the Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage (CLEAR) III trial.

METHODS: We analyzed diagnostic and day 30 CT scans from all 500 patients. We measured bicaudate index, frontooccipital horn ratio, and Evan’s index and estimated association of indices with blinded assessment of stroke severity at day 30 and 180. Generalized linear models were used to estimate whether Evan’s index correlates with functional outcomes, after adjusting for confounders.

RESULTS: Evan’s index at day 30 had stronger correlation with both diagnostic and end of treatment IVH volume than other indices. Only bicaudate index was significantly associated with alteplase treatment (median[iqr] 0.21[.18,.24] vs. 0.22[.19,.25]; p=0.02). Indices did not differ by permanent shunt status. Patients were categorized into tertiles of Evans index. Proportion of patients with poor day 30 modified Rankin Scale increased in successive tertiles (p<0.001). Adjusted odds ratio for highest tertile vs. lowest was 3.19 (95%CI: 1.45, 7.05; p=0.004). Day 30 Barthel Index, Mini mental status exam, Stroke Impact Scale (SIS) and all but one domain-specific SIS score were inversely associated with Evan’s and bicaudate index. Day 180 functional outcomes were not associated with hydrocephalus indices.

CONCLUSIONS: Extent of ventricular dilatation after IVH is a strong risk factor for poor early functional outcome independent of known severity factors. Persistent hydrocephalus may adversely affect outcomes despite early use of EVD, and intraventricular alteplase treatment.

UsefulInformation




Use

ful I

nfor

mat

ion

Useful Information


113

Official LanguageThe official language of the Meeting is English.

Venue and DatesHydrocephalus 2016 Cartagena, the 8th Meeting of the International Society for Hydrocephalus and Cerebrospinal Fluid Disorders is being held on October 8-10 at Hilton Cartagena Hotel.

AddressAvenida Almirante BrionEl Laguito, CartagenaColombiaTel: +57-5-6948000Website: www3.hilton.com

Social EventsWelcome Reception, Jardines at Hilton HotelFriday, October 7, 2016 20:00

Colombian Dinner, Baluarte San Francisco JavierSaturday, October 8, 2016 19:30

Gala Dinner, Santa Clara Cartagena - Capilla Del Convento Chapel at Sofitel HotelSunday, October 9, 2016 20:00

Industry-sponsored Lunch Seminars Saturday, 8 October 2016 12:30-14:00Lunch Seminar by

Sunday, 9 October 2016 12:30-14:00Lunch Seminar by

Go to the map

Useful Information


114

3

45

6

1 2

CON

FER

ENC

ER

OO

M

FOY

ER

Gra

n S

alón

Bol

ívar

EXIT

Frei

gh

tEl

evat

or

Smo

kin

gZo

ne

Firs

t Flo

or

Lob

by

WC

Fem

ale

WC

Mal

e

EXIT

EXIT

EXIT

EXIT

EXIT

MEZ

AN

INE

Saló

n C

arta

gen

a d

e In

dia

sF

Post

er A

rea Registration

1,75

m

2,94

m

2,40

m

2,20

m

Doo

r Hei

ght

2,05

m

Doo

r Hei

ght

2,05

mM

axim

um H

eig

ht5,

40m

Foye

r Max

imum

Hei

ght

: 2,5

0mM

axim

um H

eigh

t for

C, D

, E: 2

,50m

Max

imum

Hei

ght f

or M

ezan

ine:

2,5

0m

Max

imum

Hei

ght

for A

: 5,2

0m

A DC

E

2,20

m

2,20

m

0,90

m

2,20

mD

oor H

eig

ht 2

,05m

Doo

r Hei

ght

2,0

5mD

oor H

eig

ht 2

,05m

1,90

m

3,11

m

2,60m

2,00

m2,

00m

2,00

m

VENUE FLOOR PLAN 1

Codm

an N

euro

36 m

2

2M

edtr

onic

18 m

2

3M

oelle

r Med

ical

Gm

bH9

m2

4So

phys

a6

m2

5B.

Brau

n Ae

scul

ap6

m2

6An

unci

a, In

c.3

m2

Useful Information


115

Secretariat & Information Desk The Secretariat Desk will be located at the Meeting Venue and will operate:

Saturday, 8 October 2016, 08:00 - 18:00Sunday, 9 October 2016, 08:00 - 18:00Monday, 10 October 2016, 08:00 - 18:00

Tel.: +30 2310257808 (direct line), +30 2310272275Fax: +30 2310272276E-mail: [email protected]: www.hydrocephalus-meeting.com

Name BadgeΤhe Name Badge needs to be worn to get access to the Meeting’s sessions and its events.

Internet FacilitiesWI-FI connection is provided at the Meeting premises (at an extra charge in the rooms). For any further information please contact the Meeting Secretariat.

Suggested Dress CodesCasual throughout the Meeting SessionsGala Dinner: Business Casual

Useful Information


116

SPONSORS ACKNOWLEDGMENTS

The Organizing Committee of “Hydrocephalus 2016 Cartagena, the 8th Meeting of the International Society for Hydrocephalus and Cerebrospinal Fluid Disorders” would like to thank the sponsors and exhibitors for their contribution and support to the Meeting.

Platinum Sponsor

Gold Sponsor

Sponsor of Lunch Seminar

+The StrataMR valves are intended to maintain performance level setting under magnetic resonance imaging (MRI) exposure when scanned in accordance with the MR conditions in the labeling. The valve setting should be veri� ed following MRI exposure.

CAUTION: Federal Law (USA) restricts this device for sale by or on the order of a physician. Refer to product instruction manual/package insert for instructions, warning, precautions and contraindications.

©2016 Medtronic plcUC201608283ENAll Rights Reserved. StrataMR ™ is a trademark of Medtronic plc

+Simplicity, quality, convenience for managing hydrocephalus and other CSF disorders

StrataMR™

Adjustable Pressure Valve and Handtools

YOUREXPERTISEOURTECHNOLOGY

medtronicneurosurgery.com

Index




Inde

x

Index


121

AAdam, A . . . .11, 12, 15, 18, 25, 26, 27, 28, 29, 30,

90, 91, 92, 105, 106, 107, 108Ahmadi, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

Akiba, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84

Alafuzoff, I . . . . . . . . . . . . . . . . . . . . . . . . . 73, 74, 78Al-Ghamdi, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28

Almeida-Lopes, L . . . . . . . . . . . . . . . . . . . . . .85, 86Almotairi, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .102

Al-Mutawa, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28

Alperin, N . . . . . . . . . . . . . . . . . . . . . . . . . 14, 31, 35Aquilina, K. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56

Arai, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84

Asgari, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .17, 32Aygok, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4

BBach, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89

Badran, N . . . . . . . . . . . . . . . . . . . . . . . . . 25, 26, 28Baghawatti, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56

Balardy, L . . . . . . . . . . . . . . . . . . . . . . . 34, 76, 93, 95Balédent, O . . . . . . . 11, 13, 15, 21, 33, 34, 35, 76Baudracco, I . . . . . . . . . . . . . . 36, 42, 43, 44, 79, 80Bechter, K . . . . . . . . . . . . . . . . . . . . . . . . . 14, 21, 37Beez, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

Belcher, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .26, 28Bermúdez, S . . . . . . . . . . . . . . . . . . . . . . . . . . .40, 41Bezerra, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87

Bilston, LE . . . . . . . . . . . . . . . . . . . . . . . . . 14, 22, 38Blitz, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .106

Bock, HC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

Bohner, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

Bradley, W . . . . . . . . . . . . . . . . . . . 12, 16, 21, 22, 39Buitrago, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41

Buttner-Ennever, JA . . . . . . . . . . . . . . . . . . . . . . . 96

CCalia, G. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87

Cárdenas, MF . . . . . . . . . . . . . . . . . . . 11, 13, 40, 41Carson, K . . . . . . . . . . . . . . . . . . . . . . . 27, 29, 30, 90Chandran, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81

Chater, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16

Cheng, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38

Cifuentes, H . . . . . . . . . . . . . . . . . . . . . . . . 4, 12, 14Clemens, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90

Cognard, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94

Cohen, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41

Cortes, W. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15

Craven, C. . . . . . . . . . . . . .17, 36, 42, 43, 44, 79, 80Crawford, JA . . . . . . . . . . . . . . . . . . . . . . . . 106, 107Cruz, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41

Curtis, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45

Czosnyka, Z . . . . . . . . . . . . . . . . . . . . 34, 76, 94, 95

DDasgupta, D . . . . . . . . . . . . . . . . . . . . 13, 16, 20, 45Davidson, JS . . . . . . . . . . . . . . . . . . . . . . . . . . .40, 41da Vigua, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85

Dawood, M. . . . . . . . . . . . . . . . . . . . . . . . . . . .26, 28de Oliveira, MF . . . . . . . . . . . . . . . . . . . . . . . . . . . 86

de Zélicourt, D . . . . . . . . . . . . . . . . . . . . . . . . . . . 32

Dlugash, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .110

Dobyns, WB . . . . . . . . . . . . . . . . . . . . . . . . . . . . .104

Doherty, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .104

Domínguez, L . . . . . . . . . . . . . . . . . . . . . . . . .15, 46Dutra, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87

EEdwards, R . . . . . . . . . . . . . . . . . . . . . 14, 16, 20, 47Eklund, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60

Elder, B . . . . . . . . . . 15, 17, 48, 49, 50, 51, 105, 108Eleftheriou, A . . . . . . . . . . . . . . . . . . . . . . . . . .15, 52Eslami, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .110

FFabre, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94

Fialho, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48, 50Filippidis, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22

Flores, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62

Foley, S . . . . . . . . . . . . . . . . . . . . . . . . . . . 27, 29, 30Fountas, KN . . . . . . . . . . . . . . . . . . . . . . . . . . .12, 53Fritsch, MJ . . . . . . . . . . . . . . . . . . . . . . 13, 54, 55, 99

Index


122

GGantet, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93

García, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40

Garnotel, S . . . . . . . . . . . . . . . . . . . . . . . . 33, 34, 76Garzon, M . . . . . . . . . . . . . . . . 14, 16, 18, 56, 57, 58Gehlen, M . . . . . . . . . . . . . . . . . . . . . . 12, 15, 59, 60Ghotme, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41

Giese, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

Gölz, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

Gomez, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . .18, 61González, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40

Goodwin, CR . . . . . . . . . . .48, 49, 50, 51, 105, 108Grainger, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58

Gray, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96

Grijalba, MA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46

Guenego, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94

Guerra, M . . . . . . . . . . . . . . . . . . . . . . 14, 18, 62, 63Guerrero-Cazares, H . . . . . . . . . . . . . . . . . 106, 107

HHaapasalo, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73

Hakim, C . . . . . . . . . . . . . . . . . . . . . . . 13, 15, 17, 18Hakim, F . . . . . . . . . . . . . . . . . . . 3, 4, 19, 40, 41, 61Hakim, R . . . . . . . . . . . . . . . . . . . . . . . . 4, 11, 18, 20Hall, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78

Hamilton, M . . . . . . . . . . . . . . . 4, 13, 14, 20, 64, 89Hammad, M . . . . . . . . . . . . . . . . . . . . . . . . . . .26, 28Hanley, DF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .110

Häyrinen, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66

Heldt, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21

Helisalmi, S . . . . . . . . . . . . . . . . . . . . . 72, 73, 75, 78Hellström, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69

Herrmann, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

Herukka, SK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78

Herzka, DA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .106

Hiltunen, M . . . . . . . . . . . . . . . . . . . . . . . 73, 75, 78Hockley, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64

Hoffberger, J . . . . . . . . . . . . . . . . 27, 29, 30, 51, 90Holubkov, R . . . . . . . . . . . . . . . . . . . . . . . . . . .64, 89Hung, A . . . . . . . . . . . . . . . .48, 49, 50, 92, 105, 108Huovinen, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75

IIsaacs, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64

Ishikawa, M. . . . . . . . . . . . . . . . . 12, 19, 20, 65, 109Iwamuro, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .109

JJääskeläinen, JE . . . . . . . . . . . 66, 71, 73, 74, 75, 78James, G . . . . . . . . . . . . . . . . . . . . . . . . . . 56, 57, 58Januel, AC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94

Jara, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62

Jeelani, O . . . . . . . . . . . . . . . . . . . . . . . . . . . . .57, 58Jeon, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48, 50Jimenez, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63

Jones, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4

Jose, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25, 26, 28Jugé, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38

Juhler, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .4, 11Jumaly, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88

Junkkari, A . . . . . . . . . . . . . . . . . . . . . . . . 17, 66, 78Jurjević, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82

Jusué-Torres, I . . . . . . . . 27, 29, 30, 48, 49, 50, 51,90, 105, 106, 107, 108

KKang, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56

Kapsalaki, EZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53

Kapsalakis-Fountas, E . . . . . . . . . . . . . . . . . . . . . 20

Karagiozov, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84Kästner, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

Katzen, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89

Kawauchi, D . . . . . . . . . . . . . . . . . . . . . . . 16, 67, 83Kehler, U . . . . . . . . . . . . . . . . . . . . . . . . 4, 13, 17, 68Khan, AA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45

Klinge, P . . . . . . . . . . . . . . . . . . . . 15, 21, 27, 29, 30Kockum, K. . . . . . . . . . . . . . . . . . . . . . . . . . . . .20, 69Koivisto, AM . . . . . . . . . . . . . . . . . 66, 71, 74, 75, 78Kojoukhova, M . . . . . . . . . . . . . . 16, 17, 70, 71, 78Korhonen, V . . . . . . . . . . . . . . . . . . . . . . . 17, 72, 74Kukull, WA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .104

Kurki, MI . . . . . . . . . . . . . . . . . . . . . . . . . . 73, 74, 75Kurtcuoglu, V . . . . . . . . . . . . . . . . . . . 21, 32, 59, 60

Index


123

LLaiterä, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .17, 73Larsson, EM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69

Laurell, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69

Leinonen, V . . . . . . . 16, 66, 71, 72, 73, 74, 75, 78Lemcke, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

Lilja-Lund, O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69

Limbrick, DD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63

Liu, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51

Lokossou, A . . . . . . . . . . . . . . . . . . . . 16, 34, 35, 76Lopez, ER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55

Loth, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77

Lötjönen, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78

Luciano, M . . . . . . . . . . . . . . . . . . . . . 12, 21, 77, 97Luikku, A . . . . . . . . . . . . . . . . . . . . . . . . . . 13, 66, 78Lu, J . . . . . . . .25, 26, 27, 28, 29, 30, 48, 49, 50, 51,

90, 91, 92, 105, 106, 107, 108Lundin, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52

MMaghaslah, M . . . . . . . . . . . . . . . . . . . . . . . . .26, 28Mahieu, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94

Maitani, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .107

Malm, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60

Mancini, MW . . . . . . . . . . . . . . . . . . . . . . . . . .85, 86Martin, B . . . . . . . . . . . . . . . . . . . . . . . . . . . 4, 22, 77Martinez, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41

Matiz, MC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41

Matloob, S . . . . . . . . . . . . . . . 36, 42, 43, 44, 79, 80Matsutani, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67

Mattila, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78

Maykot, RH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87

Mayorga, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41

McAllister, P . . . . . . . . . . . . . . . . . . . . . . . . . . .21, 63McBee, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .110

McMahon, C . . . . . . . . . . . . . . . . . . . . . . . . . .19, 81Mehlig, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103

Mejía, JA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41

Mendes, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87

Miyajima, M . . . . . . . . . . . . . . . . . . . . . . . 13, 82, 84Modesto, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87

Moghekar, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88

Morales, DM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63

Mora, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41

Moran, D . . . . . . . . . . . . . . . . . . 48, 49, 50, 105, 108Moreno, I. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62

Mori, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .106

Murai, H . . . . . . . . . . . . . . . . . . . . . . . . . . . 19, 67, 83Murcia, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41

NNakajima, M . . . . . . . . . . . . . . . . . . . . . . . 12, 82, 84Naqvi, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91

Nekoovaght-Tak, S . . . . . . . . . . . . . . . . . . . . . . .110

Nerg, O . . . . . . . . . . . . . . . . . . . . . . . . . . . 66, 74, 78

OO’Connor, J . . . . . . . . . . . . . . . . . . . . . . . . . . . .57, 58Ogino, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84

Oliveira, MF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87

Omoush, O . . . . . . . . . . . . . . . . . . . . . . . . 26, 28, 91Omrani, O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57

Onouchi, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98

Orakciouglu, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

Ortega, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62

Ory-Magne, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93

PPaananen, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75

Page, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34, 76Papisov, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21

Patel, MA . . . . . . . . . . . . . . . . . . . . . . . . 51, 105, 108Payoux, P. . . . . . . . . . . . . . . . . . . . . . . . . . 34, 76, 93Petitto, CE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87

Pinto, FCG . . . . . . . . . . . . . . . . . . . 11, 19, 85, 86, 87Pletnikov, MV . . . . . . . . . . . . . . . . . . . . . . . 106, 107Polemikos, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

Pong, AC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38

Pulhorn, H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81

Pursiheimo, J-P . . . . . . . . . . . . . . . . . . . . . . . . . . . 73

QQuiñones-Hinojosa, A . . . . . . . . . . . . . . . 106, 107

Index


124

RRamón, JF . . . . . . . . . . . . . . . . . 4, 11, 16, 40, 41, 61Rao, AS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .19, 88Rauramaa, T . . . . . . . . . . . . . . . . . 66, 71, 72, 73, 74Reis, RC . . . . . . . . . . . . . . . . . . . . . . . . . . . 85, 86, 87Reizo, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4

Rekate, H . . . . . . . . . . . . . . . . . . . . . . . 16, 18, 21, 22Relkin, N . . . . . . . . . . . . . . . . . . . . . . . . . . 11, 31, 89Remes, AM . . . . . . . . . . . . . . . . . . 72, 73, 74, 75, 78Remolina, AJ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46

Rigamonti, A . . . . . . . . . . . . . . . . . . . . . . . . . .19, 90Rigamonti, D . . . . 4, 12, 19, 25, 26, 27, 28, 29, 30,

48, 49, 50, 51, 90, 91, 92, 105, 106, 107, 108Rigamonti, K . . . . . . . . . . . . . . . . . . . . . . . . . .19, 91Riklund, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69

Riveros, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41

Robison, J . . . . . .19, 25, 26, 27, 28, 29, 30, 48, 49,51, 53, 90, 91, 92, 105, 106, 107, 108

Rodriguez, EM . . . . . . . . . . . . . . . . . . . . . 16, 62, 63Rodríguez, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62

Rohde, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

Roine, RP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66

Rosengren, A . . . . . . . . . . . . . . . . . . . . . . . . . . . .103

Rummukainen, J . . . . . . . . . . . . . . . . . . . 71, 74, 78

SSalas, JE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .16, 18Salmon, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33

Sandhu, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56

Sankey, E . . . . . . . . . . . . . . . . . . . . . . . . 90, 105, 108Sankey, EW . . . . . . . . . . . . . . . . . . . . . 48, 49, 50, 51Sanyal, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90

Sattar, A . . . . . . . . . . . . . . . . . . . . . . . . . . . 26, 28, 91Savolainen, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74

Schaumann, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

Schmid-Daners, M . . . . . . . . . . . . . . . . . . . . .59, 60Schmidt, E . . . . . . . . 13, 14, 19, 34, 76, 93, 94, 95Schuhmann, M . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

Schuster, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

Sevestre, MA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35

Sharkey, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90

Shin, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .67, 83Silvestre, SSS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87

Sintonen, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66

Sival, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63

Smisson, HF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53

Söderström, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69

Soininen, H . . . . . . . . . . . . . . . . . . 66, 73, 74, 75, 78Solje, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72

Solomon, D . . . . . . . . . . . . . . . . . . . . 19, 88, 96, 97Soto, HA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41

Sousa, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87

Stockhammer, F . . . . . . . . . . . . . . . . . . . . . . . . . . 99

Sutela, A . . . . . . . . . . . . . . . . . . . . . . . . . . 71, 74, 78Szeöke, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

TTakagi, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .19, 98Tall, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94

Teixeira, MJ . . . . . . . . . . . . . . . . . . . . . . . . . . . .85, 86Thai, QA . . . . . . . . . . . . . . . . . . . . . . . . . . . 27, 29, 30Thomale, UW . . . . . . . . . . . . . . . . . . . . . . . . . .20, 99Thompson, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56

Thompson, S . . .12, 15, 18, 20, 36, 42, 43, 44, 79, 80, 100, 101Thorne, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45

Thorne, LD . . . . . . . . . . . . . . . . . . . . . . . . . 100, 101Timonen, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71

Tisell, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20, 102Toma, AK . . . . . 36, 42, 43, 44, 45, 79, 80, 100, 101Torén, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103

Tornai, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87

Toscano, M . . . . . . . . . . . . . . . . . . . . . . . . . . . .11, 18Treviño, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .107

Tullberg, M . . . . . . . . . . . . . . . . . . . . . . . . . . 13, 103Tully, HM . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14, 104

UUrbaneja, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64

Useche, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . .40, 41

VVajkoczy, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

Index


125

Vakili, S . . . . . . . . . . . . . . . . . . . . 48, 49, 50, 105, 108Valêncio, CG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85Vallejo, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41Vanha, KI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71Vanninen, R . . . . . . . . . . . . . . . . . . . . . . . 71, 72, 74Viinamäki, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66Vío, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62Vivas-Buitrago, T . . . . . . 18, 20, 25, 26, 27, 28, 29,

30, 90, 91, 92, 105, 106, 107, 108

WWatkins, LD . . . . . . . . . . . . . . 4, 18, 36, 42, 43, 44,

45, 79, 80, 100, 101Wemmer, J . . . . . . . . . . . . . . . . . . . . . . . . 27, 29, 30Wenger, TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .104Whitehouse, KJ . . . . . . . . . . . . . . . . . . . . . . . . . . . 47Wikkelsø, C . . . . . . . . . . . . . . . . . . . . 11, 13, 19, 103Williams, M . . . . . . . . . . . . . . . . . . . . . . . . . 4, 11, 89

XXu, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106, 107

YYamada, S . . . . . . . . . . . . . . . . . . . . . . . . 14, 65, 109Yamamoto, K . . . . . . . . . . . . . . . . . . . . . . . . 65, 109Yang, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103Yasar, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27, 29, 30Yenokyan, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . .110

ZZetterberg, H . . . . . . . . . . . . . . . . . . . . . . . . 73, 103Ziai, WC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12, 110Zitoun, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35Zuspan, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89

Notes




Not

es

Notes


129

Notes


130

Notes


131

Notes


132

Notes


133

Notes


134

Notes


135

Notes


136

See youon 22-25 September 2017

in Kobe, Japan!

International Society for Hydrocephalusand Cerebrospinal Fluid Disorders

www.ishcsf.com

cartagena, colombia october 8-10 - ishcsf 2016 abstract book.pdf · hydrocephalus 2016 cartagena,...

Documents